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Twins, especially identical twins, have fascinated humanity over the cen-
turies. In perinatology, however, fascination for the twinning process is 
often outweighed by concerns due to increased medical complications 
associated with twin pregnancies. Perinatal mortality and morbidity in 
twins is significantly increased compared to singletons, partly due to 
a higher incidence of prematurity and very low birth weight in twins1. 
Mortality is reported to be 3 to 7-fold higher in twins than in singletons2, 
whereas morbidity, particularly risk of cerebral palsy, is 7-fold higher in 
twins than in singletons1. Risk of adverse outcome is particularly pro-
nounced in monochorionic twins. Perinatal mortality in monochorionic 
twins is 2.5-fold higher than in dichorionic twins3, whereas neurological 
morbidity is 7-fold higher in preterm monochorionic twins than in preterm 
dichorionic twins4. Adverse outcome in monochorionic twinning is due to 
complications associated with the presence of placental vascular anasto-
moses. 
Vascular anastomoses are extremely rare in dichorionic placentas but 
ubiquitous in monochorionic placentas5, and may lead, amongst other 
complications, to twin-to-twin transfusion syndrome (TTTS). TTTS occurs 
in approximately 15% of monochorionic twin pregnancies6. TTTS usually 
develops during the 2nd trimester of pregnancy, resulting in hypovolemia, 
oliguria and oligohydramnios in the donor twin and hypervolemia, polyuria 
and polyhydramnios in the recipient twin6. TTTS is associated with high 
perinatal mortality and morbidity. In the past, diagnosis of TTTS was 
based on neonatal criteria such as birth weight discordance and hemo-
globin difference. Nowadays, diagnosis of TTTS is reached strictly on 
prenatal ultrasound criteria. The main diagnostic criterion for TTTS is the 
twin oligo-polyhydramnios sequence (TOPS). A significant evolution in 
prenatal care strategies and management options for patients with TTTS 
has occurred during the last decade. The two main therapeutic options in 
TTTS are serial amniodrainage and fetoscopic laser occlusion of commu-
nicating placental vascular anastomoses6. Fetoscopic laser surgery is a new 
treatment modality that has led to an increase in survival rates. In perina-
tology, a decrease in mortality rates may be associated with an increase in 
morbidity rates. Follow-up studies in infants with TTTS are shedding more 
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light on the wide range of morbidity associated with TTTS, such as neuro-
logical, cardiac and renal sequelae.
Since monochorionic twinning is known to occur worldwide in 1 in every 
400 pregnancies6, the estimated number of TTTS cases in The Netherlands 
is approximately 75 cases per year. The majority of TTTS cases in The 
Netherlands are referred to the Leiden University Medical Center (LUMC). 
The LUMC is a tertiary medical center and serves as the national referral 
center for fetal therapy, including fetoscopic laser surgery for TTTS. The 
laser surgery program at the LUMC started in August 2000. 
Outline of the thesis
In June 2002 the Leiden’s TTTS study (LETTS’ study) was started. The aim 
of this prospective study was to investigate the short-term and long-term 
outcome in TTTS treated with fetoscopic laser surgery. With an intense 
and ongoing collaboration between the obstetric and neonatology depart-
ments of the LUMC, several other study projects associated with the patho-
genesis, diagnosis and treatment of TTTS were also initiated. The aim of 
these studies can be summarized as follows:
Chapter 2 - Review of the literature on TTTS. This review analyzes the pos-
sible pathophysiologic mechanisms involved, discusses the latest findings 
in diagnosis, therapy and prognosis, and focuses on neonatal and pediatric 
morbidity associated with TTTS.
Chapter 3  - Description of a novel technique to determine the net feto-fetal 
blood flow through placental arterio-venous anastomoses in a unique case 
of TTTS. 
Chapter 4  - Study on the role of velamentous umbilical cord insertion and 
discordant placental territories in the pathogenesis of TTTS by comparing 
monochorionic placentas with and without TTTS. 
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Chapter 5 - Study on the frequency of residual placental vascular anasto-
moses after fetoscopic laser surgery for TTTS in relation to associated risks 
and outcome. 
Chapter 6  - Description of a new form of TTTS, named twin anemia-polycy-
themia sequence (TAPS), not associated with the characteristic twin oligo-
polyhydramnios sequence (TOPS) found in TTTS. 
Chapter 7 - Study on hemoglobin differences at birth in monochorionic 
twins without TTTS compared to a control group of dichorionic twins, in 
relation to birth order and placental vascular anatomy. 
Chapter 8 - Study on the neonatal outcome in TTTS survivors treated with 
fetoscopic laser surgery compared to a control group of monochorionic 
twins without TTTS.
 
Chapter 9 - Study on the short-term neurological outcome in TTTS sur-
vivors treated with fetoscopic laser surgery compared to a control group of 
monochorionic twins without TTTS, using cranial ultrasonography.
Chapter 10 - Study on the short-term cardiac outcome in TTTS survivors 
treated with fetoscopic laser surgery compared to a control group of 
monochorionic twins without TTTS, using echocardiography. 
Chapter 11 - Study on the long-term outcome in TTTS treated conservatively 
at the LUMC between January 1990 and December 1998.
Chapter 12 - Study on the long-term outcome in TTTS treated with feto-
scopic laser surgery at the LUMC between August 2000 and December 
2003.
Chapter 13 - General discussion concerning the results of these studies.
Chapter 14 - Future perspectives and proposals for future research. 
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Introduction
Twin-to-twin transfusion syndrome (TTTS) is a complication of 
monochorionic twin gestations and is one of the most lethal conditions 
in perinatal medicine. TTTS is thought to result from an unbalanced net 
transfusion of blood between one twin, the donor, and the other twin, 
the recipient, via placental vascular anastomoses. In the 19th century, 
Friedrich Schatz, a German obstetrician, extensively studied the twinning 
process and was the first to speculate on the relationship between 
vascular anastomoses and the development of TTTS7. The number, size 
and type of these anastomoses appear to play an important role in the 
etiology of TTTS8. Despite a growing understanding of TTTS, the exact 
pathophysiology remains to be elucidated. Various new hypotheses 
question the validity of the classic concept of TTTS resulting mainly 
from inter-twin transfusion of blood. Recently, a staging system based 
on antenatal ultrasound findings has been introduced and appears to 
have prognostic significance9. Most importantly, this staging system may 
be used to compare various therapeutic modalities in TTTS. The two 
main current treatment options in TTTS are serial amnioreduction and 
fetoscopic laser occlusion of vascular anastomoses. Both treatments 
are associated with improved survival rates. The first randomized trial 
designed to compare the effectiveness of these two therapeutic options 
has recently been published and has shown that fetoscopic laser surgery is 
associated with less mortality and less short-term neurological morbidity 
than serial amnioreduction10. The results of other ongoing randomized 
trials are eagerly awaited. Despite the improvement in overall survival 
rates, mortality and morbidity rates remain strikingly high, especially in 
TTTS managed expectantly or with serial amnioreduction. A high risk of 
long-term neurodevelopmental disability has been reported, particularly 
after intrauterine fetal demise of a co-twin during the second or third 
trimester11-16. Severe cerebral damage in the surviving monochorionic twin 
may even occur during the first trimester17. In TTTS with double survival, 
recipient twins are at risk for life-threatening cardiovascular complications 
such as hypertrophic cardiomyopathy and right ventricular outflow tract 
obstruction18;19, whereas donor twins are at risk for acute or chronic renal 
failure due to chronic renal hypoperfusion20;21.  
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This review examines the various theories on the pathogenesis of TTTS, 
describes the diagnostic tools and criteria, discusses some of the 
randomized trials on the efficacy of various treatments and focuses on 
neonatal and pediatric morbidity associated with TTTS.
The twin-to-twin transfusion syndrome
Several forms of TTTS have been described: chronic, acute perimortem, 
acute perinatal and twin reversed arterial perfusion sequence11. The 
chronic form of TTTS is the most common form and complicates about 
10 to 15% of monochorionic twin pregnancies22-24. Chronic TTTS usually 
becomes clinically apparent during the second or early third trimester 
of pregnancy. Recent reports suggest that chronic TTTS may occur even 
in the first trimester of pregnancy25;26. Clinical symptoms are due the 
rapid development of polyhydramnios, causing maternal discomfort, 
premature rupture of the membranes, or preterm labor. Chronic TTTS 
is then diagnosed if the oligo-poyhydramnios sequence is detected on 
ultrasound examination27. The donor twin has severe oligohydramnios due 
to hypovolemia and oliguria and appears tightly wrapped in his amniotic 
sac and “stuck” to the uterine wall despite changes in maternal position, 
hence referred to as the “stuck” twin. Conversely, the recipient twin has 
severe polyhydramnios due to hypervolemia and polyuria. In the most 
severe cases, the recipient may subsequently develop circulatory volume 
overload and fetal hydrops. Inter-twin growth discrepancy and hemoglobin 
discordance are often reported, but are not key criteria for the diagnosis 
of chronic TTTS27-29. Both fetuses are at risk for intrauterine fetal demise, 
either due to hypoxia and anemia in the donor, or cardiac failure in the 
recipient. Moreover, both fetuses may die as a result of preterm delivery. 
An acute form of TTTS, referred to as acute perimortem TTTS, occurs after 
intrauterine fetal demise of a co-twin and is due to acute exsanguination 
from the surviving twin into the low-pressure circulation of the demised 
co-twin through the vascular anastomoses30-32. Acute exsanguination often 
leads to co-twin death or may lead to severe hypoxic-ischemic damage in 
the surviving twin due to hypovolemia, hypotension and anemia, resulting 
in co-twin death, multicystic encephalomalacy and multi-organ 
damage12-16;33. 
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Anecdotal reports suggest that acute TTTS may also occur during 
delivery34-39. This form of TTTS, often referred to as acute perinatal 
TTTS, may then lead to a difference in hemoglobin concentration at birth 
between the donor and the recipient twin without necessarily discordance 
in birth weight40-44. Acute shifts of blood from one twin to the other 
are thought to result from blood pressure differences due to uterine 
contractions or changes in fetal positions36;44;45. The donor twin has often 
signs of acute hemorrhagic hypovolemic shock and requires treatment 
with urgent blood transfusion or volume expanders35-37. Research data on 
acute perinatal TTTS is however extremely scarce. Hemoglobin differences 
between monochorionic twins at birth have also been shown to be related 
to birth order35;38;46. In a recent study in monochorionic twins without 
chronic TTTS, we reported that hemoglobin levels in second-born twins are 
significantly higher than in first-born twins47. Once the umbilical cord of the 
first-born twin is clamped, the second-born twin has the sole connection to 
the entire placenta and may not only receive blood from its own placenta 
but also from the placenta-share of the co-twin, through the vascular 
anastomoses38;41.   
The most extreme form of TTTS is acardiac twinning, which occurs in 1 
out of 35 000 pregnancies48. Acardiac twinning, also named twin reversed 
arterial perfusion sequence, occurs when a large arterio-arterial and 
veno-venous shunt is present, causing reversed flow in the single umbilical 
artery of the acardiac fetus. The acardiac fetus is severely malformed 
without a functional heart. The donor twin is otherwise structurally normal 
and is referred to as the pump twin as it pumps blood both into its own 
circulation as well as directly into the circulation of the acardiac co-twin. 
The pump twin is therefore also at risk for intrauterine fetal demise due to 
high output cardiac failure.
Incidence
Twin gestations represent 1 to 2% of all pregnancies. Two thirds of twin 
gestations are dizygotic (therefore always dichorionic) and are not at 
risk for developing TTTS. One third of twin gestations are monozygotic 
and may give rise to either monochorionic or dichorionic placentation. 
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Chorionicity in monozygotic twinning depends upon the time interval 
between fertilization and cleavage of the embryo49. Cleavage within 
three days of fertilization results in a dichorionic placentation, whereas 
cleavage occurring within four to eight days of fertilization will lead to 
a monochorionic placenta49. Two third of monozygotic pregnancies are 
monochorionic. Only monochorionic twins are at risk for developing 
TTTS. Approximately 10 to 15% of all monochorionic twin pregnancies will 
eventually develop chronic TTTS22-24. The incidence of acute perinatal TTTS 
is not known.
Increased infertility treatments have led to a higher rate of multifetal 
gestations. Twinning rate in the United States was 31 per 1000 total live 
births in 2002, an increased twinning rate of 65% since 1980 and 38% 
since 199050.  To date, approximately one million children world-wide 
were conceived through assisted reproductive technology, with associated 
rates of multifetal gestations up to 50%51;52. Most twins born after assisted 
reproduction techniques are dizygotic. However, various studies have also 
shown a significant increase in monozygotic twinning after various forms 
of infertility treatment such as in vitro fertilization related techniques (in 
particular blastocyst transfer), ovulation induction and intracytoplasmic 
sperm injection, mostly due to alterations on the zona pellucida53-56. 
Monozygotic twinning is increased 2 to 6 times in babies born after in vitro 
fertilization57-59. Consequently, increased rates of multifetal gestations due 
to infertility treatments may theoretically also lead to increased rates of 
TTTS.
Pathogenesis
The presence of placental vascular anastomoses is a conditio sine qua non for 
the development of TTTS. Injection studies of twin placentas have shown 
that such anastomoses are almost invariably present in monochorionic 
twins and extremely rare in dichorionic twins5. Three types of anastomoses 
have been documented: from artery to artery, from vein to vein and from 
artery to vein. Arterio-venous anastomoses are unidirectional and are 
referred to as “deep” anastomoses since they proceed through a shared 
placental cotyledon, whereas arterio-arterial and veno-venous anastomoses 
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are bi-directional and are referred to as “superficial” since they lie on the 
chorionic plate (Figure 1). Injection studies of monochorionic placentas 
have demonstrated that arterio-arterial, arterio-venous and veno-venous 
anastomoses are present in 80%, 95% and 20% of monochorionic 
placentas, respectively 60-62. 
The presence of at least one arterio-venous anastomosis has been shown 
to be essential for the development of chronic TTTS26;61-63. According 
to the classic pathophysiological concept, chronic TTTS is caused by 
net imbalance of blood flow between the twins due to arterio-venous 
anastomoses7;8. Blood from one twin (the donor) is pumped through an 
artery into the shared placental cotyledon and then drained through a 
vein into the circulation of the other twin (the recipient). Unless blood is 
pumped back from the recipient to the donor through oppositely directed 
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FiGURE 1 Placenta injection study with colored dye from a monochorionic twin gestation without chronic twin-to-
twin transfusion syndrome delivered after 38 weeks of gestation. Arteries are injected with dark-blue dye and veins 
with orange dye. The arrow at the bottom of the picture indicates an arterio-arterial anastomosis. An arterio-venous 
anastomosis from twin 2 to twin 1 is pointed out in the center of the picture, whereas an arterio-venous anastomosis 
from twin 1 to twin 2 is indicated at the top of the picture. Twin 2 has a velamentous cord insertion.
deep arterio-venous anastomoses or through superficial anastosmoses, an 
imbalance of blood volumes occurs, gradually leading to the development 
of chronic TTTS. The presence of arterio-arterial anastomoses in 
particular is thought to give some protection against the development of 
chronic TTTS by compensating for the circulatory imbalance caused by 
the uni-directional arterio-venous anastomoses7;8. Various studies have 
demonstrated that these bi-directional arterio-arterial anastomoses occur 
more frequently in monochorionic placentas of twins without chronic 
TTTS compared to placentas of twins with chronic TTTS around 80% 
and 25%, respectively 26;64-67. The antenatal detection of an arterio-arterial 
anastomosis with color Doppler ultrasound examination is associated with 
a 9-fold reduction in likelihood ratio of developing chronic TTTS68. This 
protective role of arterio-arterial anastomoses which was already proposed 
by Schatz in the 19th century7, has recently also been demonstrated in 
a mathematical computer model of chronic TTTS69. Conversely, the 
pathogenesis of acute perimortem and acute perinatal TTTS is mainly 
mediated through large superficial low-resistance arterio-arterial or veno-
venous anastomoses13;29-32;44;70;71.  
The validity of the traditional theory of unbalanced blood shunting from 
the donor to the recipient as the major factor causing the development of 
chronic TTTS has frequently been questioned. Several studies report the 
absence of differences in hemoglobin, erythropoietin and iron metabolism 
between donors and recipients72-74. However, these data are not in direct 
conflict with the classic pathophysiologic concept of inter-twin transfusion 
in TTTS and may simply reflect the inter-twin transfusion of blood 
components and various hormones through the vascular anastomoses. 
Several new hypotheses have been added to the classic pathophysiologic 
concept of TTTS and may also play a role in the pathogenesis of chronic 
TTTS (Table 1).
Significant higher concentrations of fetal atrial natriuretic peptide as well 
as brain natriuretic peptide have been found in recipient twins compared 
to donor twins75-78. The release of these peptides is stimulated by cardiac 
overload and causes increased fetal urine production, leading consequently 
to polyhydramnios and to the further development of chronic TTTS. The 
fetal renin-angiotensin system is reported to be up-regulated in donor 
twins due to hypovolemia and decreased renal perfusion79-81. Although 
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up-regulation of renin synthesis may be necessary to restore euvolemia 
in the donor, the activation of the renin-angiotensin system also leads 
to vasoconstriction and may further aggravate renal hypoperfusion and 
oligohydramnios in the donor twin. Similarly, raised concentrations 
of vasopressin were recently found in donor twins, suggesting that 
oligohydramnios may also result from the antidiuretic and vasoconstricitve 
activity of vasopressin82. Furthermore, vasoconstriction may contribute 
to placental dysfunction and aggravate intrauterine growth restriction 
in the donor. Activation of the renin-angiotensin system may also 
have a paradoxical effect in the recipient twin. Transfer of renin and 
angiotensin II through the vascular anastomoses from the donor into the 
hypervolemic recipient may increase the blood pressure and aggravate 
cardiac dysfunction in the recipient. Increased blood pressure has indeed 
often been reported in recipient twins after birth12;83 and may also be 
due to other vasoconstrictive substances circulating in the recipient twin. 
Various studies have demonstrated a significantly higher concentration of 
endothelin-1 in recipient twins compared to donor twins78;84;85. Endothelin-
1, a potent vasoconstrictor, may cause hypertension and therefore also 
aggravate cardiac dysfunction in the recipient. 
TABLE 1 Summary of theories on pathogenesis of chronic TTTS.
Author (year) Pathogenesis
Schatz (1882)7 Donor “pumps” blood into recipient through placental vascular 
 anastomoses
Schatz  (1882)7 Absent compensatory arterio-arterial anastomoses
Nageotte  (1989)75 Increased atriopeptin in recipient
Wieacker  (1992)77 Increased atriopeptin and decreased antidiuretic hormone in 
 recipient
Wax  (1992)92 Compression of placental vessels of donor
Fries  (1992)89 Compression of velamentous inserted cord of donor
Bajoria  (1999)84 Increased endothelin concentrations in recipient
Mahieu-Caputo (2000)80 Up-regulation of renin-angiotensin system in donor
Bajoria (2000)88 Reduced amino-acids levels in donor
Sooranna  (2001)87 Reduced leptin levels in donor
Bajoria  (2001)86 Reduced insulin-like growth factor II levels in donor
Bajoria  (2004)82 Increased vasopressin concentrations in donor
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Several other hormones, such as insulin-like growth factor-II and leptin 
may also contribute to the development of chronic TTTS. Levels of insulin-
like growth factor-II and leptin, both playing a role in intrauterine growth 
restriction, were recently reported to be significantly lower in donor 
twins, suggesting that growth restriction in the donor twin might result 
from abnormal placental development86;87. Similarly, lower essential and 
non-essential amino acids have been reported in growth restricted donor 
twins suggesting that fetal undernutrition may be partly due to impaired 
placental transport of amino acids88. 
Velamentous cord insertion is reported to be more common in pregnancies 
affected by chronic TTTS compared to monochorionic gestations without 
chronic TTTS, and occur principally in donor twins89-91. It is suggested that 
a velamentous inserted cord may be more easily compressed resulting in 
reduced blood flow through the umbilical vein to one twin89. A vicious 
circle may then be established as less blood flows to one twin (the donor), 
more blood will flow to the other twin (the recipient) through the placental 
anastomoses. The consequent development of polyhydramnios in the 
recipient twin may then compress the umbilical vein of the donor twin 
even further, ultimately leading to the development of chronic TTTS. A 
comparable mechanism is advocated by other authors who speculated that 
polyhydramnios may partially compress the venous placental vessels of the 
donor twin, leading, through a similar vicious circle, to the development 
of chronic TTTS92. However, these theories do not explain why chronic 
TTTS also occurs in twins without velamentous inserted cords. Moreover, 
similar rates of velamentous insertion between monochorionic pregnancies 
with chronic TTTS compared to monochorionic pregnancies without 
chronic TTTS have recently been reported93. We are currently performing 
a prospective study on the rate of velamentous cord insertion and type of 
placental vascular anastomoses in monochorionic twins with chronic TTTS 
compared to monochorionic twins without chronic TTTS.
In summary, the development of TTTS is associated with a multitude 
of complex hormonal and hemodynamic mechanisms. More research 
is needed in order to determine which of these mechanisms is the most 
important. However, monochorionic twinning does not occur in the 
animal world except in humans and in armadillos94, and animal models 
for studying the pathogenesis of TTTS are not available. Lack of a suitable 
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experimental animal model may hamper further investigations on the 
pathogenesis of TTTS. Nevertheless, computer modeling studies may 




The diagnostic criteria of TTTS have dramatically changed since the advent 
of prenatal ultrasonography. In the past, the definition of chronic TTTS 
was based on two main neonatal criteria: a birth weight discordance > 
20% and a hemoglobin difference > 5 g/dL between the two infants. These 
traditional criteria have been abandoned because similar differences 
in hemoglobin and birth weight exist also in dichorionic twins and in 
monochorionic without chronic TTTS44;71. Moreover, studies with fetal 
blood sampling in chronic TTTS pregnancies have shown that the donor 
twin does not necessarily have a lower hemoglobin concentration than 
the recipient twin72;102;103. Absence of significant inter-twin hemoglobin 
differences may be due to compensatory increased hematopoiesis in the 
donor twin103;104. However, erythropoietin concentrations have recently 
been shown to be similar between donors and recipients, questioning the 
validity of the hypothesis on discordant hematopoiesis between twins with 
chronic TTTS73. 
The diagnosis of chronic TTTS is currently defined by prenatal ultrasound 
criteria27;28;105;106. Firstly, since TTTS occurs only in monochorionic twins, 
chorionicity must be determined through prenatal ultrasound scanning 
in the first (or early second) trimester of pregnancy. Ultrasound criteria 
for monochorionicity are the absence of a lambda-sign at the inter-twin 
membrane junction and the presence of a thin dividing membrane with a T-
sign. Assessment of monochorionicity must imply a higher level of alertness 
from doctors and parents in order to detect the first clinical symptoms 
related to chronic TTTS, such as excessive uterine growth and premature 
contractions due to polyhydramnios. Prenatal diagnosis of chronic TTTS 
is then reached by demonstrating the characteristic oligo-polyhydramnios 
sequence on ultrasound. Oligohydramnios is present in the donor who 
is often also stuck to the uterine wall and tightly wrapped in his amniotic 
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sac, whereas polyhydramnios is found in the recipient. Oligohydramnios is 
defined as a deepest vertical amniotic fluid pool ≤ 2cm in the donor’s sac, 
and polyhydramnios as a deepest vertical pool ≤ 8cm in the recipient’s sac 
until 20 weeks of gestation and ≥ 10 cm after 20 weeks of gestation105;106.  
A staging system according to Quintero has recently been introduced and 
stratifies chronic TTTS in 5 stages based on ultrasound criteria (Table 2)9. 
This staging system allows comparison of different management strategies 
in chronic TTTS and is also useful in monitoring disease progression9;12;107.
Several sonographic signs, such as increased nuchal translucency, folding 
of the inter-twin membrane, presence of a velamentous insertion of the 
umbilical cord and absence of arterio-arterial anastomoses are associated 
with a higher probability of the development of chronic TTTS66;89;108. 
However, accurate prediction of chronic TTTS is not yet possible and more 
research on the diagnostic value of early ultrasound findings is necessary. 
A study on early ultrasound predictors in monochorionic twins without 
chronic TTTS has been performed at our institution109. 
Diagnostic criteria for acute perinatal TTTS vary among studies, but 
usually include an hemoglobin difference > 5 g/dL at birth34;35;38;39;44. Most 
studies also rely on the absence of birth weight discordance to exclude 
chronic TTTS. However, birth weight discordance is not a reliable criterion 
to exclude chronic TTTS27;28;44;71;93. Moreover,  rapid shifts of blood 
during labor can occur in any monochorionic twins with patent vascular 
anastomoses, with or without birth weight discordance44. Diagnostic 
TABLE 2 Staging classification of chronic TTTS according to Quintero9.
Stage Sonographic criteria
stage I Bladder of the donor twin still visible, Doppler studies are normal
stage II Bladder of the donor twin not visible, Doppler studies are still normal
stage III Doppler studies are critically abnormal*
stage IV Ascites, pericardial effusion or pleural effusion, scalp edema, or overt hydrops are present
stage V One or both twins are dead
* reversed flow in the ductus venosus or pulsatile umbilical venous flow in the recipient, and/or 
 absent or reversed end-diastolic flow in the umbilical artery of the donor
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criteria of acute perinatal TTTS should therefore include an hemoglobin 
difference > 5 g/dL, with or without birth discordance44. Furthermore, 
diagnosis of chronic TTTS based on antenatal ultrasound examination and 
acute perimortem TTTS, should first be excluded.
Therapy
The intrauterine management of chronic TTTS remains a significant 
challenge in perinatal medicine. In severe TTTS, conservative treatment is 
associated with mortality rates from 73 to 100%110-114. Therefore, a wide 
variety of aggressive, sometimes even desperate treatment modalities 
have been attempted. Some reported treatments are not considered 
to be effective first-line treatments, including maternal treatment with 
digoxin to treat cardiac failure in the recipient115, maternal treatment with 
indomethacin in order to reduce polyhydramnios116 and fetal blood-letting 
from the hypervolemic recipient117. Other treatments are considered to be 
more effective, such as selective feticide by occlusion of the umbilical cord 
through ligation or bipolar diathermy to order to save one infant118, inter-
twin septostomy by creating a hole in the dividing membrane aiming at 
equilibrating the amniotic fluid between the donor’s sac and the recipient’s 
sac119, serial amnioreduction120 and fetoscopic laser occlusion of vascular 
anastomoses121;122. The latest two treatment options, serial amnioreduction 
and fetoscopic laser coagulation of vascular anastomoses, are the two main 
current treatment options in chronic TTTS. Although chorioamnionitis, 
rupture of the membranes, preterm labor and placental abruption are 
potential risks associated with these procedures, both treatments are 
widely reported to be associated with improved outcome. The aim of 
serial amnioreduction is to prevent uterine stretch and preterm labor by 
reducing the intrauterine pressure. Usually, repeated drainage procedures 
of the recipient’s sac are needed as amniotic fluid re-accumulates leading 
to a relapse of polyhydramnios. The major advantage of treatment with 
amnioreduction is that it is widely available. Overall perinatal survival rates 
in case series treated with serial amnioreduction are reported to range 
from 47 to 80%12;123-130. However, serial amnioreduction does not treat the 
underlying pathology and is therefore mainly a symptomatic treatment. 
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Fetoscopic laser coagulation of vascular anastomoses was first described 
by De Lia et al in 1990121. The aim of fetoscopic laser surgery is to occlude 
the anastomosing vessels along the vascular equator of the chorionic plate 
in order to interrupt the inter-twin transfusion of blood, as shown in 
Figure 2. After fetoscopic laser coagulation of the anastomoses, the 
amniotic sac of the recipient is drained a single time to reduce the 
polyhydramnios. Fetoscopic laser surgery is therefore a combination 
of a symptomatic and a causal treatment. Overall perinatal survival 
rates in case series treated with fetoscopic laser coagulation of vascular 
anastomoses vary from 48 to 71%9;121-124;131-137. The true efficacy of the 
various treatments can only be assessed with prospective, randomized 
controlled trials designed not only to establish the survival rate but also 
the long-term neurodevelopmental sequelae. Assessment of the stage of 
chronic TTTS before treatment is crucial to be able to compare various 
FiGURE 2  Schematic image of fetoscopic laser occlusion of vascular anastomoses in chronic twin-to-twin transfusion 
syndrome. The image shows a saggital view of the uterus with a posterior placenta. A fetoscope (2mm diameter) is 
placed under ultrasound guidance through the maternal abdominal wall into the recipient’s sac with polyhydramnios. 
After studying the anatomy/angioarchitecture of the placenta vessels, a 0.7-mm neodymium:yttrium-aluminium-
garnet (Nd:YAG) laser fiber is inserted in the fetoscope to ablate the anastomoses (from Deprest J, with permission).
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treatments. Recently, Senat et al showed in a large multicenter randomized 
trial comparing fetoscopic laser surgery with serial amnioreduction that 
laser treatment leads to better survival rates and fewer neurological 
abnormalities in the neonate than serial amnioreduction10. The overall 
survival rate in the laser group was significantly higher compared to 
the amnioreduction group, 57% versus 41%, respectively (p = 0.01). 
Cystic periventricular leucomalacia grade III or IV was detected in 6% of 
the children in the laser group compared to 14% in the children in the 
amnioreduction group at 6 months of age (p = 0.02), but long-term 
neurodevelopmental outcome of the surviving children has not yet been 
reported. Two other ongoing multicenter randomized trials, one in the 
United Kingdom138 and one in the United States (http://fetalsurgery.chop.
edu), are also comparing serial amnioreduction with fetoscopic laser 
surgery. Whether fetoscopic laser coagulation of vascular anastomoses 
will emerge as the treatment of choice for chronic TTTS depends also on 
the results of these other trials. Some authors also suggest a stage-based 
treatment of chronic TTTS, in which milder TTTS cases are managed with 
amnioreduction and severe TTTS cases with laser surgery.  Whether a 
tailored approach to management of chronic TTTS will improve outcome is 
currently under investigation139.
Lastly, an international multicenter randomized controlled trial for 
the evaluation of septostomy versus serial amnioreduction has been 
performed140. No difference in overall survival was found between both 
treatments. The benefit as well as the rationale of septostomy has 
frequently been questioned27;141. Septostomy may result in complete 
disruption of the dividing membrane and the creation of iatrogenic 
monoamniotic twins27;142. Monoamniotic twins are known to be at risk 
for cord entanglement and are associated with severe perinatal morbidity 
and mortality. Moreover, results of a study with a mathematical model 
for chronic TTTS suggest that septostomy is unlikely to offer significant 
therapeutic efficacy98. 
A flow-chart showing the current management protocol for TTTS at our 
institution is presented in Figure 3.
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FiGURE 3  Flow-chart of antenatal and postnatal management in monochorionic twin gestations at our institution 
(aTTTS: Twin-to-twin transfusion syndrome, biUFD: intrauterine fetal demise, cMRi: Magnetic Resonance imaging, 
dUS: UltraSound) 
Neonatal mortality and morbidity
Multifetal pregnancies have a 2 to 5 times higher risk of perinatal mortality 
compared to singleton pregnancies143. Higher mortality rates are mostly 
due to the higher proportion of infants with preterm delivery and low birth 





































Review of the literature  |   Chapter 2
31
twins are also at risk for morbidity associated with prematurity such as 
chronic lung disease, periventricular leucomalacia, and intraventricular 
hemorrhage. Worse perinatal outcome is also specifically related to 
monochorionicity. Monochorionic twins have a significantly higher 
risk of adverse outcome than dichorionic twins (RR 2.5; 95% CI, 1.1-
2.5)3. Additional morbidity found in surviving twins with TTTS includes 
neurological, cardiovascular and renal complications. Hypoxic-ischemic 
lesions to limbs, intestines and liver caused by infarctions have also been 
reported in TTTS survivors. Morbidity is known to be particularly high in 
surviving twins after intrauterine fetal death of their co-twin. 
Neurological morbidity
Cerebral palsy is estimated to occur 7 times more often in twins than in 
singletons and is due to the higher incidence of prematurity and very low 
birth weight in twins1. The higher risk for cerebral damage in twins is also 
related to monochorionicity. Neurological morbidity is 7-fold higher in 
monochorionic twins compared to dichorionic twins4 and is associated 
with selective intrauterine growth restriction144, intrauterine fetal demise 
of a co-twin145 and chronic TTTS11;146. Cerebral damage in chronic TTTS is 
presumed to be partly of antenatal origin and is related to hemodynamic 
disturbances70;146. The exact pathogenesis of cerebral damage is not 
fully understood yet. Hypoxic-ischemic damage caused by cerebral 
hypoperfusion is probably the major cause for cerebral injury in donor 
twins, whereas hyperviscosity and polycythemia causing vascular sludging 
may be an important cause for cerebral injury in the recipient93. Donors 
and recipients are equally at risk for adverse neurological outcome12;129;146. 
Early neonatal brain scans show that antenatally acquired cerebral white-
matter lesions occur in 30 to 35% of survivors of chronic TTTS compared 
to only 3% in dichorionic twins70;146. Abnormalities on neonatal brain 
scans may also be secondary to postnatal injury associated with severe 
prematurity, which predisposes to periventricular leucomalacia and 
intraventricular hemorrhage. The incidence of major abnormal neonatal 
brain scans in chronic TTTS ranges from 17 to 41%12;128;147;148. The large 
difference in incidence is due to different definitions of abnormal scans 
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and relatively small sample sizes (inherent to the rarity of TTTS). Cerebral 
lesions include periventricular leucomalacia, cerebral white-matter cysts, 
severe intraventricular hemorrhage, cerebral infarct, ventricular dilatation 
and cerebral atrophy12;128;147;148. Minor lesions such as subependymal 
pseudocysts and lenticostriate vasculopathy have also been described in 
monochorionic twins with chronic TTTS146;149. Abnormal neonatal brain 
scans are reported less frequently in survivors of chronic TTTS treated with 
fetoscopic laser occlusion of vascular anastomoses than in survivors of 
chronic TTTS treated with serial amnioreduction10.  
Various studies have reported the long-term neurodevelopmental outcome 
in chronic TTTS. Rates of major neurodevelopmental deficiencies in 
children born after serial amnioreduction range from 5% to 
25%12;125;147;148;150. Major neurodevelopmental sequelea in children born after 
fetoscopic laser coagulation of vascular anastomoses occur less frequently, 
and range from 2 to 11%122;131;133;151;152. However, results of the long-term 
outcome of the previously mentioned randomized trial form Senat et 
al10 must be awaited before conclusions can be drawn on the possible 
beneficial aspects of laser surgery. Regardless of the antenatal treatment, 
the reported risks of neurological impairment in chronic TTTS remain high. 
Careful neurodevelopmental follow-up of all TTTS survivors is therefore 
of major importance to rule out cerebral palsy and global developmental 
delay. Whether neurological disabilities are mainly due to chronic TTTS or 
also partly caused by hemodynamic disturbances which may also occur in 
monochorionic twins without chronic TTTS, remains unclear. To address 
this issue, we are currently assessing the differences between long-term 
neurodevelopmental outcome between monochorionic twins with chronic 
TTTS treated with fetoscopic laser occlusion of vascular anastomoses and 
monochorionic twins without chronic TTTS153.    
Cardiovascular morbidity
Cardiovascular complications occur more frequently in monochorionic 
twins than in singletons, respectively 3.8% versus 0.6% and are mostly 
due to cardiac dysfunction occurring in monochorionic chronic TTTS 
gestations19. Congenital heart disease occurs 12 times more frequently in 
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monochorionic twins with chronic TTTS than in the general population 
and is found mainly in recipient twins19. Reported cardiovascular 
morbidity can be transient, progressive and sometimes persist beyond 
the neonatal period and includes fetal hypertension83;154, hypertrophic 
cardiomyopathy18;19;155, tricuspid regurgitation156, left chamber myocardial 
infarction157,  pulmonary artery calcification158 and right ventricular outflow 
tract obstruction18;159;160.
Two theories have been postulated to explain the pathogenesis of 
cardiovascular morbidity in recipients with chronic TTTS. The first theory 
suggests that cardiovascular complications are a consequence of increased 
preload due to chronic hypervolemia causing cardiac hypertrophy. The 
second theory states that cardiovascular morbidity is due to an increased 
afterload induced by elevated levels of vasoconstrictive substances such as 
endothelin-1 found in recipients84. Higher rates of hypertension reported in 
recipients may support this second theory12;83;154. Whether cardiomyopathy 
in the recipient is primarily due to increased afterload or increased preload, 
is still open for debate. 
Biventricular hypertrophy with prevalent left ventricular hypertrophic 
cardiomyopathy may be present in 40 to 100% of the recipient twins 
depending on the criteria18;155;156;161. Fetal hypertrophic cardiomyopathy may 
lead to hydrops fetalis in 10 to 15% of the recipient twins161. Nevertheless, 
hypertrophic cardiomyopathy appears to be reversible in most cases after 
delivery155. Cardiac hypertrophy may also lead to a functional obstruction 
of the outflow tract of the right ventricle, due to valvular or subvalvular 
pulmonary stenosis. Right ventricular outflow tract obstruction occurs in 5 
to 11% of the recipients and is associated with high mortality rates19;159;162. 
Right ventricular outflow tract obstruction may be progressive and require 
urgent treatment with pulmonary balloon valvuloplasty or surgery after 
birth18;159;163
Improvement of cardiac function after delivery is also often reported in 
recipient twins, suggesting that removal of the causal factors helps the 
heart function to recover155. Whether removal of the causal factors by 
fetoscopic laser occlusion of the vascular anastomoses also results in a 
lower incidence of cardiac dysfunction in chronic TTTS is not yet known. 
We are currently performing a prospective study on echocardiographic 
abnormalities in monochorionic twins with chronic TTTS treated with laser 
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surgery compared to a control group of monochorionic twins without 
chronic TTTS153. 
Renal morbidity
Various renal complications have been reported in donor twins in 
TTTS and include renal cortical necrosis and fibrosis164, transient renal 
insufficiency and hematuria20, acute renal failure requiring long-term 
peritoneal dialysis165, or permanent tubular dysfunction with polyuria due 
to renal tubular dysgenesis21;166. Autopsy studies in chronic TTTS report 
that renal tubular dysgenesis, characterized by loss of proximal convoluted 
tubules, is found in almost 50% of donor twins21. The pathogenesis of 
glomerular and tubular injury is probably secondary to hypoxic-ischemic 
injury due to chronic prenatal renal hypoperfusion in donor twins. Even 
though oliguric renal failure occurs frequently in donor twins, complete 
recovery of adequate renal function is usually reported148. Renal injury in 
donor twins may also lead, sporadically, to the development of chronic 
renal insufficiency requiring dialysis and kidney transplantation12;165. Renal 
function should be monitored carefully at birth in donor twins with TTTS 
by measuring urine output and serial serum creatinin levels to rule out renal 
insufficiency.      
Antenatal hypoxic-ischemic lesions
Antenatal hypoxic-ischemic injury to various organs has been described 
mainly in recipient twins with TTTS, and includes lower limb necrosis167-
169, intestinal injury such as ileal atresia170, and hepatic infarctions171. 
Most pathophysiologic mechanisms proposed to explain these injuries 
are based on hemodynamic disturbances. Necrotic tissue injury and 
gangrene can result from vascular sledging and peripheral ischemia due 
to the polycythemia-hyperviscosity syndrome since most of these injuries 
occur in recipient twins167;168. Idiopathic thrombosis, thrombotic injury 
induced by laser-surgery, anomalous vasculature and umbilical artery steal 
phenomenon have also been proposed as possible mechanisms167;170;172. 
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Morbidity due to intrauterine fetal demise of co-twin
Risk of death or severe cerebral damage in the surviving twin after 
intrauterine fetal demise of a co-twin is 3 to 4-fold higher in monochorionic 
than dichorionic twins14;32;173. In the past, damage was thought to occur 
due to the release of thromboplastin and necrotic emboli from the demised 
fetus into the circulation of the surviving twin, causing disseminated 
intravascular coagulation, embolization and infarction174-176. However, 
current opinion is that damage results from acute exsanguination of the 
surviving twin into the low-pressure circulation of the demised co-twin, 
causing severe hypoxic-ischemic damage30;32;70;173. 
Severe neurological sequelae, such as multicystic encephalomalacy, 
occur in 20 to 40% of surviving twins after intrauterine fetal death of a 
co-twin11;13-16. Careful antenatal radiological evaluation by ultrasound or 
fetal magnetic resonance imaging should be performed after intrauterine 
fetal demise of a co-twin in a monochorionic twin gestation. Fetal 
magnetic resonance imaging detects brain damage earlier and with better 
definition of the brain abnormalities than ultrasound177.  A multitude of 
abnormalities on neuro-imaging studies have been reported, including 
multicystic encephalomalacy, white-matter infarctions, hydranencephaly, 
holoprosencephaly, lisencephaly, polymicrogyria, and  cortical atrophy 
associated with ventriculomegaly178;179. The type of cerebral abnormalities 
probably depends on the timing of intrauterine fetal demise of the co-twin. 
Intrauterine fetal demise of the co-twin in the early second trimester may 
lead to abnormalities related to disturbances in neuronal migration, such 
as polymicrogyria, whereas demise of the co-twin later during the third 
trimester may result in abnormalities typically associated with cerebral 
ischemic injury occurring in late gestation, such as white-matter infarctions 
or multicystic encephalomalacy178;180.  
Spontaneous fetal reductions in twin pregnancies diagnosed in the first 
trimester are not uncommon181. Approximately 30% of twin pregnancies 
will ultimately result in singletons181. This so-called “vanishing” twin 
phenomenon in monochorionic twins may also lead to severe cerebral 
damage182. Some authors hypothesize that a significant proportion of 
singletons with cerebral palsy of unknown etiology may in fact be surviving 
co-twins of undetected, initial monochorionic twin pregnancies183. 
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A recent publication of a case report on multicystic encephalomalacy 
after first-trimester intrauterine fetal death in a monochorionic twin 
pregnancy, supports this hypothesis, and concludes that obstetricians 
and pediatricians should be aware that severe cerebral injury may occur 
earlier than previously thought17. Intrauterine fetal demise of a co-twin can 
also lead to renal cortical necrosis and subsequent renal failure, as well as 
splenic and hepatic infarctions in the surviving co-twin174;184. 
Conclusion
Though recent research has shed more light on the development of 
TTTS, the multitude of complex pathophysiologic mechanisms involved 
in the development of TTTS needs further exploration. The intrauterine 
management of TTTS remains a significant challenge in perinatal medicine. 
Although significant improvement in perinatal survival in TTTS has been 
achieved, this syndrome remains one of the most lethal conditions in 
perinatal medicine. Ongoing randomized controlled trials comparing 
different therapeutic regimens may eventually lead to universally accepted 
treatment protocols. 
Considering the high incidence of cerebral white-matter damage, early 
neonatal brain scans and careful neurodevelopmental follow-up should be 
performed in all surviving twins to rule out severe neurological disabilities. 
Awareness of cardiovascular complications occurring in recipient twins 
and renal complications in donor twins may help improve neonatal care for 
these children. Surviving twins after intrauterine fetal demise of their co-
twin are at high risk for developing severe cerebral and renal sequelae and 
require therefore adequate and complete work-up after birth. 
Lastly, continuing close collaboration between obstetricians and 
neonatologists is crucial in order to improve the care of infants with TTTS. 
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Abstract
Objective: In vivo measurements of blood flow through arterio-venous 
anastomoses in monochorionic twin placentas have recently been 
attempted with Doppler ultrasound, but the accuracy is questionable. 
We present a new method to determine the arterio-venous anastomotic 
blood flow.
Methods: Detailed description of a unique twin-to-twin transfusion 
syndrome case treated with fetoscopic laser surgery and subsequently with 
an intrauterine blood transfusion. Prospective measurements of decreasing 
hemoglobin levels between the intrauterine transfusion and birth allowed 
us to assess the net blood flow through the residual anastomoses.
Results: A case of twin-to-twin transfusion syndrome was treated 
with fetoscopic laser surgery at 27 weeks’ gestation. The ex-recipient 
subsequently became severely anemic and was treated with an intrauterine 
blood transfusion at 29 weeks’ gestation. After birth, a placental injection 
study identified five residual unidirectional arterio-venous anastomoses 
from the ex-recipient to the ex-donor without arterio-venous anastomoses 
in the opposite direction. The net feto-fetal blood flow through the five 
residual arterio-venous anastomoses was determined to be 27.9 mL/24h. 
Conclusions: We found the blood flow across a single arterio-venous  
anastomosis at 29 weeks’ gestation to be 5.6 mL/24h, much lower than 
previously measured with Doppler ultrasound. This finding may also 
explain the inaccuracy of Doppler flow measurements, as such low flow 
velocities cannot possibly be detected with current Doppler techniques.
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Introduction
Twin-to-twin transfusion syndrome (TTTS) is the most common 
complication in monochorionic twin pregnancies and is associated with 
high perinatal morbidity and mortality rates186. TTTS is attributed to 
imbalanced inter-twin blood transfusion through placental anastomoses, 
leading to hypovolemia and oligohydramnios in the donor twin and 
hypervolemia and polyhydramnios in the recipient twin. Despite major 
advances in this field, the exact pathogenesis of TTTS remains incompletely 
understood186. Lack of a suitable experimental animal model has hampered 
further investigation on the development of TTTS. Computer modeling for 
TTTS has helped to elucidate several pathophysiological mechanisms187. 
in vivo assessment of blood flow through an arterio-venous (AV) 
anastomosis would help to further unravel the complex pathophysiology of 
TTTS. Recently, several attempts have been made to measure anastomotic 
blood flow using Doppler ultrasound188;189. However, the results of these 
studies are highly discordant and lead to a fierce debate on the “correct” 
blood flow down an AV anastomosis190.
In a case of TTTS treated with fetoscopic laser surgery, the ex-recipient 
became severely anemic due to residual AV anastomoses and required an 
intrauterine blood transfusion 48 hours before emergency delivery. This 
offered the opportunity to quantify the inter-twin blood flow through 
the unidirectional AV anastomoses with a novel method by analyzing the 
decrease in hemoglobin (Hb) concentrations at different time points. 
Case presentation
A 31-year-old gravida 1 para 0 was referred to our institution at 
27 + 0 weeks’ gestation with signs of TTTS (Quintero stage II) and was 
treated with fetoscopic laser coagulation of vascular anastomoses. Serial 
ultrasound examinations after laser surgery showed normalization of 
amniotic fluid in both sacs and normal bladder filling in both fetuses. 
However, Doppler measurement of the middle cerebral artery peak systolic 
velocity (MCA-PSV) in the ex-recipient gradually increased up to 120 cm/
sec (> 2 Multiples of Median)191 suggesting the presence of severe fetal 
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anemia. An intrauterine blood transfusion was performed at 29 + 3 weeks’ 
gestation. A total volume of 53 ml of blood with an Hb concentration of 
27.2 g/dL was transfused during 30 minutes. Hb concentrations in the 
ex-recipient before and after the transfusion were 3.0 g/dL and 11.2 g/dL, 
respectively. However, within 48 hours after the intrauterine transfusion, 
MCA-PSV Doppler studies showed again signs of severe fetal anemia and 
cardiotocography demonstrated a sinusoidal pattern. A caesarean section 
was performed 48 hours after the intrauterine transfusion. The first-born 
twin (ex-donor) was plethoric and weighed 1210 g. The second-born twin 
(ex-recipient) was pale and weighed 1527 g. Hb concentrations in twin 
1 and twin 2 were 24.3 g/dL and 7.7 g/dL, respectively. Blood pressures 
at birth in twin 1 and twin 2 were 53/32 mmHg and 47/27 mmHg, 
respectively.
Macroscopic examination of the placenta revealed a fetoscopic hole in 
the membranes of twin 2, confirming that the second-born twin was 
the ex-recipient. Injection with color-latex showed four small residual 
unidirectional AV anastomoses from the ex-recipient to the ex-donor with 
a diameter of about 0.5 mm (Figure 1). A residual arterio-arterial (AA) 
anastomosis was also detected. However, this anastomosis was initially not 
detected after dye injection, but became patent only after injection with 
increased pressure and forced manual compression of the dye. Placental 
casting showed additionally a shared cotyledon underneath the placental 
surface connecting an ex-recipient chorionic artery with an ex-donor 
chorionic vein, hence a fifth unidirectional AV anastomosis. 
Calculation of blood transfusion
As a result of the intrauterine transfusion, the ex-recipient received 53 mL 
blood of 27.2 g/dL, which equals 14.4 g of Hb, resulting in an increase 
in Hb concentration from 3.0 g/dL to 11.2 g/dL. We used the method 
described by Hoogeveen et al to calculate the dilution of fetal Hb192, with 
a post-transfusion feto-placental blood volume supposed to return to the 
pre-transfusion volume, i.e. 149 mL. The AV transfusion rate can then be 
calculated from the known amount of Hb transfused from ex-recipient to 
ex-donor, assuming that the AV flow and the ex-recipient’s blood volume 
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remain unaltered during the 48 hours following intrauterine transfusion. 
This is by standard physics as follows:
 The change of the ex-recipient’s Hb concentration, d[Hb]t, at time t (t is 
between the moment of transfusion, at t = 0, and birth, at t = 48 hours), in 
an infinitesimal short period of time, dt, equals the amount of ex-recipient 
Hb concentration [Hb]t transfused to the other twin by the AV in time 
period dt. The ex-recipient’s decrease in Hb concentration is the grams of 
Hb transfused, i.e. [Hb]t times AVflow times dt, divided by the ex-recipient’s 
blood volume, or
FiGURE 1  Monochorionic placenta after dye-injection (blue or green for arteries and orange or yellow for veins). 
The white arrows indicate the residual AV anastomoses from the ex-recipient (left side) to the ex-donor (right side). 
Details of the four residual anastomoses between arteries of the ex-recipient (blue) and veins of the ex-donor (orange) 
are shown in the top-right and bottom-right corner. The green stars show the obliterated anastomoses after laser 
coagulation. The white star indicates the obliterated but during dye-injection fiercely re-opened arterio-arterial 
anastomosis. 
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                    AVflow = . [Hb]t   d[Hb]t = –                           . dt (1)                      BloodVol
The minus sign just implies that the increase in [Hb]t which is d[Hb]t 
is negative. This equation actually represents the following standard 
differential equation (i.e. dividing by dt)
 d[Hb]t      AVflow                = –                  . [Hb]t (2)     dt           BloodVol
with solution 
                                              AVflow    [Hb]t  = [Hb]t=0  exp   [–                 t] (3)                                          BloodVol
Dividing by [Hb]t=0, taking the natural logarithm of both sides, and solving 
for the AVflow (in mL/h) gives
                 BloodVol          [Hb]t=48  AVflow  =                 . ln (          ) (4)                 – 48               [Hb]t=0
When the begin-Hb and end-Hb concentrations, i.e. at the moment 
of transfusion [Hb]t=0 and at birth [Hb]t=48, and the blood volume are 
substituted in equation 4, i.e. [Hb]t=0 = 11.2, [Hb]t=48 = 7.7, BloodVol = 
1.49 dL, the solution of the combined AV flow yields 
  AVflow = 27.9 mL/24h (5) 
    
 Assuming that the blood flow through each of the five AV anastomoses 
was equal, the net transfusion flow through a single AV anastomosis was 
5.6 mL/24h.
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Comment
This study reports a unique case of TTTS that allowed us to assess 
the anastomotic blood flow through the placental anastomoses. 
Unfortunately, we did not measure the percentage of transfused adult red 
cells or adult Hb in the ex-donor after birth. This would have given us yet 
another method to calculate the feto-fetal transfusion during the last 48 
hours before birth and thus to confirm the above calculations. Through 
the calculations in this paper, we found the blood flow across a single AV 
anastomosis at 29 weeks to be 5.6 mL/24 h.  
This flow is in amazing agreement with the flow through an arterio-arterial 
anastomosis at 28 weeks (7.6 ± 4.0 x 10-8 L/s, which equals 6.6 ± 4.2 
mL/24h)188;189, which approximately equals the oppositely directed AV 
transfusion during steady state100. In contrast, Nakata et al measured in 
vivo AV blood flows of up to 25 mL/min (36 L/24 h) using Doppler flow 
during a fetoscopic procedure189. Feto-fetal blood flow of this magnitude, 
however, would lead to fatal acute hemorrhagic shock in the donor fetus 
within a few minutes and is thus physiologically implausible190. Previously, 
using micro-bubble contrast angiography, Denbow et al. measured 
an inter-twin transit time of 65 s193. in a placenta that included an 
anastomotic pattern of two AVs and one AA (Dr Mark L Denbow, personal 
communication). In our case of unidirectional AVs, assuming a 4 cm 
anastomotic length and a diameter of 0.5 mm, the transit time would be 
about 120 s. Interestingly, our TTTS mathematical model predicts AV flows 
that cause severe, i.e. Quintero stage IV, TTTS of about 10 to 15 mL/
24 h187, in excellent agreement with the value reported in this paper. 
In conclusion, by direct measurement of Hb concentration decrease in a 
unique case of TTTS with known anastomotic pattern, we were able to 
estimate the feto-fetal transfusion flow through placental arterio-venous 
anastomoses. This information can now be used to further develop 
improved computer models and to help elucidate the pathophysiology of 
TTTS.
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Abstract
Objective: To determine the incidence of velamentous cord insertion and 
placental territory discordancy in monochorionic twins with and without 
TTTS. 
Methods: All consecutive placentas of monochorionic twins delivered at 
our center between June 2002 and April 2006 were studied with vascular 
injection of the umbilical vessels with colored dyes. Velamentous cord 
insertions were recorded and placental territories were calculated by 
computer analysis. 
Results: A total of 76 monochorionic placentas with TTTS and 63 
monochorionic placentas without TTTS were studied. The incidence of 
velamentous cord insertion (per fetus) in the TTTS group and the no-
TTTS group was 13% (20/152) and 14% (18/126), respectively (p = 0.79). 
Placental territory discordancy in the TTTS group and the no-TTTS group 
was 20% and 20% (p = 0.83). In the TTTS group, donor twins had more 
often a velamentous cord insertion than recipient twins (24% and 3%, 
respectively, p < 0.001) and smaller placental territories (44% and 56%, 
respectively, p < 0.001). 
Conclusions: Our findings suggest that velamentous cord insertion and 
placental territory discordancy are not critical factors for the development 
of TTTS.
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Introduction
Chronic twin-to-twin transfusion syndrome (TTTS) is a complication 
of monochorionic twin pregnancies and results from inter-twin blood 
transfusion via placental vascular anastomoses. Although vascular 
anastomoses are invariably found in almost all monochorionic placentas, 
only 10-15% of monochorionic twins will eventually develop TTTS6;27. 
Differences in angio-architecture, amongst those the absence of arterio-
arterial anastomoses, are one of the major factors involved in the 
development of TTTS6;27;186;194. However, angio-architecture alone does not 
fully explain the pathophysiology of TTTS6;27;186;194. Several other hypotheses 
on the pathophysiology of TTTS have been proposed, including utero-
placental insufficiency and paradoxical activation of fetal vasoactive and 
humoral factors186;194. 
Several authors found a higher incidence of velamentous cord insertions 
in TTTS placentas and hypothesized that velamentous cord insertion and 
unequal placental territories may lead to utero-placental insufficiency, 
subsequently establishing a vicious cycle resulting in the development of 
TTTS89-91;113. However, these hypotheses were mostly unsubstantiated or 
based on small studies89-91;113. Moreover, two recent reports show that 
the incidence of velamentous or marginal cord insertion is similar in 
monochorionic twins with and without TTTS195;196. 
The objective of this study was to determine the incidence of velamentous 
cord insertions and placental territory discordancy in monochorionic twins 
with and without TTTS. 
Materials and methods
All consecutive placentas of monochorionic twin pregnancies examined at 
our center between June 2002 and April 2006 were included in this study. 
Monochorionicity was confirmed after delivery by gross examination of the 
dividing membrane and/or histopathological examination of the placenta 
and the dividing membrane. Placentas were divided in a group with TTTS 
and a group without TTTS. TTTS was diagnosed using standard antenatal 
ultrasound criteria105. The Leiden University Medical Center is a tertiary 
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medical center and it is the national referral center for fetal therapy in the 
Netherlands, including laser treatment for TTTS. Most TTTS cases referred 
to our center were therefore treated with laser. 
During prenatal ultrasound in TTTS twin pairs, great care was taken to 
define which fetus, donor or recipient, would be born first. At delivery, 
umbilical cords were labeled to identify the first and second-born twin. 
The type of abnormal umbilical cord insertion, velamentous or marginal 
insertion (within 1 cm of placental margin), was recorded. Placental 
angio-architecture was studied by injecting the umbilical vessels of both 
cords with different colored dyes. Arteries were injected with (dark-) 
blue dye whereas veins were injected with orange or yellow dye. Placentas 
were then photographed in a plane view, and the picture was saved for 
computer analysis. Each fetal territory was measured by following the 
margins demarcated by the presence of color specific dye. Individual 
placental territories were measured using Image Tool for Windows version 
3.0 (Image Tool, San Antonio, Texas, USA) and expressed as a percentage 
of the total area. The percentage of individual placental territory was 
calculated by dividing each individual placental territory by the sum of 
both territories. Placental territory discordancy was then determined 
by subtracting the percentage of individual placental territory from one 
fetus with the percentage of individual placental territory from the other 
fetus. The same formulas were used to determine the percentage of birth 
weight share per infant and inter-twin birth weight discordancy. Placentas 
with intrauterine fetal demise were excluded when placental maceration 
prohibited accurate evaluation of type of umbilical cord insertion and 
placental territory discordancy. Placentas of monochorionic monoamniotic 
pregnancies and higher multiple pregnancies were also excluded from the 
study.
Results of categorical variables were compared using Chi-squared test. 
Continuous variables were analyzed with the Independent Samples T- test. 
For comparisons between donors and recipients, the Paired Samples T-Test 
and Mc Nemar test was used. A p-value < 0.05 was considered to indicate 
statistical significance. Statistical analysis was performed with SPSS for 
Windows version 11.0 (SPSS, Inc., Chicago, Illinois, USA).
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Results
The number of consecutive monochorionic diamniotic placentas delivered 
and examined at our center during the study period was 161. The data 
required for this study could not be recorded completely for 22 placentas 
(nine in the TTTS-group and thirteen in the no-TTTS group) because 
of placental maceration caused by intrauterine fetal demise (n = 9),  
placental fragmentation (n = 3), placenta fixation in formalin (n=1), loss 
or destruction of the placenta after delivery (n = 9). These 22 cases were 
excluded from further analysis.  A total of 76 monochorionic placentas 
with TTTS and 63 monochorionic placentas without TTTS were included 
in the study. Mean gestational age at birth in the TTTS group and no-TTTS 
group was 30.8 weeks (range: 17 to 38 weeks) and 33.8 weeks (range: 25 
to 38 weeks), respectively. The monochorionic pregnancies with TTTS were 
treated with fetoscopic laser coagulation (n = 61), amniodrainage (n = 10) 
or without intrauterine intervention (n = 5).
The overall incidence of velamentous cord insertion per fetus in all 
monochorionic twin pregnancies was 13% (37/278). Type of umbilical cord 
insertion and difference in placental territories between the TTTS group 
and no-TTTS group are presented in Table 1. Examples of monochorionic 
placentas with velamentous cord insertion and unequal placental territories 
are shown in figures 1, 2, 3 and 4 (pictures are taken after colored dye 
injection).
TABLE 1 Type of umbilical cord insertion and placental territory discordancy in monochorionic pregnancies with 
and without TTTS.
 TTTS group no-TTTS group p-value
 (n = 76 placentas) (n = 63 placentas)
Velamentous cord insertion – no (%)a 20 (13%) 18 (14%) 0.79
Marginal cord insertion – no (%)a 49 (33%) 33 (26%) 0.27
Velamentous or marginal cord insertion – no (%)a 69 (45%) 52 (41%) 0.49
Placental territory discordancy - %b 20 ± 14 20 ± 15 0.83
Placental territory discordancy > 20% - no (%) 31 (41%) 25 (40%) 0.64
a Refers to the type of cord insertion per fetus
b Value given as mean ± SD  
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FiGURE 1  Monochorionic placenta without TTTS. Twin 1 has a velamentous cord insertion and a placental ter-
ritory of 36%, whereas twin 2 has a central cord insertion and a placental territory of 64%. 
FiGURE 2  Monochorionic placenta without TTTS. Twin 1 has a velamentous cord insertion and a placental ter-
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FiGURE 3  Monochorionic placenta with TTTS treated with fetoscopic laser surgery. Twin 1 (ex-recipient) has a 
central cord insertion and a placental territory of 73%. Twin 2 (ex-donor) has a velamentous cord insertion and a 
placental territory of 27%.
Twin 2
Twin 1
FiGURE 4  Monochorionic placenta with TTTS treated with amniodrainage.  Twin 1 (donor) has a marginal cord 
insertion and a placental territory of 47%, whereas twin 2 (recipient) has a velamentous cord insertion and a pla-
cental territory of 53%.
Twin 2
Twin 1
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Type of abnormal umbilical cord insertion, placental territory discordancy 
and birth weight difference between donor and recipient twins in the TTTS 
group are presented in Table 2. 
Differences between monochorionic twins with and without velamentous 
cord insertion are presented in Table 3. 
TABLE 2 Type of umbilical cord insertion, birth weight and individual placental territories in donor and recipient 
twins with TTTS.
 Donor Recipient p-value
 (n = 76) (n = 63)
Velamentous cord insertion – no (%)a 18 (24%) 2 (3%)  < 0.001
Marginal cord insertion – no (%)a 30 (39%) 19 (25%)  0.06
Velamentous or marginal cord insertion – no (%)a 48 (63%) 21 (28%) < 0.001
Birth weight – gb 1547 ± 723 1763 ± 739 < 0.001
Birth weight share – %b   46 ± 6     54 ± 6   < 0.001
Individual placental territory - %b   44 ± 11    56 ± 11  < 0.001
a Refers to the type of cord insertion per fetus
b Value given as mean ± SD  
TABLE 3 Differences between twins with and without velamentous cord insertion.
 Velamentous No velamentous p-value
 insertiona insertiona
 (n = 38) (n = 240)
Gestational age at birth– weeksb 30.7 ± 5.1 32.4 ± 4.4 0.036
Birth weight – gb 1454 ± 672 1914 ± 755  0.001
Individual placental territory - %b 36 ± 10 52 ± 11 < 0.001
a Refers to the type of cord insertion per fetus
b Value given as mean ± SD  
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Discussion
In this large single center study we report on the difference in velamentous 
cord insertion and discordant placental territories between monochorionic 
twin placentas with and without TTTS. We found no difference in 
velamentous cord insertion between monochorionic placentas with and 
without TTTS. 
Velamentous cord insertions are rare in singleton placentas (2%) and far 
more common in dichorionic (7%) and particularly in monochorionic twin 
placentas (12%)197. The high incidence of velamentous cord insertions in 
monochorionic twin placentas is thought to result from a “battle” for 
space between each twin’s placental shares, a competition process also 
called trophotropism26;198;199. Velamentous cord insertions are associated 
with smaller placental mass and lower birth weights26;198;200;201. 
In monochorionic twinning, velamentous cord insertions have also been 
related to the development of TTTS. In a study of 38 monochorionic 
placentas, Fries et al89 reported a significantly higher prevalence 
of velamentous cord insertion in TTTS placentas than in no-TTTS 
placentas, 32% (7/22) and 9% (5/54), respectively (p < 0.01). In view 
of this finding, Fries et al proposed an etiologic role for velamentous 
cord insertion in the development of TTTS89. As a velamentous inserted 
cord can be easily compressed, Fries et al suggested that TTTS could 
result from hemodynamic instability due to reduced blood flow to the 
donor twin with a velamentous inserted cord. However, the number of 
placentas studied was small. Moreover, 3 of the 38 (8%) monochorionic 
pregnancies were monoamniotic. This probably represents a selection 
bias, as placental angio-architecture, type of umbilical cord insertion 
and incidence of TTTS are known to be different in monoamniotic and 
diamniotic monochorionic pregnancies60. In a study of 60 monochorionic 
placentas, Machin90 reported that roughly 30% of twins with velamentous 
or marginal cord insertion have TTTS, whereas only 6% (1/17) of twins 
without velamentous or marginal cord insertion develop TTTS. However, 
exact data on the number of placentas with TTTS was not mentioned. 
Contrarily, in a study of 58 monochorionic twin pregnancies, Bajoria report 
similar frequencies of velamentous cord insertion in TTTS and no-TTTS 
twins (16% and 19%, respectively)196. In a recent study of 89 consecutive 
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monochorionic placentas, De Paepe et al also found a similar prevalence 
of velamentous or marginal cord insertion in TTTS and no-TTTS placentas 
(37% and 36%, respectively)195. In another (unpublished) series of 90 
monochorionic placentas, Taylor et al also found equally high incidence of 
velamentous cord insertion in TTTS and no-TTTS placentas (53% and 52%, 
respectively)93. Our findings are in agreement with the findings of Bajoria, 
De Paepe et al and Taylor et al and challenge the existence of a causative 
relationship between velamentous cord insertion and the development of 
TTTS. 
This study also shows a similar frequency of placental territory 
discordancy in monochorionic placentas with and without TTTS. Only 
a few studies have expanded on the relationship between placental 
asymmetry and development of TTTS. In a small uncontrolled study of 
9 monochorionic pregnancies, Bruner et al speculated that TTTS may 
result from asymmetrical placental insufficiency89-91;113. According to this 
hypothesis, placental vascular anastomoses may become functional and 
lead to TTTS when resistance to placental perfusion reaches a threshold. 
In a study of 89 monochorionic placentas, De Paepe et al found uneven 
placental distribution (defined as greater than 25% discordance between 
the two placental territories) more frequently in TTTS placentas than in 
no-TTTS placentas (73% and 24%, respectively, p < 0.005)195. However, 
in the same study, De Paepe et al found a similar incidence in abnormal 
cord insertion195. We, as well as others, have found that velamentous cord 
insertions are associated with smaller placental territories and smaller 
birth weights26;90;198;201. Also, the method used to determine the percentage 
of each twin’s portion of the placenta was not described in de study from 
De Paepe et al195. If estimations of placental territories were performed 
by rough approximation, an obvious bias may have been introduced. In 
contrast, we used computer analysis to calculate placental territories. 
Our findings are in agreement with a recent study of 133 monochorionic 
placentas from Quintero et al202, showing similar frequencies of placental 
territory discordancy in monochorionic placentas with TTTS and without 
TTTS. Similar placental territory discordancy in TTTS and no-TTTS 
placentas suggests that a causal relationship between unequal placental 
territories and the development of TTTS is highly improbable. 
Finally, this study shows a significant difference in placentation between 
Velamentous cord insertion and unequal placental territories in TTTS  |   Chapter 4
5
donor twins and recipient twins with TTTS. We found that donor twins 
are more likely to have a velamentous or marginal cord insertion and 
smaller placental territories than recipient twins. In a study of 71 TTTS 
placentas, Quintero et al also found significant differences in individual 
placental territories between donor twins and recipient twins (44% versus 
55%, respectively, p < 0.001)202, in agreement with our results. In contrast, 
in a smaller study of 32 TTTS placentas, Bajoria found no difference in 
velamentous or marginal cord insertions between donor and recipient 
twins (65% versus 59%, respectively)196.
Our findings suggest an association between abnormal cord insertion, 
smaller placental territories and being a donor in TTTS. The cause of this 
high frequency of abnormal cord insertion and smaller placental territory 
in donor twins is not known. Placental formation is directly related to 
placental angiogenesis. Various factors, such as vascular endothelial 
growth factors and fibroblast growth factors, as well as vascular flow are 
suggested to play an important role in placental vascularization195;203. We 
speculate that abnormal cord insertion and smaller placental territories 
in donors are not a cause but a consequence of TTTS. As the donor 
twin becomes hypovolemic, vascular perfusion of its placental territory 
diminishes resulting in a decrease in villous and capillary surface areas. 
This process may then lead to a reduced expansion of placental cotyledons, 
particularly those on the outer-side of the donor’s placenta, resulting in a 
smaller placenta with a marginal or velamentous inserted cord. Cotyledons 
from the donor’s placenta that are also perfused through anastomoses by 
the recipient have a greater probability to remain intact. Fetal hypovolemia 
and placental hypoperfusion in donors may also explain the difference in 
vascular distribution patterns between donors and recipients found in the 
study by De Paepe et al195.
In conclusion, our findings show that the frequency of velamentous 
cord insertion and placental territory discordancy is similar in TTTS and 
no-TTTS monochorionic twins, challenging the notion of a causative 
relationship with the development of TTTS. 
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Abstract
Objective: To study the incidence and clinical implications of residual 
anastomoses in twin-to-twin transfusion syndrome treated with fetoscopic 
laser surgery 
Methods: We examined all placentas treated with fetoscopic laser surgery 
and delivered at our center between June 2002 and December 2005 with 
vascular injection using colored dyes. Presence of residual anastomoses was 
studied in association with adverse outcome and inter-twin hemoglobin 
difference at birth. Adverse outcome was defined as fetal demise, neonatal 
death or severe cerebral injury. The relation between residual anastomoses 
and placental localization (anterior or posterior uterine wall) was 
evaluated. 
Results: A total of 52 laser-treated placentas were studied. Residual 
anastomoses were detected in 33% (17/52) of placentas. Adverse outcome 
was similar in the groups with and without residual anastomoses, 
18% (6/34) and 29% (20/70), respectively (p = 0.23). Large inter-twin 
hemoglobin differences (> 5 g/dL) were found in 65% (11/17) of cases 
with residual anastomoses and 20% (7/35) of cases without residual 
anastomoses (p < 0.01). Anterior placental localization was not associated 
with a more frequent presence of residual anastomoses. 
Conclusions: Residual anastomoses at our institution are seen in one 
third of monochorionic placentas treated with fetoscopic laser surgery. 
Although residual anastomoses in our study were not associated with 
adverse outcome, they were often associated with neonatal hematological 
complications.
Residual anastomoses after fetoscopic laser surgery  |   Chapter 5
61
Introduction
Twin-to-twin transfusion syndrome (TTTS) presenting as oligo-
polyhydramnios sequence is a major complication of monochorionic 
twin pregnancies and is due to inter-twin blood transfusion via placental 
vascular anastomoses. Fetoscopic laser coagulation of placental vascular 
anastomoses is nowadays considered to be the treatment of choice 
in severe second trimester TTTS. Fetoscopic laser surgery in TTTS is a 
causative treatment and is associated with significantly improved outcome 
compared to serial amniodrainage10.
The aim of laser coagulation of vascular anastomoses is to completely 
separate the inter-twin placental circulation. Careful examination of the 
placenta after birth through injection studies is required to determine 
whether all vascular connections have been adequately coagulated or 
whether residual anastomoses (RA) are still present.    
Although the first report of fetoscopic laser surgery was published 
more than 15 years ago121, only few studies have since reported on the 
placental findings and incidence of RA after laser surgery135;202;204;205. Most 
importantly, the results of these studies are highly discordant and the 
incidence or RA varied from 0% to 75%135;202;204;205.  
The objective of our study was to determine the incidence and clinical 
implications of RA in a large series of placentas treated with fetoscopic 
laser surgery. We hypothesized that the presence of RA may lead to a 
higher incidence of adverse outcome and larger inter-twin hemoglobin 
difference at birth. Furthermore, we tested the hypothesis that RA may 
be found more frequently in anterior placentas due to the more complex 
approach in these cases. 
Material and methods
All consecutive placentas of monochorionic twin pregnancies with TTTS 
treated with fetoscopic laser surgery and delivered at our center between 
June 2002 and December 2005 were included in the study. The Leiden 
University Medical Center is the national referral center for laser treatment 
for TTTS in the Netherlands. TTTS was diagnosed using standard antenatal 
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ultrasound criteria105. The fetoscopic laser surgery technique used was 
described in detail previously137 and is similar to the method reported by 
Hecher et al123 and Senat et al10. 
After birth, presence of RA was studied by placental colored dye injection. 
The umbilical vessels of both cords were injected with different-colored 
dyes (blue or green for arteries and orange or yellow for veins). Injection 
was continued until dye was seen to flow through the distal end of the 
vascular tree and into the placental substance. Placentas were then 
photographed in a plane view, and the picture was saved in a computerized 
data base. Placentas were divided in two groups, a group with RA and a 
group without RA. Placentas of TTTS pregnancies with single or double 
intrauterine fetal demise were excluded when placental maceration 
prohibited accurate evaluation of RA. 
Adverse outcome was defined as intrauterine fetal demise, neonatal death 
or severe cerebral injury on neonatal ultrasound examination. The criteria 
used for determining severe cerebral injury were published in a previous 
study206. Hemoglobin was measured at birth from cord blood. Anemia and 
polycythemia at birth were defined as previously described207. 
Results of categorical variables were compared using Chi-squared test. 
Continuous variables were analyzed with the Independent Samples T- 
test. A p-value < 0.05 was considered to indicate a statistical significance. 
Statistical analysis was performed with SPSS version 11.0 (SPSS, Inc., 
Chicago, Illinois, USA).
Results
A total of 61 monochorionic placentas of TTTS pregnancies treated 
with laser were examined at our center during the study period. Overall 
perinatal mortality was 21% (26/122: intrauterine fetal demise, n= 18; 
neonatal death, n = 8). The data required for this study could not be 
recorded completely for nine placentas due to maceration caused by 
single intrauterine fetal demise (n = 8) or placental fragmentation (n = 1). 
These nine cases were excluded from further analysis. Fifty-two placentas 
were thus included in the study. RA were found in 33% (17/52) of laser 
treated placentas. A total of 39 RA were detected, with an average of 
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2.3 (±1.7) RA per placenta. The type of RA detected were arterio-venous 
anastomoses from donor to recipient (n = 16), arterio-venous anastomoses 
from recipient to donor (n = 16), arterio-arterial anastomoses (n = 4) and 
veno-venous anastomoses (n = 3). Some placentas with RA (5/17) had 
multiple types of anastomoses. Twenty-five of the 39 (64%) RA were very 
small (< 1 mm diameter) (example shown in Figure 1 and 2). Superficial 
arterio-arterial or veno-venous anastomoses were found in 35% (6/17) of 
placentas with RA. Adverse outcome occurred in 8% (1/12) of infants with 
superficial RA compared to 23% (5/22) in infants with only deep arterio-
venous RA (p = 0.39). Further details on placentas, vascular anastomoses 
FiGURE 1  Placenta of TTTS-pregnancy treated with laser at 17 week’s gestation, followed by spontaneous 
delivery of 2 healthy girls at 38 weeks. The placental share of the ex-donor (birth weight 3055 g) is on the left-side 
of the picture (arteries are blue, veins are orange). The placental share of the ex-recipient (birth weight 2915 g) is on 
the right-side (arteries are green, veins are yellow). Hemoglobin level in the ex-donor and ex-recipient were 13.2 g/dL 
and 19.2 g/dL respectively. The white arrows indicate the successfully coagulated anastomoses. The light blue arrow 
indicates a residual veno-venous anastomosis. A very small residual arterio-venous anastomosis from the ex-donor to 
the ex-recipient is in the white square that is enlarged in Figure 2.  
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TABLE 1 Characteristics of TTTS pregnancies with and without residual anastomoses.
 RAe group no-RAe group p-value
 (n = 17 twin pairs) (n = 35 twin pairs)
Gestational age at laser surgery – weeksa 19.9 ± 4.1 20.6 ± 3.2 0.51
Anterior placentab  5 (29%)  11 (31%) 0.83
Number of anastomoses coagulated per placentaa 7.2 ± 4.5 6.0 ± 2.6 0.23
Gestational age at birth – weeksa 31.8 ± 3.2  31.1 ± 5.2  0.61
Birth weight – ga,c 1718 ± 608  1633 ± 855 0.60
Inter-twin birth weight difference > 20%b 7 (41%) 11 (31%) 0.49
Intrauterine fetal demiseb,c 0 (0%) 10 (14%) 0.02
Neonatal deathb,c 1 (3%) 6 (9%) 0.28
Severe cerebral injuryb,c 6 (18%) 7 (10%) 0.27
Adverse outcomeb,c,d 6 (18%) 20 (29%) 0.23
a Value given as mean ± SD
b Percentages are between brackets 
c Refers to single infants instead of twin pair
d Adverse outcome was defined as intrauterine fetal demise, neonatal death or severe cerebral injury
e RA: residual anastomoses
FiGURE 2  Detail of the 
very small residual anastomosis 
(diameter < 1 mm)  between an 
artery (blue) from the ex-donor and 
a vein (yellow) from the ex-recipient. 
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and clinical outcomes in the RA group and no-RA group are presented in 
Table 1. The ten cases of intrauterine fetal demise in the no-RA group were 
all double demises: 4 pairs of twins died within 2 weeks of laser surgery and 
one pair of twins died 6 weeks after laser surgery. 
In two of the 17 (12%) cases in the RA group, the presence of RA had 
already been predicted by the fetoscopic operator. In the first case a 
large arterio-arterial anastomosis was detected during fetoscopy but 
could not be coagulated due to its size. In the second case, surgery was 
complicated by intra-amniotic hemorrhage impeding further intervention 
due to blood-stained amniotic fluid. In two other cases (12%), presence 
of RA was suspected during the weeks following intervention because of 
fetal Doppler measurements (high middle cerebral artery peak systolic 
velocity (MCA-PSV) in one fetus). In the first case there was persistence of 
feto-fetal transfusion, in the second case there was a reversal of feto-fetal 
transfusion. In the remaining 13 cases (76%), RA had not been suspected 
antenatally. 
The results of hematological values at birth are presented in Table 2. 
TABLE 2 Hemoglobin values at birth in TTTS pregnancies with and without residual anastomoses.
 RAc group no-RAc group p-value
 (n = 17 twin pairs) (n = 35 twin pairs)
Hemoglobin – g/dLa 15.4 ± 5.6 16.0 ± 3.8 0.60
Anemia in one twinb 9 (26%) 8 (11%) 0.06
Polycythemia in one twinb 4 (12%) 2 (3%) 0.07
Inter-twin hemoglobin difference > 5 g/dLb 11 (65%) 7 (20%) < 0.01
Twin pairs with anemia or polycythemiab 10 (59%) 8 (23%) 0.01
a Value given as mean ± SD
b Percentages are between brackets 
c RA: residual anastomoses
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Discussion
This study is the first large single center study reporting on the frequency 
and clinical implications of RA after fetoscopic laser surgery. We found that 
RA are present in one third of laser treated placentas. In a small study, De 
Paepe et al found a much higher incidence of RA in laser treated placentas, 
namely 75%204. Quintero et al, on the other hand, described a much 
lower incidence of RA, ranging from 0% to 5%135;202;205. Such an extreme 
discrepancy between the various studies can be due to several factors, 
namely (1) number of placentas studied, (2) differences in laser technique 
and surgical results and (3) differences in placental injection techniques. 
Obviously, no reliable conclusions on incidence of RA can be drawn if the 
number of studied placentas is too small. De Paepe et al, for example, were 
able to study only 8 placentas204. The second factor, adequate identification 
and successful coagulation of vascular anastomosis, probably depends 
on the ability of each fetal surgeon. Hecher et al reported an association 
between improved outcome and growing experience in the laser technique, 
possibly attributable to an improved efficiency in laser surgery123. However, 
the relation between RA and inter-individual or inter-center variation 
in fetoscopic laser surgery has not been studied. Nevertheless, we have 
previously shown that the overall outcome after laser surgery in our 
center is similar to that in other large centers137. Finally, the third factor, 
differences in placental injection technique, may influence the results on the 
incidence of RA. Discordant opinions on the sensitivity of various injection 
methods have recently resulted in a fierce debate in the literature208. 
Quintero et al performed placental injection studies with air and claimed 
that this method has similar sensitivity compared to other methods202;209. 
Most other authors, as well as our group, advocate placental injection 
with colored dye8;61;67;204;210-212. Which of the two methods (air injection or 
colored dye injection) is superior in detecting RA is not known. However, 
in our experience, the vast majority of RA are very small (with diameters 
< 1mm) and therefore difficult to detect without accurate injection with 
colored dye.
Several reasons can be envisaged to explain the occurrence of RA, namely 
(1) anastomoses (particularly the minuscule ones) were not detected 
during fetoscopy, (2) anastomoses were not coagulated because surgery 
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was too selective in order to spare cotyledons, (3) placental vessels of the 
donor were collapsed due to hypovolemia and vasoconstriction preventing 
adequate detection, (4) insufficient coagulation led to temporary 
anastomotic flow obstruction, but revascularization occurred later, and 
(5) anastomoses were detected during fetoscopy, but were considered 
too large to tackle. These reasonings may have consequences for the 
laser surgery technique. If (1), (2) or (3) are true, RA can be avoided 
using a technique of complete coagulation (with a 5 mm width) of the 
entire vascular equator. If (4) is true, then RA can be avoided by creating 
sufficient placental damage using a technique of deeper, longer-lasting and 
more frequent coagulation.
This study shows that, despite the fact that laser surgery in anterior 
placentas is technically more complex, anterior placentas are not 
associated with increased incidence of RA. Furthermore, the overall 
outcome of TTTS pregnancies with RA in our study was similar to those 
in TTTS pregnancies without RA. Both hypotheses, that RA could be 
associated with anterior placentas and adverse outcome, were thus not 
confirmed in our study. Lack of association between RA and adverse 
outcome may partly be due to the frequent presence (35%) of residual 
superficial anastomoses. Superficial arterio-arterial anastomoses are 
known to protect against TTTS186.
An important (but inevitable) bias in our study may have been introduced 
by the exclusion of nine cases in which placental fragmentation or 
postmortem placental changes prohibited the injection and demonstration 
of the vessels on the placental surface. Adverse outcome in the nine 
excluded pregnancies was 50% (9/18; intrauterine fetal demise: n = 8, 
severe cerebral injury: n = 1). If adverse outcome in these pregnancies 
would have been caused by RA, then the incidence of adverse outcome 
in the RA group would have increased from 18% (6/34) to 29% (15/52). 
This is still similar to the incidence of adverse outcome in the no-RA group 
(29%) (p = 0.97). Therefore, it seems reasonable to deduce that RA in our 
study were not associated with adverse outcome. 
We have shown in this study that large inter-twin hemoglobin differences 
(> 5 g/dL) were significantly more frequent in the presence of RA 
compared to the group without RA. Therefore, the hypothesis related to 
the association between RA and larger inter-twin hemoglobin difference 
seems legitimate. RA were also associated with a higher incidence of 
anemia or polycythemia at birth. Overall, RA were associated with isolated 
hemoglobin discordance at birth or recurrent TTTS in 11 of the 52 (21%) 
TTTS pregnancies treated with laser surgery. Our findings are in agreement 
with recent reports suggesting that incomplete coagulation results in 
isolated hemoglobin discordance or recurrent TTTS in up to 27% of double 
survivors after laser surgery213;214. Routine serial ultrasound examination 
with MCA-PSV measurement after laser surgery proved invaluable in the 
early detection of severe fetal hematological disorders and is nowadays 
strongly recommended213;214. Similarly, we also strongly recommend 
routine placental injection study in TTTS treated with laser because it 
may give equally invaluable information to perinatologists to understand 
the etiology of severe hematological disorders. Finally, placental injection 
studies are an important feedback source to individual fetoscopic surgeons.
In conclusion, clinicians involved in the care for monochorionic twins 
should be aware that RA occur frequently after fetoscopic laser surgery in 
TTTS. Although RA are not clearly associated with adverse outcome, these 
anastomoses may be associated with severe hematological disorders in 
fetuses and neonates. Routine Doppler measurements after laser surgery 
and accurate placental injection studies after birth can help in detecting 
and understanding fetal and neonatal hematological complications. 
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Abstract
Objective: To report an uncommon form of chronic inter-twin transfusion, 
referred to as twin anemia-polycythemia sequence (TAPS), with 
severe anemia in one twin and polycythemia in the other, without the 
characteristically associated twin oligo-polyhydramnios sequence (TOPS) 
seen in the classical twin-to-twin transfusion syndrome (TTTS).
Methods: Description of the clinical course and placental characteristics of 
two pairs of monochorionic twins with TAPS.
Results: The two pairs of monochorionic twins were born at 33 and 
34 weeks’ gestation, respectively. Serial fetal ultrasound examinations 
revealed no signs of TOPS. At birth, both donor twins were severely anemic 
requiring blood transfusion and both recipients were polycythemic, one 
requiring partial volume exchange transfusions. Inter-twin difference 
in reticulocyte counts was extremely high, suggesting a chronic form 
of inter-twin blood transfusion. Placental injection studies revealed a 
preponderance of very small (< 1 mm) arterio-venous anastomoses in one 
direction.
Conclusions: Chronic inter-twin transfusion may lead to an uncommon form 
of inter-twin transfusion, named TAPS, not associated with TOPS, resulting 
in severe fetal or neonatal hematological complications. We hypothesize 
that TAPS is mediated through minuscule unidirectional anastomoses. 
TAPS can be diagnosed antenatally with Doppler studies and postnatally by 
hemoglobin and reticulocyte measurements. 
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Introduction
Twin-to-twin transfusion syndrome (TTTS) is a heterogeneous disease 
affecting monochorionic twin pregnancies and results from hemodynamic 
imbalance due to placental vascular anastomoses27;186. Various forms of 
TTTS have been described: acute perimortem TTTS, acute perinatal TTTS 
and chronic TTTS. Acute perimortem TTTS occurs after intrauterine 
fetal demise of a co-twin and is due to acute exsanguination from the 
surviving twin into the low-pressure circulation of the demising co-twin. 
Acute perinatal TTTS may occur during birth due to acute inter-twin 
shifts of blood resulting from blood pressure differences associated with 
uterine contractions or changes in fetal position. Both acute forms of 
TTTS are mediated through superficial arterio-arterial and veno-venous 
anastomoses29;47;71. The most common form of TTTS, referred to as chronic 
TTTS, occurs usually during the second trimester of pregnancy and affects 
15% of monochorionic twin pregnancies. Chronic TTTS results from 
chronic inter-twin transfusion of blood mediated through arterio-venous 
anastomoses186. Chronic TTTS itself is also a highly heterogeneous disease 
and may be staged using Quintero’s classification based on ultrasound 
criteria9. Chronic TTTS is diagnosed when antenatal sonographic evidence 
of twin oligo-polyhydramnios sequence (TOPS) is found6;27;28;93;102;186. TOPS 
is defined by deepest vertical pool of ≤ 2 cm and ≥ 8 cm in the donor’s and 
recipient’s amniotic sac, respectively27;28;93;186.
We report two cases of monochorionic twins with an unusual form of 
chronic TTTS. Both cases had hematological evidence of severe chronic 
inter-twin transfusion but no antenatal sonographic signs of TOPS. 
Placental injection studies revealed a preponderance of very small (< 1 mm) 
arterio-venous anastomoses in one direction.
Case presentation
Case 1
A 35-year-old gravida 2 para 1 was referred at 27 + 1 weeks’ gestation 
with a dichorionic-triamniotic triplet pregnancy after in vitro fertilization. 
Weekly ultrasound examination throughout pregnancy showed no signs 
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of TTTS (last ultrasound examination was performed at 33 + 1 weeks’ 
gestation). Doppler measurement of the middle cerebral artery peak 
systolic velocity (MCA-PSV) showed a mild increase (1.2 multiples of 
median) in MCA-PSV in one of the monochorionic fetuses (maximum 
velocity of 58 cm/sec at 33 + 1 weeks’ gestation). Labor was induced and 
three girls were born vaginally at 34 + 0 weeks’ gestation. The last two 
girls were the monochorionic twin pair. The second-born infant was pale 
and weighed 1725 g (between 9th and 25th percentile for gestational age). 
The third-born infant was plethoric and weighed 1695 g (9th percentile for 
gestational age). Birth weight discordance was 2%. Apgar scores for the 
second-born and third-born infant were 8/9/10 and 7/8/8, respectively. 
Hemoglobin values for twin 2 and twin 3 were 7.6 g/dL (< 5th percentile for 
gestational age) and 21.7 g/dL (> 95th percentile for gestational age) with 
reticulocyte counts of 21% (absolute reticulocyte count 399 x 103/mm3) 
and 4% (absolute reticulocyte count 181 x 103/mm3), respectively. The 
anemic infant, who was also the fetus with increased MCA-PSV, required 
a blood transfusion on day 1. No signs of acute hemorrhagic hypovolemic 
shock at birth (heart rate 140 bpm, blood pressure 44/35 mmHg) were 
present in the anemic infant. No evidence of placental abruption was found 
and none of the infants were hypoxic at birth. Kleihauer-Betke test was not 
done. The hematocrit value in the co-twin increased up to 69% on day 1, 
but the infant remained asymptomatic and did not require a partial volume 
exchange transfusion. Cranial ultrasound examination in both twins was 
normal and further neonatal course was uneventful. 
Macroscopic placental examination showed a velamentous insertion of the 
umbilical cord of twin 3 and an injection study with colored dye revealed 
five very small (< 1 mm) arterio-venous anastomoses (< 1 mm) from twin 2 
to twin 3 (Figures 1 and 2). 
Case 2
A 31-year-old gravida 5 para 3 was referred to our center at 16 weeks’ 
gestation with a twin pregnancy. The twin pregnancy had been diagnosed 
as dichorionic in the referring hospital based on an ultrasound examination 
at 10 weeks’ gestation. The course of the pregnancy was uneventful and no 
signs suggestive of TTTS were found on monthly ultrasound examination. 





FiGURE 1  Case 1. Triplet placenta after injection with colored dye. There is a monochorionic placenta 
(left-bottom side of the picture) and a fused dichorionic placenta (top-right) (blue for arteries and orange or
yellow for veins). The five anastomoses from donor to recipient are in the white square that is enlarged in figure 2.
FiGURE 2  Case 1. The sky-blue arrows indicate five very small (< 1 mm) arterio-venous anastomoses from twin 2 
(donor) to twin 3 (recipient).
Twin-to-twin transfusion syndrome: from placental anastomoses to long-term outcome
6
MCA-PSV measurements were not done. One day after the last ultrasound 
examination at 33 + 3 weeks’ gestation, spontaneous rupture of 
membranes occurred and was followed by the birth of two boys. The first-
born infant was pale and weighed 1880 g (between 9th and 25th percentile 
for gestational age). The second-born twin was extremely plethoric and 
weighed 1980 g (between 25th and 50th percentile for gestational age). 
Birth weight discordance was 5%. Apgar scores were 8/9/9 and 7/8/8 for 
the first-born and second-born infant, respectively. Hemoglobin values for 
twin 1 and twin 2 were 6.0 g/dL (< 5th percentile for gestational age) and 
26.3 g/dL (> 95th percentile for gestational age) with reticulocyte counts 
of 30% (absolute reticulocyte count 525 x 103/mm3) and 3% (absolute 
reticulocyte count 192 x 103/mm3), respectively. The anemic infant had 
no signs of acute hemorrhagic hypovolemic shock at birth (heart rate 
120 bpm; blood pressure 51/37 mmHg) but required a blood transfusion 
on day 1. No clinical or laboratory evidence of placental abruption was 
found. Kleihauer-Betke test was not performed. The second-born twin 
required oxygen administration and ventilatory support with CPAP due 
to cyanosis and respiratory failure. Severe hypoglycemia was corrected by 
intravenous glucose infusions. The hematocrit increased up to 90% on day 
1 and two partial volume exchange transfusions were performed because 
of symptomatic polycythemia-hyperviscosity syndrome. Cranial ultrasound 
showed persistent bilateral periventricular echodensities in both twins.
At macroscopic examination, the placenta was monochorionic-diamniotic. 
Colored-dye injection showed four very small (< 1 mm) arterio-venous 
anastomoses from twin 1 to twin 2 and one very small (< 1 mm) arterio-
venous anastomosis from twin 2 to twin 1 (Figures 3 and 4). Microscopic 
examination showed that the dividing membrane was diamniotic. 
Comment
In this study, we found evidence that monochorionic twin pregnancies 
without signs of TOPS can still be affected by chronic inter-twin transfusion 
resulting in severe fetal or neonatal hematological complications. We 
have named this condition twin anemia-polycythemia sequence (TAPS). 
Differential diagnosis in monochorionic twins with highly discordant 
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Twin 1
FiGURE 3  Case 2. Monochorionic placenta after injection with colored dye (blue or green for arteries and 
orange or yellow for veins). The five small arterio-venous anastomoses are only visible after enlargement. The four 
anastomoses from donor to recipient are in the white square that is enlarged in figure 4 (the single anastomosis from 
recipient to donor is not in the white square). 
FiGURE 4  Case 2. The sky-blue arrows indicate four small arterio-venous anastomoses from twin 1 
(donor) to twin 2 (recipient). 
Twin 2
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hemoglobin values at birth includes acute peripartum TTTS, chronic TTTS 
with TOPS and chronic TTTS with TAPS. 
Other possible causes for isolated anemia or polycythemia should also 
be ruled out. Chronic anemia in newborns may result from partial 
placental abruption, infection or chronic feto-maternal hemorrhage. 
Unfortunately, Kleihauer-Betke test was not performed in our two cases, 
which is a limitation of our study. However, the associated combination 
with polycythemia in the co-twin clearly suggests a form of feto-fetal 
transfusion rather than feto-maternal transfusion. Common causes 
for polycythemia should also be excluded, such as chronic hypoxia 
associated with intrauterine growth retardation. Polycythemia due to 
chronic in utero hypoxia results from increased erythropoietin levels 
and reticulocytosis215;216. Reticulocyte counts in the polycythemic infants 
in our reported cases were normal for gestational age, suggesting that 
polycythemia resulted from chronic inter-twin transfusion rather than from 
increased erythropoiesis secondary to chronic hypoxia. 
A first possible diagnosis in both reported cases is that of acute peripartum 
TTTS. However, the anemic infant in acute peripartum TTTS has clinical 
signs of hemorrhagic hypovolemic shock such as pallor, tachycardia 
and hypotension47;186. Also, reticulocyte counts after acute blood 
loss are typically not increased due to lack of time for compensatory 
hematopoiesis. Although it is difficult to completely rule out an acute 
peripartum TTTS event in our cases, acute peripartum TTTS should be 
disregarded for several reasons. First, no clinical signs of acute perinatal 
blood loss were found in the anemic infants. Second, very high reticulocyte 
counts were measured in both anemic infants, suggestive of chronic 
rather than acute blood loss. Finally, acute peripartum TTTS is mediated 
through (large) superficial anastomoses47;71. Placental injection studies in 
both reported cases showed only minuscule arterio-venous anastomoses 
without superficial anastomoses. Small-caliber anastomoses have a high 
vascular resistance and theoretically do not allow large amounts of blood 
volume to be transfused acutely from one twin to the other (according to 
Poisseuille’s law of fluid dynamics).
A second possible diagnosis, that of the common form of chronic TTTS 
can be disregarded due to absence of the typical signs of TOPS. We 
suggest therefore that atypical forms of chronic TTTS without TOPS, but 
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associated with anemia in one twin and polycythemia in the other, be 
referred to as TAPS. TAPS differs significantly in terms of diagnosis and 
management from the typical form of chronic TTTS with the characteristic 
signs of TOPS. Therefore, a clear distinction between TAPS and TOPS is 
clinically more useful and reflects more accurately the heterogeneity of 
TTTS. TAPS may occur spontaneously (natural form) as reported in this 
study, but may also develop after laser surgery (iatrogenic form). Recent 
reports suggest that the iatrogenic form of TAPS may occur in up to 13% of 
cases after laser surgery213;214. Interestingly, in iatrogenic TAPS, it is usually 
the former recipient who becomes anemic, whereas the former donor 
becomes polycythemic213;214. 
Most authors consider the presence of TOPS to be the major diagnostic 
criterion for chronic TTTS27;28;93;186. Marked fetal growth discordances and 
inter-fetal hemoglobin differences may also be present but these features 
are not considered key elements in the diagnosis of chronic TTTS27;93;102. 
Doppler studies are a standard requirement to determine Quintero staging 
once chronic TTTS is diagnosed27;28 and are also helpful in the diagnosis 
of fetal anemia after single intrauterine fetal death (acute perimortem 
TTTS)33. Routine Doppler studies are also recommended after laser surgery 
to rule out fetal anemia213;214.
We suggest that Doppler studies and MCA-PSV measurements also be 
performed during each follow-up visit in all uncomplicated monochorionic 
twin pregnancies, even in the absence of TOPS. Signs of fetal anemia in a 
monochorionic twin should then alert the perinatologist of the possibility 
of TAPS. Fetal anemia may affect cerebral oxygenation and result in 
hypoxic-ischemic cerebral injury, whereas polycythemia has been suggested 
to cause cerebral injury in TTTS by vascular sludging206. Hypothetically, 
TAPS may also be responsible for some cases of unexplained fetal demise in 
monochorionic pregnancies without signs of chronic TTTS. 
Whether TAPS is associated with increased mortality or morbidity is 
not known. If so, invasive procedures such as fetoscopic laser surgery, 
intrauterine blood transfusion or a combination of both, may improve 
outcome. At present, however, we think that invasive procedures are 
not indicated because the risk of procedure-related complications may 
outweigh the risk of mortality or morbidity. 
There as several hypotheses on the origin of inter-twin amniotic fluid 
discordances in the common form of chronic TTTS with TOPS186. It is 
Twin-to-twin transfusion syndrome: from placental anastomoses to long-term outcome
0
however not yet clear why there are no inter-twin amniotic fluid discordances 
in TAPS. One of the common denominators between the two reported cases 
is the preponderance of very small (< 1 mm), arterio-venous anastomoses 
in one direction. Vascular resistance in small-caliber vessels is higher than in 
larger vessels and reduces the volume of fluid passage (Poisseuille’s law). We 
hypothesize that if only a few very small placenta vascular anastomoses are 
present, inter-twin blood transfusion occurs very slowly and allows more 
time for hemodynamic compensatory mechanisms to take place. Activation 
or inactivation of the renin-angiotensin system may then induce the 
hypovolemic donor and the hypervolemic recipient to remain euvolemic, 
which in turn explains the absence of TOPS. However, compensatory 
hematopoiesis may not be sufficient to prevent severe anemia in the donor, 
despite the extremely high reticulocyte count. Another possible explanation 
is that the reported infants were born before TOPS had time to develop. 
Inter-twin hemoglobin discordance and amniotic fluid discordance varies 
with the state of progression of chronic TTTS102. It is conceivable that 
some twins with chronic TTTS may first develop TAPS and then TOPS. As 
placental blood vessels enlarge throughout pregnancy, these vessels may 
eventually become just large enough to produce TAPS at a certain point in 
gestation, but not before this time. Regardless of the various hypotheses, 
our understanding of TAPS is clearly still incomplete.
In conclusion, perinatologists involved in the care of monochorionic 
twins should maintain a high index of suspicion, as antenatal ultrasound 
examination without Doppler studies does not rule out a chronic 
form of inter-twin transfusion. TAPS can occur in the absence of the 
characteristic inter-twin discordance in amniotic fluid volumes. TAPS 
should be diagnosed when large inter-twin discordance in fetal or neonatal 
hemoglobin levels and reticulocyte counts are found, in absence of TOPS. 
Placental injection studies may then reveal a preponderance of very small 
arterio-venous anastomoses in one direction.
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Abstract
Objectives: To determine the hemoglobin (Hb) differences at birth in 
monochorionic (MC) twins without chronic twin-to-twin transfusion 
syndrome (TTTS) in relation to birth order and placental vascular anatomy. 
Methods: All consecutive cases of MC twins without chronic TTTS and 
dichorionic (DC) twins delivered at our center and admitted to our 
neonatal nursery between June 2002 and December 2004 were included in 
our study. We analyzed Hb differences at birth and on day 2, in relation to 
birth order and placental vascular anatomy.
Results: Forty-five pairs of MC twins and 71 pairs of DC twins were 
included. Mean Hb differences at birth in MC and DC twins were similar, 
1.5 and 1.4 g/dL, respectively. Hb differences > 5 g/dL at birth were found 
in 2% (1/45) of MC twins compared to 8% (6/71) in DC twins. On day 2, 
mean Hb differences in MC twins increased to 3.8 g/dL, and the rate of MC 
twins with Hb differences > 5 g/dL increased to 27% (12/45) (p < 0.001). 
Mean Hb differences and the percentage of twins with Hb differences 
> 5 g/dL in DC twins did not change on day 2. 
In MC twins, Hb levels measured on day 2 were significantly higher in 
second-born twins than in first-born twins, 17.7 and 15.5 g/dL, respectively 
(p = 0.002). Hb differences on day 2 were significantly higher in MC twins 
with superficial vascular anastomoses than those without superficial 
anastomoses, 4.0 g/dL and 1.5 g/dL, respectively (p = 0.036).  
Conclusions: Hb differences occur more frequently in MC twins without 
chronic TTTS than in DC twins, but only when measured on the second 
day of life. Hb differences in MC twins are associated with birth order and 
superficial vascular anastomoses.
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Introduction
Placental vascular anastomoses are almost invariably present in 
monochorionic (MC) twin gestations, but are extremely rare in dichorionic 
(DC) twin gestations5. In contrast to DC twins, MC twins are therefore 
at risk for twin-to-twin transfusion syndrome (TTTS). Several forms 
of TTTS have been described: chronic TTTS, acute perimortem TTTS 
and acute perinatal TTTS11;30;42;45. The chronic form of TTTS is the most 
common form and complicates about 15% of monochorionic twin 
pregnancies. Chronic TTTS occurs during the second or early third 
trimester of pregnancy due to unbalanced blood flow from one twin to 
the other through placental vascular anastomoses8;108. The recipient twin 
gradually becomes hypervolemic, polyuric, and develops polyhydramnios, 
whereas the donor twin becomes hypovolemic, oliguric and develops 
oligohydramnios. The pathogenesis of chronic TTTS is mainly mediated 
through deep arterio-venous anastomoses, in the absence of compensatory 
superficial arterio-arterial anastomoses62. Acute perimortem TTTS occurs 
in MC twins after intrauterine death of the co-twin. This form of acute 
TTTS results from acute exsanguination from the surviving twin into the 
low-pressure circulation of the demised co-twin through superficial arterio-
arterial or veno-venous anastomoses and leads to severe hypoxic-ischemic 
injury in the surviving twin13;30-32;70;217. Risk of neurological handicap or 
death in the surviving twin is then extremely high 11;13;14. Acute TTTS is also 
reported to occur in MC twins during labor, hence referred to as acute 
perinatal TTTS34;40-44;218. Acute perinatal TTTS is thought to result from 
uterine contractions or changes in fetal position leading to inter-twin blood 
pressure differences and inter-twin blood transfusion36;44;45. Rapid transfer 
of blood from the donor twin into the circulation of the recipient twin is 
probably mediated through superficial arterio-arterial or veno-venous 
anastomoses71. Acute perinatal TTTS may then lead to hemoglobin (Hb) 
differences at birth without necessarily discordance in birth weight39;43. So 
far, knowledge on acute perinatal TTTS is mainly speculative and based on 
case reports34-39.
In 1972, Klebe and Ingomar hypothesized that Hb difference in MC twins at 
birth may be due to differences in placental blood transfusion in relation to 
birth order38. They postulated that once the umbilical cord of the first-born 
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twin is clamped, the second-born twin may not only receive blood from its 
own placenta but also from the placenta-share of the co-twin, through the 
patent vascular anastomoses. Other authors also share this opinion35;41;44.
The aim of this study was to determine the Hb differences and 
hemodynamic disturbances at birth in MC twins without chronic TTTS 
and DC twins in relation to birth order, and establish if there was an 
association between Hb differences and the presence or absence of 
superficial vascular anastomoses. 
Materials and methods
All consecutive cases of MC twins without chronic TTTS and DC twins 
delivered at our obstetrical department and admitted to our neonatal 
nursery between June 2002 and December 2004 were included in our 
study. The prenatal diagnosis of chronic TTTS was made by using standard 
ultrasound criteria105: 1.) Monochorionicity established by absence of 
a “twin peak” sign and the presence of a thin dividing membrane, 2.) 
Oligohydramnios (deepest vertical pocket ≤ 2cm) in the twin sac of one 
fetus, and 3.) Polyhydramnios (deepest vertical pocket ≥ 8cm before 20 
weeks of gestation or ≥ 10cm after 20 weeks of gestation) in the twin sac 
of the other fetus. Monochorionicity was confirmed by histopathological 
examination of the placenta. Placental vascular anastomoses in MC 
placentas were studied by injection with colored dye (blue or green for 
arteries, yellow or orange for veins). Arterio-venous anastomoses were 
classified as deep anastomoses, whereas arterio-arterial and veno-venous 
anastomoses were classified as superficial anastomoses.
We excluded pregnancies complicated by maternal red blood cell 
alloimmunization, major fetal congenital malformations, higher multiples 
gestations, and twin gestations with intrauterine fetal death of a co-twin.
The following obstetrical data were collected: gestational age at delivery, 
mode of delivery and time interval (in minutes) between delivery of twin 
1 and twin 2. The following neonatal data were gathered: birth weight, 
Apgar score at 5 minutes, arterial blood pressure measured by Dinamap 
at birth and heart rate at birth. Renal function was assessed by measuring 
urine output during the first 24 hours after birth (in ml/kg/h). Growth 
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discordance was calculated by dividing the difference in birth weights by 
the birth weight of the larger twin. Hb levels were assessed at birth from 
umbilical cord blood. Since Hb levels are not reliable when measured 
shortly after acute shifts in blood volume, a second (venous) Hb level was 
analyzed on the second day of life, when clinically indicated39;46;219;220. Inter-
twin Hb difference was defined as absolute Hb difference (higher Hb value 
minus lower Hb value). Inter-twin Hb differences were analyzed in relation 
to birth order (twin 1 versus twin 2) and in relation to birth weight (smaller 
twin versus larger twin). We recorded the use of blood transfusions during 
the first and second day of life, as well as the need for volume expanders 
and inotropic support during the first day of life. For the purpose of our 
study we defined acute perinatal TTTS in MC twins as an Hb difference of 
at least 5 g/dL at birth, without an obvious other cause for such difference. 
Acute hemorrhagic hypovolemic shock was defined as a combination of 
pallor, tachycardia (heart rate >160 bpm) and/or hypotension, requiring 
treatment with volume expanders, blood transfusion and/or inotropic 
support 220. Hypotension was defined as a systolic blood pressure below 
the 3rd percentile for gestational age221. Serial cranial ultrasound scans were 
performed routinely in all neonates. Periventricular hemorrhage (grade 
classification according to Papile222) and cystic periventricular leucomalacia 
(grade classification according to de Vries223) were recorded. Other 
significant neonatal problems were also reviewed, including respiratory 
distress syndrome, chronic neonatal lung disease, patent ductus arteriosus, 
necrotizing enterocolitis, retinopathy of prematurity and hyperviscosity 
syndrome. We also recorded the total number of days during which 
phototherapy treatment was required.
Results of categorical variables were compared using Fisher’s exact test 
or Chi-square test, as appropriate. McNemar’s test was used for analysis 
of paired nominal data. The paired Student’s t test was used to study 
normally distributed values within twin pairs, whereas the unpaired 
Student’s t test was used to compare normally distributed values between 
two groups. The Spearman rank correlation was used to study the 
relationship between time-interval at birth between twin 1 and twin 2 and 
Hb differences between both infants. A p-value < 0.05 was considered to 
indicate statistical significance. Analysis was performed using SPSS version 
11 (SPSS, Inc., Chicago, Illinois, USA).
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Results
During the study period 1699 neonates were admitted to our nursery, 
among which 21% (349/1699) were born from 174 multifetal gestations. 
55% (95/174) of the multifetal pregnancies were MC, and 45% (79/174) 
were DC. The Leiden University Medical Center is a tertiary medical 
center and serves as the national referral center for fetal invasive therapy 
in the Netherlands, which explains the high percentage of MC multifetal 
gestations and red blood cell immunization compared to other academic 
centers. A total of 45 MC pregnancies without chronic TTTS and 71 DC 
pregnancies were included in our study. The derivation of the included and 
excluded twin pregnancies is shown in Figure 1. Reasons for admission to 
our neonatal nursery were all mainly related to prematurity. Perinatal death 
did not occur in any of the MC twins without chronic TTTS delivered at our 
center during the study period.
Patients’ characteristics for both MC and DC infants are shown in Table 1. 
There were no significant differences in baseline characteristics between the 
two groups, except for a higher percentage of MC infants being delivered 
by cesarean section compared to DC infants, 38% (34/90) versus 23% 
(32/142), respectively (p = 0.012). The percentage of MC and DC twin 
pairs with birth weight discordance > 20% was similar, 27% (12/45) and 
24% (17/71), respectively.
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Hb values and hemodynamic parameters of MC and DC infants are 
presented in Table 2. Hb was measured at birth in 98% (88/90) and 93% 
(132/142) of MC and DC infants, respectively. On day 2, Hb measurements 
were available in 81% (73/90) and 85% (121/142) of MC and DC infants, 
respectively. Hb levels on day 2 were extracted from full blood count 
measurements, usually required to rule out perinatal infection associated 
with prematurity. Mean Hb differences at birth in MC twins and DC twins 
TABLE 1 Baseline characteristics.
 MC infants DC infants p-value
 (n = 90) (n = 142)
Gestational age at birth – wka 33.5 ± 3.4 32.6 ± 3.6 ns
Birth weight – ga 2040 ± 684 1885 ± 636 ns
Birth weight difference - %a 14 ± 11 13 ± 10 ns
Female – no. (%) 44 (49%) 72 (51%) ns
Cesarean section – no. (%)b 34 (38%) 32 (23%) 0.012
Median Apgar score at 5 min (range) 9 (5-10) 9 (4-10) ns
Neonatal death – no. (%) 3 (3%) 8 (6%)  ns
Respiratory distress syndrome – no. (%) 21 (23%) 46 (32%) ns
Patent ductus arteriosus – no. (%) 5 (6%) 8 (6%) ns
Periventricular hemorrhage grade 2-4 – no. (%) 2 (2%) 7 (5%) ns
a Value given as mean ± SD
b Refers to infants rather than mothers 
TABLE 2 Hb values and hemodynamic parameters in MC and DC infants.
 MC infants DC infants p-value
 (n = 90) (n = 142)
Hb at birtha 16.5 ± 2.1 16.6 ± 2.3 ns
Hb difference between twins at birtha 1.5 ± 1.4 1.4 ± 1.7 ns
Hb on day 2a 16.6 ± 3.0 16.1 ± 2.6 ns
Hb difference between twins on day 2a 3.8 ± 2.5 1.7 ± 1.8 < 0.001
Hb difference >5 g/dl at birth – no. (%) 2 (2%) 12 (8%) ns
Hb difference >5 g/dl on day 2  – no. (%) 24 (27%) 6 (4%) < 0.001
Blood transfusion on day 1 or 2 – no. (%) 3 (3%) 9 (6%) ns
Hypotensive at birth – no. (%) 9 (10%) 27 (19%) ns
Volume expanders at birth – no. (%) 12 (13%) 31 (22%) ns
Inotropic drugs – no. (%) 11 (12%)  14 (10%) ns
Acute hemorrhagic hypovolemic shock – no. (%) 0 (0%) 0 (0%) –
a Value given as mean ± SD
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were similar, 1.5 and 1.4 g/dL, respectively. Hb differences > 5 g/dL at 
birth were found in 2% (1/45) of MC twin pairs compared to 8% (6/71) 
of DC twin pairs. On day 2, mean Hb differences in MC twins increased 
to 3.8 g/dL (p < 0.001). The rate of MC twin pairs with Hb differences > 
5 g/dL increased up to 27% (12/45) (p < 0.001). In DC twins, mean Hb 
differences and percentage of twin pairs with Hb differences > 5 g/dL did 
not change on day 2. 
Birth weight discordance > 20% and Hb difference > 5 g/dL at birth was 
detected in one pair (2%) of MC twins and in one pair (1%) of DC twins, 
in which the higher Hb level was found in the larger infant. In another 
set of DC twins with birth weight discordance > 20% and Hb difference 
> 5 g/dL at birth, the higher Hb level was found in the smaller twin. No 
difference in hemodynamic parameters, including blood pressure, heart 
rate, diuresis, or treatment with volume expanders, inotropics or blood 
transfusion, was found between MC and DC twins. None of the twins in 
our study suffered from acute hemorrhagic hypovolemic shock at birth. 
Serial cranial ultrasound scans showed a similar rate of periventricular 
hemorrhage (grade 2 to 4) in MC and DC twins, 2% (2/90) and 5% 
(7/142), respectively. None of the twins in both groups had cystic 
periventricular leucomalacia. One second-born infant of a preterm MC 
pregnancy required an exchange transfusion for hyperbilirubinemia on day 
2 (serum bilirubin level: 13.9 mg/dL) despite phototherapy and adequate 
fluid administration. Routine work-up for hyperbilirubinemia showed an 
increase in Hb level from 14.3 g/dL at birth to 18.4 g/dL on day 2 without 
evidence of hemolysis and dehydration, suggesting that hyperbilirubinemia 
may have resulted from a high red cell volume. 
Differences in Hb values and hemodynamic parameters in relation to 
birth order are presented in Table 3. A fall in Hb between birth and day 
2 was found in first-born MC twins (- 0.9 g/dL), first-born DC twins (- 
0.6 g/dL) and second-born DC twins ( - 0.3 g/dL). A rise in Hb between 
birth and day 2 was found only in second-born MC twins (+ 1.1 g/dL). 
Mean Hb concentrations on day 2 in second-born MC twins on day 2 
were significantly higher than in first-born MC twins, 17.7 and 15.5 g/dL, 
respectively (p = 0.002). No association between birth order and Hb 
differences was detected in DC twins. The fall in Hb between birth and day 
2 in first-born MC twins was of similar magnitude as the fall in Hb in first-
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born DC twins (p = 0.129), but was of greater magnitude compared to the 
fall in Hb in second-born DC twins (p = 0.028). 
In MC twins, mean Hb values in the smaller and larger twin were 
respectively 16.3 and 16.8 g/dL (p = 0.065) at birth, and 16.7 and 16.4 
g/dL (p = 0.753) on day 2. In DC twins, mean Hb values in the smaller and 
larger twin were respectively 16.8 and 16.4 g/dL (p = 0.148) at birth, and 
16.3 and 16.0 g/dL (p = 0.303) on day 2.
Histopathological examination of MC placentas confirmed mono-
chorionicity in all cases. Information on the type of vascular anastomoses 
was obtained in 80% (36/45) of the MC placentas. Arterio-arterial 
anastomoses, veno-venous anastomoses and arterio-venous anastomoses 
were present in 83% (30/36), 14% (5/36) and 83% (30/36) of placentas, 
respectively. Superficial vascular anastomoses were present in 83% (30/36) 
of MC placentas and absent in 17% (6/36) of MC placentas. Differences 
in Hb values in MC twin pairs with and without superficial vascular 
anastomoses are presented in Table 4. Mean Hb differences on day 2 
were significantly higher in MC with superficial anastomoses than in MC 
twins without superficial vascular anastomoses, 4.0 g/dL and 1.5 g/dL, 
respectively (p = 0.036). Hb differences > 5 g/dL on day 2 were detected in 
27% (8/30) of MC twin pairs with superficial anastomoses and 16% (1/6) 
of MC twin pairs without superficial anastomoses. There was no significant 
association between Hb differences > 5 g/dL and superficial vascular 
anastomoses probably because of the small number of cases.
TABLE 3 Hb values and hemodynamic parameters in MC and DC twin pairs in relation to birth order.
 MC twin pairs (n = 45) DC twin pairs (n = 71)
 Twin 1 Twin 2  p-value Twin 1 Twin 2  p-value
Hb at birtha 16.4 ± 1.8 16.6 ± 2.4 ns 16.6 ± 2.4 16.6 ± 2.3 ns
Hb on day 2a 15.5 ± 2.2 17.7 ± 3.3 0.002 16.0 ± 2.6 16.3 ± 2.5 ns
Heart frequency at birth (bpm)a  150 ± 15 146 ± 19  ns 151 ± 18 151 ± 13  ns
Mean blood pressure at birth (mmHg)a  39.2 ± 7.4  38.8 ±7.9  ns  36.7 ± 7.7  35.3 ± 7.5  ns
Urine output on day 1 (ml/kg/h)a 2.7 ± 1.3 2.9 ± 1.3 ns 2.2 ± 1.1 2.3 ± 1.1 ns
Blood transfusion on day 1 or 2 – no. (%)  1 (2%) 2 (4%) ns  6 (4%) 3 (2%) ns
Volume expanders on day 1 – no. (%)   6 (13%)  6 (13%) ns   16 (11%)  15 (11%) ns
Inotropic drugs on day 1 – no. (%)  5 (11%) 6 (13%) ns 7 (5%) 7 (5%) ns
Phototherapy daysa 1.7 ± 2.5 2.1 ± 2.7 ns 2.5 ± 3.0 2.5 ± 2.9 ns
a Value given as mean ± SD
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The median time interval between delivery of twin 1 and twin 2 in the 
sub-group of MC twins delivered vaginally was 5 minutes (range 1-40 
minutes). We found a positive correlation between time interval between 
vaginal delivery of the first and second-born infants and Hb differences 
on day 2 (Spearman correlation coefficient = 0.402), but the increase in 
Hb differences was not significant (p = 0.079). No correlation was found 
between time interval between vaginal delivery of the first and second-
born infants and Hb differences at birth. The difference in mean Hb 
concentrations between MC twins born vaginally and through caesarean 
section was not significant, respectively 1.7 versus 1.2 g/dL at birth (p = 
0.355) and 3.7 versus 3.9 g/dL on day 2 (p = 0.778).  
Comment
This study shows that Hb differences at birth between MC twins without 
chronic TTTS and DC twins are similar. Only a small number of twin pairs 
in both groups of twins have highly discordant Hb values (Hb difference 
> 5 g/dL) at birth. However, when Hb levels are measured on day 2, Hb 
differences between MC twins become more evident and one in four MC 
twin pairs has Hb differences > 5 g/dL. The different Hb values between 
birth and day 2 may be due to acute shifts in blood volume in MC twins 
during delivery39. Hb concentrations are known to be unreliable when 
measured shortly after acute shifts in blood volume. When acute blood 
loss occurs, Hb levels may initially remain within the normal range and 
not reflect the actual blood loss46;219;220. After equilibration between 
TABLE 4 Hb values in MC twin pairs with and without superficial vascular anastomoses.
 Twin pairs with Twin pairs without p-value
 superficial anastomoses superficial anastomoses
 (n = 30) (n = 6)
Hb difference at birtha 1.3 ± 1.3 1.3 ± 1.3 ns
Hb difference on day 2a 4.0 ± 2.2 1.5 ± 1.6 0.036
Hb difference >5 g/dl at birth  – no. (%)  0 (0%) 0 (0%) –
Hb difference >5 g/dl on day 2  – no. (%)  8 (27%) 1 (16%) ns
a Value given as mean ± SD
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intravascular and extravascular spaces has completed, the expected fall in 
Hb levels may appear. This compensatory mechanism of equilibration or 
hemodilution may take several hours to complete39;220;224. Hemodilution 
is due to a gradual increase in plasma volume and intravascular volume 
to compensate for the blood loss. Conversely, when an infant receives an 
acute transfusion of blood, the infant responds by gradually decreasing 
its plasma volume while the red cell mass remains unchanged224;225. After 
equilibration between intravascular and extravascular spaces is complete, 
the expected rise in Hb levels may appear. 
This study also establishes a clear association between Hb difference 
and birth order in MC twins. We found that Hb levels on day 2 were 
significantly higher in second-born MC twins than in first-born MC 
twins. Our results are in agreement with previous studies35;38;46. Once the 
umbilical cord of the first-born twin is clamped, the second twin has sole 
access to the entire placenta and may therefore receive blood through the 
vascular anastomoses from both parts of the placenta 38;41. To determine 
whether the Hb difference in MC twins was due to a relatively higher Hb 
concentration in second-born twins or a lower Hb concentration in first-
born twins, we compared Hb values between MC and DC twins. The fall 
in Hb between birth and day 2 found in first-born MC is also detected 
in first and second-born DC twins and is probably due to factors related 
to prematurity, such as blood loss caused by repeated venepunctures 
and hemodilution caused by treatment with volume expanders. The rise 
in Hb between birth and day 2 in second-born MC twins was in striking 
contrast to the fall in Hb in all other infants. Thus, Hb differences between 
MC twins are probably due to a relatively higher Hb in second-born 
twins rather than a lower Hb in first-born twins. The rise in Hb levels in 
second-born twins on day 2 compared to day 1 may reflect the process of 
hemoconcentration after acute blood transfusion. High red cell volume 
can be potentially harmful in neonates and lead to polycythemia or severe 
hyperbilirubinemia224;225 requiring an exchange transfusion, as occurred in 
one second-born twin in our study. 
We also report that Hb differences in MC twins measured on day 2 are 
greater in the presence of superficial vascular anastomoses. Superficial 
arterio-arterial and veno-venous anastomoses are known to be responsible 
for acute transfusions of blood after intrauterine fetal death of one of the 
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twins30;32;70. In analogy to acute perimortem TTTS, it is conceivable that 
superficial vascular anastomoses may also be responsible for rapid inter-
twin blood transfusion during delivery. Hypothetically, after clamping of 
the first-born’s cord, uterine contractions may allow placental blood from 
the first twin’s low-pressure placental bed to be transfused through the 
low-resistance superficial vascular anastomoses into the higher pressure 
circulation of the second twin. 
Disparity in placental blood transfusion may also be responsible for Hb 
differences in MC twins38. The amount of placental blood transfused into 
the circulation of the newborn before clamping of the umbilical cord is 
a major factor determining Hb levels225. Assuming that the time taken to 
clamp each of the umbilical cords is not different between twin 1and 2, 
other factors may be related to Hb differences in MC twins, such as mode 
of delivery or time interval between birth of twin 1 and 2. We detected no 
association between mode of delivery (vaginal delivery or cesarean section) 
and Hb differences in MC twins. A positive, but statistically not significant 
correlation was found between Hb differences and time interval between 
vaginal delivery of twin 1 and twin 2. 
A weakness of our study is that we excluded all uncomplicated term or 
near-term twin deliveries, as Hb is obviously not routinely taken on term 
infants. Risk of significant acute perinatal transfusion in term MC twins 
remains therefore unknown and needs to be investigated in future studies. 
A handful of case reports of MC twins with acute perinatal TTTS have 
been reported in the literature34-39. Most donor twins had signs of acute 
hemorrhagic hypovolemic shock and required prompt refilling of the 
intravascular compartment with blood transfusion or volume expanders. 
In our study, only one of the 45 pairs of MC twins fulfilled our criteria 
for acute perinatal TTTS and the donor twin had no characteristic signs 
of acute hemorrhagic hypovolemic shock, such as pallor, tachycardia 
and/or hypotension. Diagnostic criteria for acute perinatal TTTS vary 
among the published case reports, but always include a significant 
Hb difference at birth. Most reports also rely on the absence of birth 
weight discordance between both twins to exclude chronic TTTS34;35;38;39. 
However, birth weight and Hb discordance are not appropriate diagnostic 
criteria for chronic TTTS11;27;28;71;93. As shown in this study, birth weight 
discordance and Hb difference can also be found in DC twins and in MC 
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twins without antenatal signs of chronic TTTS. Moreover, Hb discordance 
is only present in a minority of cases with chronic TTTS102. Diagnosis 
of TTTS is nowadays based on antenatal ultrasound finding of the 
characteristic oligo-polyhydramnios sequence11;27-29;93. Therefore, most case 
reports in which acute perinatal TTTS was diagnosed without antenatal 
ultrasound examinations, may have been cases of chronic TTTS, the most 
common cause for hematological and hemodynamic discordance in MC 
twins34;35;38;39. Furthermore, acute shifts of blood volume in acute perinatal 
TTTS or acute perimortem TTTS may occur in any MC twins with patent 
vascular anastomoses, with or without birth weight discordance. 
Differential diagnosis of acute perinatal TTTS should not only include 
chronic TTTS, but also acute perimortem TTTS. In one case report of 
acute perinatal TTTS, the hyperperfused recipient twin died during delivery 
and the hypoperfused donor died postnatally due to acute renal failure36. 
However, pathologic examination showed chorioamnionitis and funisitis, 
and culture of the placenta grew a Fusobacterium species. Therefore, 
acute perimortem TTTS due to bacterial sepsis seems a more plausible 
explanation for the hematological and hemodynamic discordance at birth 
rather then acute perinatal TTTS.   
The pathogenesis of acute perinatal TTTS remains unclear. Superficial 
vascular anastomoses have been suggested to be responsible for acute 
perinatal blood transfusions71. The association between Hb differences 
and superficial vascular anastomoses reported in this study is in agreement 
with this suggestion. Acute fetal blood loss from the donor twin into the 
circulation of the recipient twin may then occur as a result of variations in 
blood pressure due to uterine contractions or fetal positions, but strong 
evidence is not available. Birth order may also play a major role in the 
etiology of acute perinatal TTTS. Uotila and Tammela treated three cases 
with acute perinatal TTTS during a 2-year period37. In all three cases, the 
donor twin was the second-born twin. The authors therefore hypothesized 
that acute hemorrhagic hypovolemic shock may result from acute feto-
placental transfusion from the second-born twin into the placenta due 
to decreased vascular resistance in the placenta-share of the first twin. 
Although the number of MC twins born at our hospital during the study 
period is almost certainly higher than the number reported by Uotila and 
Tammela, similar events were never recorded at our center. Moreover, most 
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authors suggest that after clamping the cord of the first-born twin, second-
born twins are more likely to receive a large placental blood transfusion 
rather than lose blood into the placenta35;38;41. Our findings also support 
this hypothesis, since second-born twins had significantly higher Hb values 
than first-born twins. 
We conclude that significant Hb differences are often found in MC twins 
without chronic TTTS, especially when Hb measurements are performed on 
day 2. Hb differences in MC twins are related to birth order and superficial 
vascular anastomoses.
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Abstract
Objective: To determine neonatal mortality and morbidity in monochorionic 
twins with chronic twin-to-twin transfusion syndrome (TTTS) treated with 
fetoscopic laser occlusion of vascular anastomoses. 
Methods: Prospective study of monochorionic twins delivered at our center 
between June 2002 and December 2004. Neonatal outcome was assessed 
in 40 monochorionic twin pairs with TTTS treated with laser compared to 
46 monochorionic twin pairs without TTTS.
Results: Neonatal mortality in the TTTS and no-TTTS group was 8% 
(6/76) and 3% (3/90), respectively. The rate of severe cerebral lesions on 
ultrasound scan in the TTTS and no-TTTS group was 14% (10/72) and 6% 
(5/82), respectively. The incidence of adverse neonatal outcome (neonatal 
mortality, major neonatal morbidity or severe cerebral lesions) in the TTTS 
and no-TTTS group was 26% (20/76) and 13% (12/90), respectively (RR = 
1.97, 95% CI = 1.03 to 3.77). 
Conclusions: Although perinatal outcome in TTTS has improved after laser 
therapy, neonatal mortality and morbidity remain high. Relative risk for 
adverse neonatal outcome is twofold increased in TTTS treated with laser 
than in monochorionic twins without TTTS. 
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Introduction
Chronic twin-to-twin transfusion syndrome (TTTS) is the most common 
major complication of monochorionic twin pregnancies and is due 
to unbalanced inter-twin blood transfusion via placental vascular 
anastomoses. TTTS leads to hypovolemia, oliguria and oligohydramnios 
in the donor twin and hypervolemia, polyuria and polyhydramnios in 
the recipient twin. If untreated, perinatal mortality and morbidity rates 
ranges from 50% to 100%110;111. Improved prenatal care strategies and 
management options have led to a significant increase in perinatal survival, 
to 60-70%27;28;93;129;137. As a result of the decrease in perinatal mortality, 
attention is now shifting towards short-term and long-term morbidity. 
Some studies have focused on long-term neurological morbidity and 
usually report a high risk of cerebral palsy in TTTS survivors12;147;151;152;226. 
Only a few studies have focused on other characteristic morbidities in 
TTTS, such as cardiovascular and renal morbidity. Cardiac morbidity 
occurs mainly in recipients with chronic volume overload and includes 
biventricular hypertrophy, tricuspid regurgitation and right ventricular 
outflow tract obstruction,19;159 whereas renal morbidity is especially 
reported in donor twins and is due to chronic volume depletion and renal 
hypoperfusion21;148;165. Ischemic limb injury has sporadically been reported 
in recipient twins due to polycythemia-hyperviscosity syndrome167. 
The two current treatment options in TTTS are serial amnioreduction and 
fetoscopic laser occlusion of vascular anastomoses27;93;129;130. Recently, a 
randomized trial demonstrated that the incidence of disease-free survival 
was higher after laser treatment than after serial amnioreduction10. 
Although fetoscopic laser occlusion of vascular anastomoses is advocated 
as the preferred treatment for TTTS, limited data are available on neonatal 
morbidity associated with this treatment. 
The first objective of this study was to determine the incidence of adverse 
neonatal outcome in monochorionic twins with TTTS treated with laser 
and to characterize neonatal morbidity after laser treatment, including 
cerebral, cardiac, hematological, renal and limb disorders. The second 
objective was to determine neonatal differences in outcome between 
donors and recipients after laser treatment.
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Methods
All consecutive cases of monochorionic twins with chronic TTTS treated 
with laser (TTTS group) and delivered at our center between June 2002 and 
December 2004 were included in this study. The Leiden University Medical 
Center is a tertiary medical center and is the national referral center for 
fetal therapy including laser treatment for TTTS in the Netherlands. The 
aim of fetoscopic laser surgery is to occlude the anastomosing vessels 
along the vascular equator of the placenta in order to interrupt the 
inter-twin transfusion of blood. After laser treatment, the amniotic sac 
of the recipient is drained a single time to reduce the polyhydramnios.  
Monochorionic twins with major fetal congenital abnormalities, acardiac 
twinning and triplet pregnancies were excluded from the study. The control 
group consisted of all monochorionic twins without TTTS (no-TTTS group) 
born at our center during the same study period. The institutional review 
board approved the study and all parents gave informed consent. 
TTTS was diagnosed using standard prenatal ultrasound criteria105: 
1.) Monochorionicity established by absence of a “twin peak” sign and 
presence of a thin dividing membrane, 2.) Oligohydramnios (deepest 
vertical pocket ≤ 2cm) in the twin sac of one fetus, and 3.) Polyhydramnios 
(deepest vertical pocket ≥ 8cm before 20 weeks of gestation or ≥ 10cm 
after 20 weeks of gestation) in the twin sac of the other fetus. TTTS 
pregnancies were staged prior to laser treatment according to the 
criteria of Quintero9. Monochorionicity was confirmed after delivery by 
histopathological examination of the placenta. Gestational age at laser 
treatment and delivery was recorded. A team composed of a sonographer 
specialized in fetal ultrasound (MS), a maternal fetal medicine specialist 
(JM) and a neonatologist (EL) met directly after delivery of each TTTS twin 
pair to determine which of the newborn infants was the donor and the 
recipient, using antenatal ultrasound measurements such as umbilical cord 
insertions, the positions of both fetuses before and after laser treatment 
and prior to delivery, estimated fetal weights and birth weights and careful 
examination of fetal membranes after birth to identify the fetoscopic defect 
in the recipient’s membranes. 
At birth, weight discordance was assessed and calculated as follows: ((birth 
weight larger twin – birth weight smaller twin)/ birth weight larger twin) x 
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100%. Significant birth weight discordance was defined as more than 20% 
difference in birth weight. Small for gestational age was defined as birth 
weight less than 10th percentile227. Hemoglobin levels were measured from 
umbilical cord blood. Reticulocyte count was measured only in the TTTS 
group. Anemia at birth was defined as hemoglobin level below the 3rd 
centile for gestational age requiring a blood transfusion during the first day 
of life. Polycythemia-hyperviscosity syndrome was defined as a hematocrit 
greater than 65% in symptomatic infants requiring treatment with partial 
exchange transfusion. Blood pressure was measured shortly after birth. 
Hypotension at birth was defined as a systolic blood pressure below the 
3rd percentile for gestational age and requiring treatment with volume 
expanders and/or inotropic support during the first day of life221. Cerebral 
ultrasound scans were performed in all neonates on the first day of life 
and thereafter according to our unit protocol. The cerebral ultrasound 
protocol at our neonatal ward requires a minimum of 3 scans during the 
first week of life (day 1, 3 and 7), followed by weekly scans thereafter until 
discharge or transfer to another hospital. Intraventricular hemorrhage 
with or without parenchymal involvement was graded according to the 
classification of Volpe228, and periventricular leucomalacia was graded 
according to the classification of de Vries et al223. Ventricular dilatation 
was diagnosed when measurement of the lateral ventricles exceeded the 
97th percentile, using ventricular index measurements as described by 
Levene229.  Severe cerebral lesions on ultrasound scans were defined as 
the presence of at least one of the following findings: intraventricular 
hemorrhage grade III, intraventricular hemorrhage with parenchymal 
involvement, cystic periventricular leucomalacia ≥ grade II, ventricular 
dilatation, porencephalic or parenchymal cysts or other severe cerebral 
lesions associated with adverse neurological outcome. We recorded the 
following neonatal morbidity: respiratory distress syndrome, chronic lung 
disease defined as oxygen dependency at 36 weeks postmenstrual age, 
symptomatic patent ductus arteriosus requiring indomethacin therapy 
or surgical closure, necrotizing enterocolitis ≥ stage II230, retinopathy of 
prematurity ≥ stage III231 and renal failure. Adverse neonatal outcome 
was defined as neonatal mortality or severe cerebral lesions or one of 
the following major neonatal disorders: chronic lung disease, necrotizing 
enterocolitis ≥ grade II, retinopathy of prematurity ≥ stage III, chronic renal 
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failure, major cardiac morbidity or major ischemic limb injury.
Data on neonatal morbidity and morbidity in monochorionic twins with 
TTTS, treated at our center but delivered at other centers, were reviewed 
retrospectively from medical records. The choice for in-institution or out-
of-institution delivery depended on the clinical picture and the wish of the 
parents.  
The primary outcome measure was adverse neonatal outcome. Secondary 
outcome measures were neonatal death, severe cerebral lesions and 
neonatal morbidity. Outcome was compared between the TTTS and the 
no-TTTS group, and between donors and recipients in the TTTS group. 
Statistics: We calculated that group sizes of 69 infants were required to 
demonstrate a 15% difference in adverse neonatal outcome (20% versus 
5%) with 0.05 significance and a power of 80%, by two-tailed analysis. 
Results of categorical variables were compared using Fisher’s exact test 
or Chi-square test, as appropriate. Unpaired Student’s t test was used to 
compare normally distributed values between two groups. For comparisons 
between donors and recipients, the paired Student t test was used for 
normally distributed continuous variables and the Mc Nemar test was used 
for analysis of paired nominal variables. A p-value < 0.05 was considered to 
indicate statistical significance. Analysis was performed using SPSS version 
11 (SPSS, Inc., Chicago, Illinois, USA). 
Results 
During the study period 85 women with TTTS were treated at our center 
with fetoscopic laser surgery. Laser treatment resulted in at least one 
survivor in 82% (70/85) of pregnancies. Intrauterine fetal demise occurred 
in 25% (42/170) of the fetuses.  Neonatal death occurred in 7% (9/128) 
of life-born infants. Overall perinatal survival was thus 70% (119/170). 
Forty TTTS pregnancies treated with laser were delivered at our center. 
All parents agreed to have their child participate in our study. The mean 
gestational age at laser treatment was 19.9 weeks (range 16-26 weeks). 
The median Quintero stage was II. Twenty percent (8/40) of pregnancies 
were stage I, 35% (14/40) stage II, 40% (16/40) stage III and 5% (2/40) 
stage IV. Two TTTS pregnancies were complicated: laser treatment was 
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attempted in a TTTS pregnancy presenting at 22 weeks of gestation with 
premature contractions and preterm premature rupture of the membranes. 
During fetoscopy, the donor twin appeared to be stuck on the placental 
surface hampering visualization of the placental vascular equator, resulting 
in incomplete laser treatment. After counseling, the parents opted for 
selective coagulation of the umbilical cord of the recipient twin. In another 
TTTS pregnancy, laser treatment was attempted at 22 weeks of gestation, 
although preterm labor due to massive polyhydramnios was at an 
advanced stage. After successful laser treatment, a cerclage was inserted to 
prevent premature delivery. Two weeks later, preterm premature rupture of 
the membranes occurred. Two girls were delivered at 25 weeks of gestation. 
Both pregnancies were included in this study on an intention to treat basis. 
Forty-six monochorionic pregnancies without TTTS were delivered at our 
center during the study period and all parents agreed to have their child 
participate in our study.
Intrauterine fetal death of one of the twins occurred in 4 cases in the TTTS 
group (2 donor twins and 2 recipient twins) and in 2 cases in the group 
without TTTS. The total number of twin infants included in the TTTS 
group and no-TTTS group was therefore 76 and 90, respectively. Patient’s 
characteristics, inter-twin birth weight differences and hemoglobin 
differences at delivery in both groups are presented in Table 1. 
Neonatal mortality and short-term morbidity in both groups are presented 
in Table 2. Adverse neonatal outcome occurred more often in the TTTS 
than in the no-TTTS group, 26% (20/75) and 13% (12/90), respectively 
(relative risk (RR) = 1.97, 95% confidence interval (CI) = 1.03 to 3.77). One 
donor twin in the TTTS group developed massive tricuspid regurgitation 
and severe hydrops after laser treatment. The infant died at delivery due to 
intractable cardiac failure. One recipient twin in the TTTS group was found 
to have right ventricular outflow tract obstruction and required balloon 
valvuloplasty. In another recipient twin, necrosis of the right hand and 
forearm was suspected antenatally at 24 weeks of gestations, eight weeks 
after laser treatment. Complete hypoplasia of the right hand and forearm 
was confirmed at delivery. One second-born twin in the TTTS group died 
at birth due to severe perinatal asphyxia, which was not related to TTTS. 
Transient renal failure with oliguria and high creatinin level (maximum 
serum creatinin level of 0.18 mmol/l on day 6) was present in one donor in 
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TABLE 2 Neonatal mortality and morbidity rates.
 TTTS group No-TTTS group p-value
 (n = 76) (n = 90)
Small for gestational age – no. (%) 19 (25%) 17 (19%) 0.32
Respiratory distress syndrome – no. (%)   26 (34%) 19 (21%) 0.05
Chronic lung disease – no. (%) 5 (7%) 4 (4%) 0.53
Patent ductus arteriosus – no. (%) 5 (7%) 4 (4%) 0.53
Necrotizing enterocolitis – no. (%) 2 (3%) 2 (2%) 0.85
Hypotension at birth – no (%) 11 (14%)  9 (10%) 0.34
Hydrops – no. (%) 1 (1%) 1 (1%) 0.90
Anemia at birth – no. (%) 13 (17%) 4 (5%) 0.01
Polycythemia-hyperviscosity – no. (%) 4 (5%) 1 (1%) 0.11
Severe cerebral lesions – no. (%) 10 (14%)  5 (6%)  0.09
Neonatal death – no. (%) 6 (8%) 3 (3%) 0.20
Adverse neonatal outcome – no. (%) 20 (26%) 12 (13%) 0.03
TABLE 1 Patients’ characteristics, inter-twin birth weight differences and hemoglobin differences 
at delivery.
 TTTS group No-TTTS group p-value
 (n = 76) (n = 90)
Gestational age at birth – weeksa 32.6 ± 3.5 33.6 ± 3.3  0.07
Female – no. (%) 38 (48%) 46 (51%) 0.74
Vaginal delivery – no. (%) 51 (66%) 57 (63%) 0.61
Median Apgar score at 5 min (range) 8.5 (1-10) 9 (3-10) < 0.01
BW – ga 1785 ± 676  2077 ± 681  < 0.01
BW difference – %a 19 ± 17 13 ± 11 0.07
BW difference > 20% – no. (%) 30 (39%) 22 (24%) 0.01
Hb at delivery – g/dL a 16.1 ± 4.2  16.1. ± 3.2  0.98
Hb difference – g/dL a 5.0 ± 5.1 1.4 ± 1.4 < 0.01
Hb difference >5 g/dL – no. (%)  28 (37%) 2 (2%) < 0.01
BW difference > 20% + Hb difference > 5 g/dL – no. (%)b 6 (8%) 2 (2%) 0.19
a Value given as mean ± SD
b Higher hemoglobin value in larger twin
BW: Birth weight; Hb: Hemoglobin
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the TTTS group. No infant developed chronic renal failure. 
Cerebral ultrasound scans were performed in 93% (154/166) of the 
neonates. Abnormalities detected on cerebral ultrasound in both groups 
are presented in Table 3. Cystic periventricular leucomalacia grade III 
or IV was not detected. Incidence of severe cerebral lesions detected on 
ultrasound performed on day 1 in the TTTS group and no-TTTS group 
was 8% (6/72) and 2% (2/82), respectively (p = 0.147). Incidence of severe 
cerebral lesions at discharge in the TTTS group and no-TTTS group was 
14% (10/72) and 6% (5/82), respectively (p = 0.089). One pair of twins in 
the no-TTTS group gradually developed progressive neurological disease 
during the first months after birth, associated with blindness, deafness and 
cerebral palsy. Diffuse cystic white matter disease was identified on cerebral 
ultrasound scans and magnetic resonance imaging. The combination 
of symptoms suggested a mitochondrial disorder, but this could not 
be confirmed. Although congenital anomalies occur more frequently in 
monochorionic twins232, metabolic diseases or mitochondrial disorders are 
not directly associated with monochorionicity. 
TABLE 3 Characterization of severe cerebral lesions detected on ultrasound scans.
 TTTS group No-TTTS group
 (n = 72) (n = 82)
Intraventricular hemorrhage grade III – no. (%) 2 (3%) 1 (1%)
Periventricular hemorrhagic infarction – no. (%) 1 (1%) 0 (0%)
Cystic periventricular leucomalacia grade II – no. (%) 4 (6%) 1 (1%)
Ventriculomegaly – no. (%) 6 (8%) 2 (2%)
Porencephalic cyst – no. (%) 1 (1%) 0 (0%)
Diffuse cystic white matter disease – no. (%) 0 (0%) 2 (2%)
After delivery, all donors and recipients delivered at our center were identified 
without doubt. Differences in neonatal mortality and morbidity between 
donors and recipients in the TTTS group are summarized in Table 4. No 
difference in adverse neonatal outcome was found between donors and 
recipients. The incidence of respiratory distress syndrome, chronic lung 
disease, patent ductus arteriosus, necrotizing enterocolitis, major cardiac 
disease and renal failure was similar between donors and recipients. 
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A hemoglobin difference > 5 g/dL at birth was found in 35% (14/40) of 
twin pairs. In 8 of these pairs (57%) the highest hemoglobin level was 
found in the ex-recipient, and in the 6 remaining pairs (43%) the ex-
donor had the highest hemoglobin level. Partial exchange transfusion 
for polycythemia-hyperviscosity syndrome was required in 4 cases, all ex-
donors. In 2 of these 4 cases a residual arterio-venous anastomosis from 
recipient to donor was found after placenta injection with colored dye. No 
difference in reticulocyte count was found between donors and recipients. 
Reticulocyte count was significantly higher in the infants with lower 
hemoglobin levels compared to their co-twin with higher hemoglobin levels, 
8.3% and 6.4%, respectively (p = 0.018).   
During the study period, 45 life-born neonates with TTTS, treated with 
laser at our center, were delivered at other centers. Mean gestational age at 
delivery in the group of infants delivered at other centers was significantly 
higher than the mean gestational age in the group of infants delivered 
at our center, 34.4 and 32.6 weeks, respectively (p = 0.005).  Median 
Quintero stage was similar in both groups (median: II; range I–IV). The 
incidence of adverse neonatal outcome in the group of neonates with 
TTTS delivered at other centers was 18% (8/45)(neonatal mortality: n = 3; 
severe neonatal morbidity: n = 3; severe cerebral lesions: n = 3). Outcome 
data in infants delivered at other centers was often incomplete. Cerebral 
ultrasound scans were performed in 44% (20/45) of the neonates. One 
TABLE 4 Neonatal mortality and morbidity rates in donors and recipients after laser treatment.
 Donors Recipients p-value
 (n = 38) (n = 38)
Birth weight – ga 1607 ± 625  1876 ± 657  0.001
Small for gestational age – no. (%) 15 (39%) 4 (11%) 0.01
Hemoglobin at birth – g/dLa 15.9 ± 4.6  16.3 ± 3.8  0.74
Anemia at birth – no. (%) 8 (21%) 4 (11%) 0.34
Polycythemia-hyperviscosity – no. (%) 4 (11%) 0 (0%) 0.12
Reticulocyte count – %a 7.2 ± 0.4 7.4 ± 0.3 0.82
Severe cerebral lesions – no. (%) 4 (11%) 6 (16%) 0.45
Neonatal death – no. (%) 2 (5%) 4 (11%) 0.62
Adverse neonatal outcome – no. (%) 8 (21%) 12 (32%) 0.34
aValue given as mean ± SD
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infant discharged without evidence of adverse neonatal outcome, gradually 
developed spastic hemiplegia. Cerebral ultrasound scan performed for the 
first time at 7 months of age showed large unilateral cystic white matter 
lesions consistent with middle cerebral artery infarction. 
Discussion 
This study is the first single center study reporting neonatal mortality 
and morbidity in TTTS after fetoscopic laser occlusion of vascular 
anastomoses. The data show that even though disease-free survival in 
TTTS has significantly increased with laser treatment10, neonatal mortality 
and morbidity remain high. Adverse neonatal outcome was more than 
twice as likely to occur in TTTS survivors after laser treatment than in 
monochorionic twins without TTTS. Since monochorionicity is known to be 
associated with adverse outcome even in the absence of TTTS4;144, selection 
of an adequate control group of monochorionic twins is crucial. 
Various factors may be related to adverse outcome in TTTS after laser 
treatment. Differences in laser techniques or experience is known to 
influence outcomes123. In a previous study we reported that perinatal 
outcomes of TTTS treated at our center with laser treatment were similar 
to those published by major laser centers worldwide137. Differences in 
surgical technique are therefore unlikely to have influenced our results. 
The most important factor leading to the high rate of adverse neonatal 
outcome in the TTTS group was the high rate of severe cerebral lesions. 
The 14% rate of severe cerebral lesions in TTTS survivors treated with laser 
found in this study was higher than the 7% rate reported in two other 
studies10;124. However, interpretation of the different results is difficult since 
inclusion criteria and definitions of cerebral lesions vary among the studies. 
In the study of Senat et al, severe cerebral lesions consisted only of severe 
cystic periventricular leucomalacia grade III to IV (n = 8) and IVH grade III 
to IV (n = 2)10 whereas we also included cystic periventricular leucomalacia 
grade II and other major cerebral ultrasound abnormalities. Most 
importantly, the incidence of severe cerebral lesions in the study of Senat 
et al was related to the total number of fetuses and not the number of life-
born infants10. The incidence of severe cerebral lesions in survivors in the 
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study of Senat would then be 12% (10/82) (periventricular leucomalacia 
grade III to IV: n = 8; IVH grade III to IV: n = 2)10. The incidence of cerebral 
lesions reported by Hecher et al does not include abnormal findings in the 
6 patients with neonatal death10;124, whereas the reported rate in this study 
concerns all life-born neonates regardless of neonatal survival. If we exclude 
the severe cerebral lesions found in the patients who died during the 
neonatal period, the incidence of severe cerebral lesions in this study is 10% 
(7/68). Nevertheless, rates of severe cerebral lesions found in this study 
are much lower than the reported rate of 18% to 55% in TTTS survivors 
not treated with laser70;124;128;146;147. Whether cerebral lesions in TTTS treated 
with laser are related to antenatal injury sustained before or after laser 
surgery, or are due to postnatal injury related to prematurity remains 
unclear. In the study by Banek et al, 2 fetuses had abnormal cerebral scans 
(ventriculomegaly, cystic defects) prior to laser treatment151. We found that 
severe cerebral lesions in the TTTS group were often detected on cerebral 
ultrasound examinations performed within 24 hours of delivery, suggesting 
antenatal origin of cerebral damage. However, presence or absence of 
severe cerebral lesions on ultrasound examination does not necessarily 
rule out a normal or adverse neuro-developmental outcome233. The lack 
of long-term follow-up data on neurological performance is an important 
limitation of the current study. We are therefore performing a prospective 
long-term follow-up study to determine the exact rate of cerebral palsy and 
cognitive deficits in both groups of twins.
Major cardiac disease occurred in two neonates in the TTTS group. One 
recipient had severe right ventricle outflow tract obstruction, and one 
donor twin had severe tricuspid regurgitation detected antenatally and died 
immediately after birth. Major renal morbidity was not detected and only 
one donor in the TTTS group had symptoms of transient mild renal failure. 
Even though the difference was not significant, gestational age in the TTTS 
group was slightly lower than in the no-TTTS group. This slight difference 
in gestational age may partially explain the lower birth weight and Apgar 
score in the TTTS group and the higher rate of respiratory distress 
syndrome. However, outcome in the TTTS group was also worse regarding 
items independent of gestational age, such as hematological discordance. 
Significant inter-twin hemoglobin differences were found in the TTTS-
group after laser treatment resulting in a higher incidence of anemia and 
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polycythemia-hyperviscosity syndrome. Differences in hemoglobin levels in 
the TTTS group were not due to hemoglobin differences between donors 
and recipients. When a hemoglobin difference > 5 g/dL was present, the 
higher hemoglobin level was almost as likely to be present in donors as in 
recipients. Several factors may lead to significant higher hemoglobin levels 
in donors than in recipients after laser treatment. First, reversal of TTTS 
may occur after laser treatment when arterio-venous anastomoses from 
recipient to donor remain patent due to incomplete coagulation of all 
vascular connections or due to re-vascularization. Residual arterio-venous 
anastosmoses were found to be the cause of polycythemia-hyperviscosity 
syndrome in two of the four patients requiring treatment with partial 
exchange transfusion. Secondly, higher compensatory hematopoiesis in 
donors due to chronic lower hemoglobin levels may theoretically persist 
after laser treatment and lead to higher hemoglobin levels in the donor 
than in recipients. However, no difference in reticulocyte count between 
donors and recipients was found in this study.
In the past, diagnosis of TTTS was reached on the basis of two main 
neonatal criteria: 1.) inter-twin birth weight discordance > 20% and 2.) 
hemoglobin difference > 5 g/dL. These criteria have been abandoned since 
similar differences occur in dichorionic twins and monochorionic twins 
without TTTS. As shown in this study, these criteria were only present in 
8% of TTTS twin pairs after laser treatment. Nowadays, diagnosis of TTTS 
is reached solely on prenatal ultrasound criteria when the characteristic 
oligo-polyhydramnios sequence is detected. In this study we found that 
even though mean hemoglobin levels were similar between donors and 
recipients, mean birth weight in donors was still significantly lower than in 
recipients, and donors were more often small for gestational age. When a 
birth weight difference > 20% was present, recipients were always the larger 
twin, except in one case where massive hydrops was present in the donor 
twin. With exception of birth weight discordance, no difference in neonatal 
mortality and major or minor morbidity was detected between donors and 
recipients.
The data in this study should be interpreted with care since a selection bias 
may have been introduced due to the specific nature of our tertiary referral 
center with neonatal intensive care facilities. It is conceivable that the 
more complicated or more premature TTTS cases may have been delivered 
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at our center whereas the less complicated or less premature cases were 
born elsewhere. Indeed, the mean gestational age at birth and incidence 
of disease-free survival in neonates with TTTS treated but not delivered 
at our center, was higher compared to the TTTS group delivered at our 
center. However, cerebral ultrasound scans were not routinely performed 
in neonates delivered at other centers. Therefore, the incidence of severe 
cerebral lesions and adverse neonatal outcome in the group of infants 
delivered at other centers may be underestimated. To overcome this type of 
bias we are currently performing a long term neuro-developmental follow-
up study in all TTTS cases treated at our center included those delivered 
elsewhere. 
In conclusion, even though perinatal outcome in TTTS has significantly 
improved after fetoscopic laser occlusion of vascular anastomoses, 
neonatal mortality and morbidity remain high. Neonates with TTTS after 
laser treatment therefore require close monitoring, donors and recipients 
alike. 
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Abstract
Objectives: To determine the incidence, origin and character of cerebral 
lesions in monochorionic twins with twin-to-twin transfusion syndrome 
(TTTS) treated with fetoscopic laser surgery. 
Methods: Prospective study of monochorionic twins with TTTS treated with 
fetoscopic laser surgery and monochorionic twins without TTTS delivered 
at our center between June 2002 and September 2005, using cranial 
ultrasonography.
Results: Incidence of antenatally acquired severe cerebral lesions in the TTTS 
group was 10% (8/84) and 2% (2/108) in the no-TTTS group (p = 0.02). 
Incidence of severe cerebral lesions at discharge was 14% (12/84) in the 
TTTS group and 6% (6/108) in the no-TTTS group (p = 0.04). Antenatal 
injury was responsible for severe cerebral lesions in 67% (8/12) of the TTTS 
group. 
Conclusions: Incidence of severe cerebral lesions in TTTS treated with 
fetoscopic laser surgery is high and results mainly from antenatal injury. 
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Introduction
The risk of cerebral palsy in twins is 7 times higher than in singletons 
and mainly due to a higher incidence of prematurity and very low birth 
weight in twins1. Cerebral palsy in twins is specifically associated with 
monochorionicity. The risk of cerebral white matter lesions and subsequent 
cerebral palsy is 7 times higher in monochorionic than in dichorionic 
twins4;234. The origin of cerebral injury in monochorionic twins is related to 
the characteristic angioarchitecture of monochorionic placentas. Almost 
all monochorionic placentas have placental vascular anastomoses, whereas 
dichorionic placentas have none. Placental vascular anastomoses may 
cause unbalanced inter-twin blood transfusion and lead to twin-to-twin 
transfusion syndrome (TTTS). TTTS usually occurs during the 2nd trimester 
of pregnancy, resulting in hypovolemia, oliguria and oligohydramnios in 
the donor twin and hypervolemia, polyuria and polyhydramnios in the 
recipient twin. The higher rate of cerebral palsy in monochorionic twins 
results mainly from TTTS. Incidence of long-term neurological morbidity in 
TTTS ranges between 10 and 25%186. The pathogenesis of cerebral injury in 
TTTS is not clear. Cerebral injury in TTTS may result from antenatal injury 
secondary to hemodynamic and hematological disorders and/or from 
postnatal injury associated to prematurity and low birth weight70;146;234. 
Two previous cranial ultrasound studies in TTTS report a high incidence 
of antenatally acquired cerebral lesions70;146. However, these findings were 
based on small, retrospective, uncontrolled studies.
The primary objective of this study is to examine a large prospective series 
of monochorionic twins with TTTS treated with fetoscopic laser surgery 
and a control group of monochorionic twins without TTTS using cranial 
ultrasonography, and to determine the incidence, origin (antenatal or 




This prospective study was conducted between June 2002 and September 
2005 at the Leiden University Medical Center. The Leiden University 
Medical Center is a tertiary medical center and serves as the national 
referral center for intrauterine laser treatment in TTTS pregnancies in the 
Netherlands. All consecutive cases of monochorionic twins with TTTS 
treated with fetoscopic laser surgery (TTTS group) and monochorionic 
twins without TTTS (no-TTTS group) delivered at our center were included 
in this study. Pregnancies complicated by intrauterine fetal demise of both 
twins, major congenital anomalies, triplets and TTTS-pregnancies not 
treated with fetoscopic laser surgery were excluded from the study. The 
institutional review board of the Leiden University Medical Center approved 
the study and all parents gave written informed consent for their children. 
TTTS was diagnosed using standard prenatal ultrasound criteria105, and 
staged according to the criteria of Quintero9. Monochorionicity was 
confirmed after delivery by histopathological examination of the placenta. 
Hemoglobin levels were measured at birth from umbilical cord blood. 
Anemia at birth was defined as a hemoglobin level below the 3rd percentile 
for gestational age requiring a blood transfusion during the first day of life. 
Polycythemia-hyperviscosity syndrome was defined as a hematocrit level 
greater than 65% in a symptomatic infant, requiring treatment with partial 
exchange transfusion. Inter-twin birth weight discordance was assessed 
and calculated as follows: ((birth weight larger twin – birth weight smaller 
twin)/ birth weight larger twin) x 100%. Birth weight discordance was 
defined as more than 20% difference in birth weight. 
Cranial ultrasound
Cranial ultrasound scans were performed in all neonates within 24 hours 
after delivery and thereafter according to our clinical protocol. The 
cranial ultrasound protocol at our neonatal intensive care unit requires a 
minimum of 3 scans during the first week of life (day 1, 3 and 7), followed 
by at least 1 scan weekly until discharge. If cerebral abnormalities were 
detected, scanning frequency was intensified around the date of detection 
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and repeated at the time of the estimated date of confinement. In term 
infants, repeat cranial ultrasound scans were not performed if scans were 
normal at birth. Cranial ultrasound scans were performed with an Aloka 
5000 scanner (Biomedic Nederland B.V., Almere, The Netherlands) with 
a multifrequency (5-10 MHz) transducer. The cerebral anatomy was 
visualized in the standard coronal and sagittal planes235. Experienced 
neonatologists performed all cranial ultrasound scans. Images were saved 
on magneto-optical disks and reviewed by two authors (EL and GvWM). 
Both authors were not blinded to the group to which the patients were 
assigned, since, being neonatologists, they were directly involved in the 
primary medical care of the neonates. Intraventricular hemorrhages (IVH) 
were classified according to Volpe236 and periventricular leucomalacia 
(PVL) was graded according to de Vries et al223. Severe cerebral lesions on 
cranial ultrasound scans were defined as the presence of at least one of the 
following findings: IVH grade III, periventricular hemorrhagic infarction, 
PVL ≥ grade II, porencephalic cyst and ventricular dilatation. Ventricular 
dilatation was present when the width of one or both lateral ventricles 
exceeded the 97th percentile229. Other cerebral abnormalities associated 
with adverse neurological outcome were also recorded and classified as 
severe cerebral lesions. Severe cerebral lesions were considered to be of 
antenatal onset if present on the first cranial ultrasound scan on day 1. 
Periventricular white matter cysts detected within two weeks after birth 
were also considered to be of antenatal onset. PVL grade I, subependymal 
pseudocysts and lenticulostriate vasculopathy were classified as mild 
cerebral lesions. Lenticulostriate vasculopathy was defined as branching 
echogenic streaks in the basal ganglia. 
The primary outcome measure was presence of severe cerebral lesions 
detected on cranial ultrasound scans. Outcome of the TTTS group was 
compared to the no-TTTS group. 
Statistics
We calculated that group sizes of 69 infants were required to demonstrate 
a 15% difference in severe cerebral lesions (20% versus 5%) with a 
significance of 0.05 and a power of 80%, by two-tailed analysis. Results of 
categorical variables were compared using Fisher’s exact test or 
Chi-square test, as appropriate. Unpaired Student’s t test was used to 
compare normally distributed values between two groups. For comparisons 
between donors and recipients, the paired Student t test was used for 
normally distributed continuous variables and the Mc Nemar test for 
analysis of paired nominal variables. Multiple logistic regression analysis 
with “random twin effect” was used to measure the independent effects 
of potential prognostic factors on outcome. A model with “random twin 
effect” was applied to adjust for possible correlated effects within twins. 
The results of the logistic models were expressed as an odds ratio (OR) and 
95% confidence intervals (CI). A p-value < 0.05 was considered to indicate 
statistical significance. Analysis was performed using SPSS version 11 (SPSS 
Inc., Chicago, IL, USA). Multiple logistic regression analysis was performed 
with EGRET version 2.0.1 for Windows (Cytel Software Corporation, 
Cambridge, Massachusetts, USA).
Results
During the study period, a total of 48 monochorionic twin pregnancies 
with TTTS treated with fetoscopic laser surgery and 60 monochorionic 
twin pregnancies without TTTS were delivered at our center. Patient’s 
characteristics in both groups are presented in Table 1. The median 
Quintero stage in the TTTS-pregnancies was II. Seventeen percent (8/48) of 
pregnancies were stage I, 35% (17/48) stage II, 44% (21/48) stage III and 
4% (2/48) stage IV. 
A total of 206 live-born neonates were eligible for this study. The neonatal 
outcome of monochorionic twins delivered at our center between June 
2002 and December 2004 has been published before207. Cranial ultrasound 
scans were performed in 93% (192/206) of neonates. Two neonates in 
the TTTS group died soon after birth before an ultrasound scan could be 
performed. Six pairs of twins (one twin pair in the TTTS group and five twin 
pairs in the no-TTTS group) were discharged from the hospital immediately 
after delivery before an ultrasound scan could be performed, all were term 
neonates in good clinical condition.
The overall incidence of antenatally acquired severe cerebral lesions 
monochorionic twins was 5% (10/192). The incidence of antenatally 
Twin-to-twin transfusion syndrome: from placental anastomoses to long-term outcome
116
Cerebral injury in TTTS treated with fetoscopic laser surgery  |   Chapter 9
11
acquired severe cerebral lesions in the TTTS group and no-TTTS group was 
10% (8/84) and 2% (2/108), respectively (OR: 5.58, 95% CI: 1.05 to 39.21, 
p = 0.02). Details of the antenatally acquired cerebral lesions are presented 
in Table 2. Small cysts located in the fronto-parietal periventricular white 
matter (PVL grade II) developed in three infants in the TTTS group within 
2 weeks of birth. A large right-sided porecencephalic cyst in the temporo-
parieto-occipital area was detected at birth in one donor twin. This was 
TABLE 1 Baseline characteristics in the TTTS group and  no-TTTS group.
 TTTS group No-TTTS group p-value
 (n = 48 pregnancies; (n = 60 pregnancies;
 96 infants) 120 infants)
Gestational age at birth – wka 32.1 ± 3.7  33.6 ± 3.1  < 0.01
Female – no. (%) 50 (52%) 64 (53%) 0.85
Vaginal delivery – no. (%) 59 (61%) 69 (57%) 0.54
Birth weight – ga 1710 ± 683  2074 ± 667  < 0.01
Birth weight difference – %a 18 ± 16 13 ± 11 0.07
Small for gestational age – no. (%) 21 (22%)  22 (18%) 0.33
Hemoglobin at birth – g/dLa 15.9 ± 4.5  16.1 ± 3.7  0.71
Hemoglobin difference at birth – g/dLa 5.8 ± 5.6 2.1 ± 3.2 < 0.01
Anemia at birth – no. (%) 18 (19%) 5 (4%) < 0.01
Polycythemia – no. (%)  5 (5%) 2 (2%) 0.12
Intrauterine fetal death – no. (%) 8 (8%) 2 (2%) 0.02
Neonatal death – no. (%) 7 (7%) 3 (3%) 0.10
aValue given as mean ± SD
TABLE 2 Antenatally acquired cerebral lesions detected by cranial ultrasound.
 TTTS group No-TTTS group p-value
 (n = 84 infants) (n = 108 infants)
IVH grade I – no. (%) 6 (7%) 2 (2%) 0.07
IVH grade II – no. (%) 3 (4%) 1 (1%) 0.20
IVH grade III – no. (%) 1 (1%) 1 (1%) 0.86
Periventricular hemorrhagic infarction – no. (%) 1 (1%) 0 (0%) 0.26
PVL grade II  – no. (%) 3 (4%) 0 (0%) 0.05
PVL grade III – no. (%) 0 (0%) 1 (1%) 0.38
Lenticulostriate vasculopathy – no. (%) 10 (12%) 2 (2%) < 0.01
Subependymal pseudocysts – no. (%) 3 (4%) 1 (1%) 0.20
Ventricular dilatation – no. (%) 3 (4%) 1 (1%) 0.20
Porencephalic cyst – no. (%) 1 (1%) 0 (0%) 0.26
Severe cerebral lesions – no. (%) 8 (10%) 2 (2%) 0.02
thought to be the end-stage of a middle cerebral artery infarction or a large 
periventricular hemorrhagic venous infarction. In the no-TTTS group, one 
infant was born 2 weeks after intrauterine fetal demise of its co-twin. On 
day 1, large cysts were found in the parieto-occipital periventricular white 
matter (PVL grade III). 
The incidence of severe cerebral lesions at discharge in the TTTS group 
and no-TTTS group was 14% (12/84) and 6% (6/108), respectively (OR: 
2.83, 95% CI: 0.93 to 8.94, p = 0.04). Findings on cranial ultrasound scans 
at discharge are summarized in Table 3. One recipient twin in the TTTS 
group developed extensive unilateral cystic white matter lesions six weeks 
after delivery. On MRI, this lesion was diagnosed as a middle cerebral 
artery infarction. One pair of twins in the no-TTTS group developed 
cerebral palsy, blindness and deafness and had diffuse cystic white matter 
disease on MRI, suggestive of a mitochondrial disorder. The proportion 
of severe cerebral lesions of antenatal origin versus severe cerebral lesions 
at discharge was 67% (8/12) in the TTTS group and 33% (2/6) in the no-
TTTS group. Multiple logistic regression was carried out to measure the 
independent associations between severe cerebral lesions at discharge and 
TABLE 3 Findings on cranial ultrasound scans at discharge.
 TTTS group No-TTTS group p-value
 (n = 84 infants) (n = 108 infants)
IVH grade I – no. (%)  6 (7%)  3 (3%) 0.16
IVH grade II – no. (%)  4 (5%)  2 (2%) 0.25
IVH grade III – no. (%) 2 (2%) 1 (1%) 0.42
Periventricular hemorrhagic infarction – no. (%)  2 (2%) 1 (1%) 0.42
PVL grade I – no. (%) 42 (40%) 25 (25%) 0.04
PVL grade II – no. (%) 5 (6%) 0 (0%) 0.01
PVL grade III – no. (%) 0 (0%) 1 (1%) 0.38
Lenticulostriate vasculopathy – no. (%)  10 (12%)  2 (2%) < 0.01
Subependymal pseudocysts – no. (%)  3 (3%) 1 (1%) 0.20
Ventricular dilatation – no. (%) 6 (7%)   2 (2%) 0.07
Porencephalic cyst – no. (%) 1 (1%)  0 (0%) 0.32
Other severe cerebral lesions – no. (%) 1a (1%) 2b (2%) 0.59
Severe cerebral lesions – no. (%) 12 (14%) 6 (6%) 0.04
aMiddle cerebral artery infarction 
bDiffuse cystic white matter disease
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various clinical parameters (TTTS, gestational age at birth, birth weight, 
inter-twin birth weight discordance, hemoglobin level at birth, anemia, 
polycythemia and inter-twin hemoglobin discordance). Only decreasing 
birth weight was independently associated with severe cerebral lesions at 
discharge (OR: 1.3 for each 100 gr decrease; 95% CI: 1.1 to 1.5, p < 0.01). 
The same analysis was performed in the TTTS group and showed a similar 
association between decreasing birth weight and severe cerebral lesions at 
discharge (OR: 1.2 for each 100 gr decrease; 95% CI: 1.1 to 1.3, p < 0.01). 
In the TTTS group, no difference was found in incidence of severe cerebral 
lesions at discharge was similar between donors and recipients, 15% (5/40) 
and 16% (7/44), respectively (p = 0.51). The incidence of lenticulostriate 
vasculopathy was also similar in recipient and donor twins, 16% (7/44) and 
8% (3/40), respectively (p = 0.13), as well as between TTTS infants with 
and without polycythemia-hyperviscosity syndrome, 0% (0/5) and 13% 
(10/79), respectively (p = 0.39).
Comment
In this study, we found that 14% of survivors with TTTS treated with 
fetoscopic laser surgery have severe cerebral lesions on cranial ultrasound 
scans. The majority of severe cerebral lesions in TTTS in our study 
population were already detected at birth, suggesting that the onset 
of brain injury in infants with TTTS is more often of antenatal than of 
postnatal origin. The incidence of antenatally acquired severe cerebral 
injury in TTTS was almost six-fold higher than in the control group without 
TTTS. Two previous cranial ultrasound studies reported an even higher 
incidence of antenatally acquired cerebral lesions in TTTS survivors70;146. 
Bejar et al found an incidence of antenatal white matter necrosis of 
respectively 55% (5/9) and 26% (7/27) in monochorionic twin infants with 
and without TTTS70. However, their findings were based on only 9 neonates 
with TTTS. In a small uncontrolled series, Denbow et al report a 35% 
(11/31) incidence of antenatally acquired cerebral abnormalities in TTTS146. 
Minor cerebral lesions such as subependymal pseudocysts, lenticulostriate 
vasculopathy and mild ventricular dilatation were also included in their 
final analysis. After we excluded the cases with minor cerebral lesions, the 
incidence of severe cerebral lesions in that study was 16% (5/31; cystic 
PVL: n = 4, periventricular hemorrhagic infarction: n = 1)146. In both 
reported studies, TTTS was not treated with fetoscopic laser surgery. 
This may explain the higher incidence of antenatally acquired severe 
cerebral lesions as cerebral injury in TTTS is known to be related to the 
type of antenatal treatment. In a randomized controlled trial comparing 
serial amnioreduction and laser treatment, severe cerebral lesions were 
diagnosed significantly more often after amnioreduction10. 
The exact mechanism responsible for antenatal cerebral injury in TTTS is 
not fully understood. Based on the ultrasound findings encountered in our 
study, most cerebral lesions could be classified in hemorrhagic injury (IVH 
and periventricular hemorrhagic infarction) or ischemic white-matter injury 
(PVL). Both types of injury have been reported to occur antenatally and are 
related to cerebral blood flow disorders236-238. Impaired cerebral perfusion 
in TTTS may result from hemodynamic imbalance and inter-twin shifts 
of blood through the vascular anastomoses and lead to hypoxic-ischemic 
insults that may have occurred prior to fetoscopic laser surgery. Indeed, 
cerebral lesions in TTTS have been detected prior to laser treatment151. 
However, so far it is not clear when cerebral injury occurs in TTTS treated 
with fetoscopic laser surgery: before, during or after laser treatment. Fetal 
neuro-imaging studies performed before and after laser treatment may 
shed more light on this issue.
Besides type of antenatal treatment, other risk factors have been reported 
to be related to cerebral lesions in TTTS, such as single intrauterine fetal 
demise, anemia or polycythemia and type of vascular anastomoses10;70;186. 
Cerebral injury in single intrauterine fetal demise is the result of hypoxic-
ischemia due to acute exsanguination from the surviving twin into 
the low-pressure circulation of the demised co-twin. Acute inter-twin 
exsanguination can only occur if the placental vascular anastomoses are 
still functional. In our study, severe cerebral lesions were detected in one 
of the two survivors in the no-TTTS group born after spontaneous co-twin 
demise in the presence of functional vascular anastomoses. Conversely, 
severe cerebral lesions occurred in only one of the eight infants in the 
TTTS-group whose co-twin died in utero after interruption of the inter-
twin placental vascular connections with laser surgery. Fetal anemia may 
negatively influence cerebral oxygenation and result in hypoxic-ischemic 
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cerebral injury238. Polycythemia has also been suggested to cause cerebral 
ischemic injury in TTTS by intravascular sludging167;238. However, in this 
study neither anemia nor polycythemia was independently associated with 
cerebral injury. Decreasing birth weight was the only independent predictor 
for cerebral injury in this study. The association between decreasing birth 
weight and severe cerebral lesions may be due to injury caused by very low 
birth weight as such or selective intrauterine growth restriction. Various 
studies have reported on the increased risk of cerebral injury in association 
with decreasing birth weight239.
We also detected rare cerebral lesions in the TTTS group, such as middle 
cerebral artery infarction. Neonatal cerebral artery infarction is in some 
cases associated with hypoxic-ischemia and/or coagulopathy disorders240. 
The etiology of the focal ischemic stroke in the recipient twin in our study is 
still obscure, but could theoretically be related to sludging of polycythemic 
blood. 
Apart from severe cerebral lesions, we also found a high incidence of milder 
cerebral lesions in the TTTS group, such as subependymal pseudocysts and 
lenticulostriate vasculopathy. Both type of lesions have been reported to be 
associated with miscellaneous conditions such as chromosomal disorders, 
congenital infection and metabolic disorders241;242. Neurological outcome 
in patients with isolated subependymal pseudocysts and lenticulostriate 
vasculopathy is usually not impaired241;242. Lenticulostriate vasculopathy 
was shown in previous studies to occur especially in recipient twins149;243. 
Nevertheless, in our study lenticulostriate vasculopathy was also detected 
in donor twins. The etiology of lenticulostriate vasculopathy is unclear and 
may be related to polycythemia in recipient twins149. However, in this study 
no association between lenticulostriate vasculopathy and polycythemia was 
found.
In conclusion, TTTS treated with fetoscopic laser surgery is associated with 
a high incidence of severe cerebral injury, mainly of antenatal origin. The 
high incidence of severe cerebral lesions warrants neonatal follow-up with 
serial cranial ultrasonography in all survivors of TTTS. Serial neuro-imaging 
studies performed before and after laser treatment are needed to evaluate 
the precise timing of cerebral injury in TTTS treated with fetoscopic laser 
surgery.
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Abstract
Objectives: To determine the incidence of congenital heart disease (CHD) 
and right ventricular outflow tract obstruction (RVOTO) in twin-to-twin 
transfusion syndrome (TTTS) treated with fetoscopic laser surgery and 
evaluate the role of increased afterload by determining the difference in 
blood pressure and endothelin-1 at birth between donor and recipient 
twins.
Methods: All consecutive cases of monochorionic twins with TTTS treated 
with laser (n = 46 twin pairs) and monochorionic twins without TTTS (n 
= 55 twin pairs) delivered at our center between June 2002 and June 2005 
were included in the study. Echocardiography was performed within one 
week after delivery. At birth, blood pressure was measured in all survivors 
and endothelin-1 was determined in umbilical cord blood. Data on RVOTO 
in TTTS treated with laser surgery at our center but delivered elsewhere 
were reviewed retrospectively from medical records. 
Results: The incidence of CHD in the TTTS group and no-TTTS group 
was 5.4% (4/74) and 2.3% (2/87), respectively (p = 0.42). RVOTO was 
diagnosed in one recipient twin delivered at our center and two recipient 
twins delivered elsewhere. The incidence of RVOTO in recipients was 4% 
(3/75). Mean systolic blood pressure at birth was similar in donor and 
recipient twins, 53 mmHg versus 56 mmHg, respectively (p = 0.42). Mean 
endothelin-1 level at birth was also similar between donors and recipients, 
14.3 ng/L and 13.2 ng/L, respectively (p = 0.64). 
Conclusions: The incidence of CHD in TTTS treated with fetoscopic laser 
surgery is higher than in the general population (5.4% versus 0.5%). We 
found no difference in afterload parameters between donors and recipients 
after laser treatment.
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Introduction
Congenital heart disease (CHD) occurs 12 times more frequently in 
monochorionic twins with twin-to-twin transfusion syndrome (TTTS) 
than in the general population19. TTTS is a severe complication of 
monochorionic twinning and affects 15% of monochorionic twin 
gestations11. TTTS results from unbalanced inter-twin blood transfusion 
via placental vascular anastomoses leading to hypovolemia, oliguria 
and oligohydramnios in the donor twin and hypervolemia, polyuria and 
polyhydramnios in the recipient twin11. Recipient twins are especially 
at risk for cardiovascular disorders. The etiology of cardiovascular 
disorders in recipients is still unclear and may result either from 
increased preload due to chronic hypervolemia162 or increased afterload 
due to high levels of vasoconstrictive substances such as endothelin-
184. Reported cardiovascular abnormalities in recipient twins include 
hypertension12;83;154, (bi-)ventricular hypertrophic cardiomyopathy18;19;155, 
tricuspid regurgitation156 and most importantly right ventricular outflow 
tract obstruction (RVOTO)19;159. RVOTO may occur at subvalvular, valvular 
or supravalvular level and the severity of the obstruction determines the 
necessity of treatment244. 
The first objective of this study was to determine the incidence of CHD, 
and particularly of RVOTO, in monochorionic twins with TTTS treated with 
laser compared to a control group of monochorionic twins without TTTS. 
The second objective was to study the potential role of increased afterload 
in CHD in TTTS after laser treatment by measuring endothelin-1 and blood 
pressure at birth.
Patients and methods
All consecutive cases of monochorionic twins with TTTS treated with 
laser (TTTS group) and monochorionic twins without TTTS (no-TTTS 
group) delivered at our center between June 2002 and June 2005 
were prospectively included in our study. Pregnancies complicated by 
intrauterine fetal demise of both twins, major congenital non-cardiac 
anomalies, triplets and TTTS-pregnancies not treated with fetoscopic 
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laser surgery were excluded from the study. The Leiden University Medical 
Center is a tertiary medical center and is the national referral center for 
fetal therapy including laser treatment for TTTS in the Netherlands. The 
institutional review board of the Leiden University Medical Center approved 
the study and all parents gave written informed consent for their children. 
TTTS was diagnosed using standard prenatal ultrasound criteria105 and 
staged according to the criteria of Quintero9. Monochorionicity was 
confirmed after delivery by histopathological examination of the placenta. 
Postnatal trans-thoracic echocardiography was performed in all surviving 
infants by experienced pediatric cardiologists within one week of delivery. 
Standard echocardiography included two-dimensional echocardiography, 
M-Mode and color Doppler studies. All examinations were performed 
with an Aloka 5000 scanner (Biomedic Nederland B.V., Almere, The 
Netherlands) with 8 MHz transducers. 
We recorded the presence of the following findings: atrial septal defect 
(ASD), ventricular septal defect (VSD), RVOTO, right or left ventricle 
hypertrophy, atrio-ventricular regurgitation and decreased shortening 
fraction. Patent ductus arteriosus and patent foramen ovale were not 
recorded as pathological cardiac findings. RVOTO was diagnosed in the 
presence of subvalvular, valvular or supravalvular obstruction245. Gradients 
were calculated using the modified Bernoulli formula245. Right or left 
ventricular hypertrophy was diagnosed if the anterior wall thickness of 
the right or left ventricle was more than the 95% confidence limits for 
estimated gestational age245. The presence of atrioventricular regurgitation 
was determined by color Doppler and classified as absent, mild-to-
moderate and severe245. Left ventricular shortening fraction was calculated 
as the end-diastolic diameter minus the end-systolic diameter divided 
by the end-diastolic diameter245. Left ventricular shortening fraction was 
reported as decreased if less than 25%. 
After birth, endothelin-1 was measured from umbilical cord blood. 
Endothelin was measured with a radioimmunoassay after C18 extraction 
and concentration. The interassay coefficient of variation ranged from 6.8 
to 9.7 % at different levels (Nichols Institute, San Juan Capistrano, CA 
92675, USA). Blood pressure was measured in each neonate on the right 
arm by Dinamap (Model XL, Critikon, Inc) with an appropriately sized 
cuff between 4 and 24 hours after birth, while the baby was supine and 
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quiet or asleep. A minimum of two blood pressure readings were taken and 
averaged. High systolic blood pressure at birth was defined as a systolic 
blood pressure above the 97th percentile for gestational age246. 
To assure that exclusion of out born cases does not create a bias on the 
incidence of RVOTO, we also reviewed the medical records of all twins with 
TTTS treated at our center between August 2000 (start of laser treatment 
program at the Leiden University Medical Center) and June 2005, including 
those delivered at other centers. The choice for in-institution or out-of-
institution delivery depended on the clinical picture and the wish of the 
parents. 
The primary outcome measures were CHD and RVOTO. The secondary 
outcome measures were blood pressure and endothelin-1 levels at birth. 
Results were compared between the TTTS and the no-TTTS group and 
between donors and recipients in the TTTS group. 
Statistics
Results of categorical variables were compared using Fisher’s exact test 
or Chi-square test, as appropriate. Unpaired Student’s t test was used to 
compare normally distributed values between two groups. For comparisons 
between donors and recipients, the paired Student t test was used for 
normally distributed continuous variables and the Mc Nemar test for 
analysis of paired nominal variables. A p-value < 0.05 was considered to 
indicate statistical significance. Analysis was performed using SPSS version 
11 (SPSS, Inc., Chicago, Illinois, USA). 
Results
Over the 3-year study period, 46 monochorionic pregnancies with TTTS 
treated with laser and 55 monochorionic pregnancies without TTTS were 
delivered at our center. All parents agreed to have their children participate 
in our study. Patient’s characteristics are presented in Table 1. The median 
Quintero stage in the TTTS group was II. Seventeen percent (8/46) of 
pregnancies were stage I, 37% (17/46) stage II, 41% (19/46) stage III and 
4% (2/46) stage IV. The overall neonatal outcome of monochorionic twins 
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delivered at our center has been published before207.
A total of 194 live-born infants were eligible for the study. 
Echocardiography was performed in 86% (74/86) of infants in the TTTS 
group and 81% (87/108) of infants in the no-TTTS group. Two neonates 
in the TTTS group died shortly after birth before echocardiography could 
be performed. One neonate, a recipient twin, died due to severe perinatal 
asphyxia. The other neonate, a donor twin, developed severe fetal hydrops 
after laser treatment in association with massive tricuspid regurgitation 
and died at delivery due to intractable cardiac failure. The parents refused 
to authorize autopsy. Echocardiography was also not performed in one 
premature neonate in the no-TTTS group who died on day 1 due to 
early onset sepsis. We were not able to perform echocardiograms in 5 
pairs of twins in the TTTS group and 10 twin pairs in the no-TTTS group 
due to early discharge from the hospital after delivery or transfer to 
TABLE 1 Baseline characteristics.
 TTTS group No-TTTS group
 (n = 64 pregnancies; (n = 55 pregnancies;
 92 fetuses) 110 fetuses)
Gestational age at birth – weeksa 32.0 ± 3.7  33.6 ± 3.1 
Female – no. (%) 44 (48%) 60 (55%)
Birth weight – gramsa 1706 ± 679  2075 ± 670 
Intrauterine fetal demise – no. (%) 6 (7%) 2 (2%)
Neonatal death – no. (%) 7 (8%) 3 (3%)
Hydrops – no. (%) 2 (2%) 0 (0%)
aValue given as mean ± SD 
TABLE 2 Findings on postnatal echocardiography.
 TTTS group No-TTTS group
 (n = 74 infants) (n = 87 infants)
Right ventricular hypertrophy – no. (%) 5 (7%) 2 (2%)
Left ventricular hypertrophy – no. (%) 1 (1%)  0 (0%)
Tricuspid regurgitation mild-moderate – no. (%) 4 (5%) 4 (5%)
ASD – no. (%) 1 (1%) 0 (0%)
VSD – no. (%) 2 (3%) 2 (2%)
RVOTO – no. (%) 1 (1%) 0 (0%)
Overall CHD – no. (%) 4 (5%) 2 (2%)
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another hospital. These 15 pairs of twins were all alive and well at birth. 
Abnormalities detected on echocardiography are presented in Table 2.
The overall incidence of CHD in monochorionic twins was 3.7% (6/161). 
The incidence of CHD in the TTTS group was 5.4% (4/74) (RVOTO, 
n = 1; VSD, n = 2; ASD, n = 1). The incidence of CHD in the no-TTTS 
group was 2.3% (2/87) (VSD, n = 2). The incidence of CHD in the sub-
group of recipient twins in the TTTS group was 7.9% (3/38). No significant 
difference was found in incidence of CHD between the TTTS group and 
no-TTTS group (p = 0.42) or between recipient twins and infants in the no-
TTTS group (p = 0.14). 
RVOTO was diagnosed in one recipient twin born at 29 weeks of gestation. 
This patient has been reported earlier207. Routine echocardiography 
performed on day 1 showed pulmonary valve stenosis. The degree of 
pulmonary valve stenosis increased during neonatal life from moderate 
to severe. At one month of age the Doppler-gradient at the valvular 
level increased up to 125 mm Hg requiring balloon valvuloplasty. Serial 
echocardiographic examinations until one year of age showed no residual 
pulmonary valve stenosis and a mild pulmonary valve regurgitation.
Since the start of the laser treatment program in August 2000, a total of 
112 TTTS twin pairs treated with fetoscopic laser surgery at our center 
were born. Overall perinatal survival was 70% (156/224) (intrauterine 
fetal demise: n = 58; neonatal death: n =10). Eighty-one (52%) survivors 
were donor twins and 75 (48%) were recipient twins. RVOTO (valvular 
pulmonary stenosis, n = 2, supravalvular pulmonary stenosis, n =1) was 
diagnosed in three TTTS survivors, including the previously reported 
patient and 2 other patients born elsewhere after fetoscopic laser 
treatment at our center. All patients with RVOTO were recipient twins. 
The overall rate of RVOTO in recipient twins with TTTS treated with laser 
was therefore 4% (3/75). Detailed information on the three recipients with 
RVOTO is presented in Table 3.
Results of blood pressure measurements and endothelin-1 concentrations 
in the TTTS group and no-TTTS group are shown in Table 4. We found 
no significant differences in blood pressure and endothelin-1 levels at 
birth between both groups or between donor and recipient twins. None 
of the neonates had persistent hypertension or required treatment for 
hypertension at the time of study.
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TABLE 3 Prenatal and postnatal findings in the 3 recipients (1 born at our center and 2 born elsewhere) with 
RVOTO after laser therapy. 
GA at Quintero Recipient fetal GA at Postnatal cardiac diagnosis and course
laser stage echocardiography birth 
(wk)   (wk)
  Evidence of RVOTO  Progression from moderate to severe valvular PS
 15     2 AP max 4.5 m/s  29 Balloon valvuloplasty at 1 month of age
    No residual PS. Mild PI
    Systolic heart murmur detected at 2 months of age
 22     2 No evidence of RVOTO  37 Severe supravalvular PS detected at 2 months of age
    Surgical repair at 2 months of age
    No residual PS. Mild PI
    Severe respiratory failure at birth requiring ECMO
    Severe valvular PS detected at 1 week of age
 18     2 No evidence of RVOTO  33 Balloon valvuloplasty at the age of 1 week
    Repeat balloon valvuloplasty at the age of 4 months
    No residual PS. Mild PI
GA, gestational age; RVOTO, right ventricular outflow tract obstruction; AP, pulmonary artery flow velocity; PS, pulmonary 
stenosis; Pi, pulmonary valve insufficiency; ECMO, extra corporeal membrane oxygenation
TABLE 4 Systolic blood pressure and endothelin-1 levels at birth in donor and recipient twins.
 TTTS group No-TTTS group p-value
All monochorionic twins (n = 86 infants) (n = 108 infants)
Systolic blood pressurea – mm Hg 55 ± 13 55 ± 10 0.91
Systolic blood pressure > 97th centile – no. (%) 8 (9%)  5 (4%)  0.08
Endothelin-1a – ng/L 15.3 ± 7.7   15.3 ± 8.8  0.97
 Donors Recipients p-value
TTTS group (n = 41 infants) (n = 45 infants)
Systolic blood pressurea – mm Hg 53 ± 14 56 ± 11 0.21
Systolic blood pressure > 97th centile – no. (%) 5 (12%) 5 (11%) 1.0 
Endothelin-1a – ng/L 15.6 ± 7.7  15.1 ± 8.2  0.64
aValue given as mean ± SD
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Discussion
In this study, we report a high incidence of CHD in TTTS survivors 
(5.4%) after fetoscopic laser surgery and particularly in recipient twins 
(7.9%). The actual incidence of CHD in TTTS in this study is probably 
underestimated as prenatal findings of fetuses who died in utero or were 
aborted were not included, and postnatal cardiac evaluation was not 
assessed in one hydropic infant who died at birth due to intractable cardiac 
failure. Overall, the reported rates of CHD in TTTS are higher than in the 
general population (0.5%)247. These results are in accordance with two 
previous studies on CHD in TTTS survivors19;248. Karatza et al reported an 
overall prevalence of CHD of 6.9% (6/87) in TTTS and 11.9% (5/42) in 
recipients19, whereas Herberg et al reported a prevalence of CHD of 11.2% 
(10/89) in TTTS and 13.7% (7/51) in recipients248. The overall incidence 
of RVOTO in all TTTS survivors treated with laser at our center was 4%. 
The RVOTO was hemodinamically significant in all patients requiring 
surgical or catheter-interventional treatment. As echocardiographic 
examination is not routinely performed in TTTS survivors born in other 
hospitals, however, mild RVOTO may not have been recognized. Herberg 
et al reported a 7.8% postnatal rate of RVOTO (4/51) in recipient twins 
with TTTS treated with fetoscopic laser surgery, but also included 2 cases 
with moderate and mild RVOTO treated expectantly248. The prenatal and 
postnatal rate of RVOTO in recipient twins with TTTS not treated with 
laser ranges from 4.8% to 11.3%19;159;162. Whether cardiovascular morbidity 
in recipient twins, and in particular RVOTO, is associated with the type of 
antenatal treatment is not known. The two current treatment options in 
TTTS are serial amnioreduction and fetoscopic laser treatment. A recently 
published randomized controlled trial comparing both treatments showed 
that perinatal mortality and neurological morbidity were significantly lower 
after laser surgery10. However, cardiovascular morbidity was not reported 
in this trial10. 
This study is the first controlled single center study reporting cardiovascular 
morbidity in TTTS after fetoscopic laser surgery. Comparison with 
a control group of monochorionic twins without TTTS is of crucial 
importance because monochorionicity is associated with increased 
incidence of CHD even in the absence of TTTS19. We found no difference 
in incidence of CHD in recipient twins treated with laser compared to 
monochorionic twins without TTTS. A possible reason for the lack of 
difference between the two groups may have been that our study was 
underpowered. To detect a 10% difference in CHD rate (12% versus 2%) 
between recipient twins and monochorionic infants without TTTS we 
would have needed a sample size of at least 100 children in each group 
(with 0.05 significance and a power of 80% by two-tailed analysis). Such 
large cohorts in TTTS studies can only be achieved with multi-center 
studies or longer study-periods. 
The etiology of CHD in recipients with TTTS has been linked with increased 
preload due to volume overload following feto-fetal transfusion, as well as 
increased afterload due to high levels of vasoconstrictive hormones, such 
as endothelin-1249. Endothelin-1 levels have been reported to be 
2 ½ -fold higher in recipients than in donors84. Increased afterload and 
systemic hypertension during fetal life may then lead to the development 
of hypertrophic cardiomyopathy and eventually RVOTO. Reports of high 
blood pressure in recipient twins in fetal and neonatal life are consistent 
with this hypothesis12;83;154. We, as well as others, have previously shown 
that systemic hypertension, a clinical parameter for increased afterload, 
occurs more often in recipient twins than in donor twins12;83;154. In this 
study, however, we found no difference between donors and recipients 
in blood pressure and endothelin-1 concentrations at birth. Absence of 
difference in blood pressure and endolthelin-1 levels may be related to the 
type of antenatal treatment. Other reports showing increased afterload 
in recipients, have been performed in TTTS not treated with laser12;83;84;154, 
whereas in our study all TTTS cases were treated with laser antenatally. 
Fetoscopic laser surgery occludes the placental vascular anastomoses and 
is therefore considered to be a causal treatment. Hypothetically, initial 
differences in blood pressure and endothelin-1 levels that were present 
before laser treatment may have gradually diminished and disappeared 
after laser treatment. 
In conclusion, the incidence of CHD in TTTS survivors treated with 
fetoscopic laser occlusion of vascular anastomoses is low, but still higher 
than in the general population. In particular, the increased risk for RVOTO 
in recipient twins warrants close cardiac monitoring during fetal and 
neonatal life.
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Abstract
Objective: To determine the long-term neurodevelopmental outcome in 
children after twin-to-twin transfusion syndrome (TTTS). 
Methods: Maternal and neonatal medical records of all TTTS-cases 
admitted to our center between 1990 and 1998 were reviewed. 
Neurological and mental development at school age was assessed during a 
home visit in all TTTS survivors.  
Results: A total of 33 pregnancies with TTTS were identified. Four couples 
opted for termination of pregnancy. All other pregnancies were managed 
conservatively, 18 (62%) with serial amnioreductions and 11 (38%) 
without intrauterine interventions. Mean gestational age at delivery was 
28.6 (range: 20-37) weeks. Perinatal mortality was 50% (29/58). Birth 
weight of donor twins was less than recipient twins (p < 0.001). Systolic 
blood pressure at birth was lower in donors than in recipients (p = 0.023) 
and donors required more frequently inotropic support postnatally than 
recipients (p = 0.008). The incidence of hypertension at birth was higher in 
recipients than in donors (p = 0.038). Abnormal cranial ultrasonographic 
findings were reported in 41% (12/29) of the neonates. All long-term 
survivors (n = 29) were assessed during a home visit. Mean gestational age 
at birth of the surviving twins was 31.6 (range: 25-37) weeks. Mean age at 
follow-up was 6.2 (range: 4-11) years. The incidence of cerebral palsy was 
21% (6/29). Five out of six children with cerebral palsy had an abnormal 
mental development. The incidence of cerebral palsy in the group of 
survivors treated with serial amnioreduction was 26% (5/19). Four children 
were born after intrauterine fetal demise of their co-twin: two of them had 
cerebral palsy.
Conclusions: The incidence of adverse neurodevelopmental outcome in TTTS 
survivors is high, especially after intrauterine fetal demise of a co-twin.
Twin-to-twin transfusion syndrome: from placental anastomoses to long-term outcome
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Introduction
Cerebral palsy is estimated to occur seven times more often in twins 
than in singletons1. The higher relative risk for cerebral damage is not 
only attributable to the higher incidence of premature birth and low 
birth weight in twins compared to singletons. Monochorionic twinning 
predisposes to cerebral damage due to complications caused by twin-
to-twin transfusions250. Twin-to-twin transfusion syndrome (TTTS) 
occurs in approximately 15% of monochorionic pregnancies and results 
from shunting of blood from one twin, the donor, to the other twin, the 
recipient. The donor becomes hypovolemic and oliguric, whereas the 
recipient becomes hypervolemic and polyuric11. The management of TTTS 
remains a significant challenge in perinatal medicine and the perinatal 
mortality rate in untreated TTTS is reported to be 75-100%112;114. Treatment 
of TTTS with serial amnioreductions or with laser coagulation of placental 
vascular anastomoses has decreased the perinatal mortality rate to an 
average rate of approximately 40%123;124;129. Nevertheless, the morbidity in 
surviving twins, which includes mainly neurological, cardiovascular and 
renal complications, remains high11. Cerebral white-matter lesions have 
been reported to occur antenatally in up to 35% of TTTS survivors146. To 
date, few studies have reported long-term neurodevelopmental outcome 
in TTTS. The incidence of cerebral palsy and global developmental delay 
in surviving twins varies from 4% to 23%39;133;147;148;150;152. However, in most 
studies, follow-up of the surviving twins did not extend beyond a mean age 
of 2 years corrected for prematurity. Assessment at school age is essential 
since neurological handicaps and mental retardation may only become 
evident several years after birth251-253. The main purpose of our study was 
to evaluate long-term neurodevelopmental outcome in school-aged twins 
after TTTS.  
Material and Methods
We identified all cases of TTTS who were admitted at our center from 
January 1990 to December 1998. Written information on the aims of the 
study was sent to the parents of all surviving twins. Parents were asked 
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for consent to examine their children. Neurological outcome was assessed 
in all children by a single pediatrician during a home visit. Neurological 
outcome was defined as abnormal when evidence of cerebral palsy was 
found. Cerebral palsy was classified as diplegia, hemiplegia, quadriplegia, 
dyskinetic or mixed. We estimated the level of mental development of 
the children according to their school performance. School entry in 
the Netherlands starts at four years of age. All children with learning 
disabilities due to mental retardation or behavioral problems are referred 
to a school for special education. For the purposes of the study, children in 
mainstream education with or without special assistance were considered 
to have a normal mental development, whereas children who needed 
special education as well as children one or more grades below the 
appropriate school-level for their age were considered to have an abnormal 
mental development.   
Diagnosis of TTTS was reached according to the following prenatal 
ultrasound criteria: 1.) monochorionicity established by absence of a 
“twin peak” sign and the presence of a thin dividing membrane, 2.) 
oligohydramnios (deepest vertical pocket < 1cm) in the twin sac of  one 
fetus and 3.) polyhydramnios (deepest vertical pocket > 8cm) in the twin 
sac of the other fetus. During the study period, the standard treatment 
at our center for TTTS was serial amnioreduction. Monochorionicity was 
confirmed after delivery. 
The following obstetrical data were extracted from the medical charts: 
gestational age at the time of diagnosis, number of therapeutic 
amnioreductions and total volume of amniotic fluid removed, intrauterine 
fetal death, gestational age at delivery and mode of delivery. We also 
recorded the stage of TTTS on admission9. In short, staging according to 
Quintero has five stages: stage I, bladder of donor twin still visible; stage 
II, anuria of donor twin; stage III, critically abnormal Doppler studies; 
stage IV, hydrops; stage V, demise of one or both twins19. The following 
neonatal data were extracted: birth weight, Apgar score at 5 minutes, 
arterial blood pressure on admission measured with Dinamap, hematocrit 
on day 1 of life. Growth discordance between recipient and donor was 
calculated by dividing the difference in birth weights by the birth weight 
of the recipient twin. Hypotension or hypertension at birth was defined 
as a systolic blood pressure respectively below the 3rd or above the 97th 
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percentile for gestational age246. We also recorded the use of inotropic 
support during the stay in our nursery. Neonatal cranial ultrasound 
findings were reviewed, such as periventricular leucomalacia (PVL) (grade 
classification according to de Vries et al 223), intraventricular hemorrhage 
(IVH) (grade classification according to Volpe et al236), porencephalic or 
parenchymal cysts, subependymal pseudocysts, ventriculomegaly and 
lenticulostriate vasculopathy. Other significant neonatal problems were 
also reviewed, including transient tachypnoea of the newborn, respiratory 
distress syndrome, chronic neonatal lung disease, patent ductus arteriosus, 
necrotizing enterocolitis, renal failure, hydrops fetalis, retinopathy of 
prematurity and congenital malformation. 
Analysis of the TTTS group according to whether the twins were donor or 
recipient was performed in order to detect eventual differences in perinatal 
mortality and morbidity as well as differences in long-term outcome. 
Results of categorical variables were compared using Fisher’s exact test, 
whereas continuous normally distributed variables were examined with 
paired Student’s t test. Chi-square test for trend was used in order to 
evaluate the relationship between stage of TTTS and outcome. A p-value 
< 0.05 was considered to indicate statistical significance. Analysis was 
performed using SPSS version 10 (SPSS, Inc., Chicago, Illinois, USA).
Results 
Obstetrical  results
During the 8-year study period, 33 multiple pregnancies (31 twins and 
2 triplets) with TTTS were admitted to our center. The mean gestational 
age at the time of diagnosis was 22.4 (range: 15-28) weeks. The 
Quintero stage at admission was I in nine cases, II in eight cases, III in 
ten cases, IV in three cases and V in three cases. Four couples opted for 
termination of pregnancy. In the remaining 29 pregnancies, intrauterine 
fetal demise of both twins occurred in 38% (11/29) of the pregnancies. 
In four pregnancies, one twin survived while the co-twin died in utero. 
Caesarean delivery was performed in 9 (31%) of the 29 pregnancies. 
The mean gestational age at delivery was 28.6 (range: 20-37) weeks. 
Serial amnioreduction was performed in 18 (62%) of the 29 TTTS-
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pregnancies. Mean gestational age at birth of the group of twins treated 
with serial amnioreduction was 31.3 weeks (range: 28-35). The median 
number of amnioreductions per case was 1 (range: 1-7) and the mean 
amount of amniotic fluid removed 2 liters (range: 0.5-15) per pregnancy. 
Amnioreduction was not performed in the remaining 15 pregnancies either 
due to intrauterine death of one or both twins at presentation (n = 7), 
because the patient opted for termination of pregnancy (n = 4), because of 
mild TTTS (Quintero stage I) (n = 3), or due to imminent delivery (n = 1).  
We found a direct relationship between stage of TTTS and mortality rate (p 
= 0.042) as well as stage of TTTS and adverse outcome (cerebral palsy or 
death) (p = 0.015) (Table 1). Cases in which parents opted for termination 
of pregnancy (n = 4) and cases with stage V (n = 3) of TTTS were not 
included in this analysis. 
TABLE 1 Mortality rate and adverse outcome (cerebral palsy or death) by stage of TTTS. 
Stage Deatha Cerebral palsy or Deathb
 I  31% (5/16) 37% (6/16)
 II 33% (4/12) 42% (5/12)
 III 61% (11/18) 83% (15/18)
 IV 67% (4/6) 67% (4/6)
Total 46 % (24/52) 58 % (30/52)
Values are percentages (numbers)
Cases in which parents opted for termination of pregnancy (n = 4) and cases with stage V (n = 3) of TTTS were not 
included in this analysis. 
aChi-square test for trend = 4.1, df = 1, p = 0.042
bChi-square test for trend = 5.9, df = 1, p = 0.015
Neonatal results
Thirty-six (55%) fetuses were male, 30 (45%) were female. The overall 
perinatal survival rate was 50% (29/58) and in the subgroup treated with 
serial amnioreduction, 53% (19/36). Neonatal death occurred in 3 
infants, all donor twins, and was caused by terminal renal failure (n =1), 
Escherichia coli sepsis (n = 1) and severe respiratory distress syndrome 
(n = 1). There was no difference in overall perinatal mortality between 
donor and recipient twins (Table 2). The mean birth weight in donors was 
1016 gr (range: 220-2740), whereas the mean birth weight in recipients 
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was 1291 gr (range: 310-2790). The difference in birth weight between 
donors and recipients was significant (p < 0.001). Eight of the seventeen 
donors (47%) were also small for gestational age as compared to none of 
the recipients (p = 0.003). The mean birth weight discordance between life 
born recipients and donors was 24% (range: 2%-41%). The median Apgar 
score at 5 minutes was 8 (range: 4-10). There was no significant difference 
in Apgar score between donors and recipients. The mean hematocrit at 
birth in donors was 48.2 (range: 28-68) l/l and in recipients, 51.8 (range: 
39-66) l/l. The difference in hematocrit between donors and recipients 
was not significant. The mean systolic blood pressure at birth in donor 
twins was 45.6 (range: 30-60) mmHg and in recipients 61.8 (range: 44-
94) mmHg. The difference in systolic blood pressure at birth between 
donors and recipients was significant (p = 0.023). Eight of the seventeen 
donors (47%) also required inotropic support as compared to only one 
of the recipients (p = 0.008). Hypertension at birth was found in 27% 
(4/15) of the recipients, but in none of the donors (p = 0.038).  Renal 
failure occurred in two neonates, both donor twins. One of them died from 
terminal renal failure, the other child requires hemodialysis. Fetal hydrops 
was found in two twins at delivery (6%). One of them was a recipient twin. 
The other case of fetal hydrops occurred in a donor after the co-twin died 
in utero and was secondary to severe fetal anemia (hemoglobin value of 4.5 
g/dL) probably following acute blood loss into the dead co-twin through 
the vascular anastomoses. An intrauterine blood transfusion raised the 
hemoglobin to 13 g/dL. The donor twin was born a few days later and 
was still hydropic. The incidence of respiratory distress syndrome was 31% 
(10/29). The incidence of chronic lung disease was 10% (3/29). Patent 
TABLE 2 Mortality and morbidity in donor and recipient twins.
 Donor Recipient p-value
 (n = 29) (n = 29)
IUFD  41% (12/29) 48% (14/29) NS
NND  18% (3/17) 0% (0/15) NS
Overall perinatal death  52% (15/29) 48% (14/29) NS
Cerebral Palsy 17% (3/17) 17% (3/17) NS
Cases in which parents opted for termination of pregnancy (n = 4) were not included in this analysis.
iUFD, intrauterine fetal demise; NND, neonatal death; NS, not significant.
Twin-to-twin transfusion syndrome: from placental anastomoses to long-term outcome
142
ductus arteriosus was found in 25% (8/32) of the neonates. Necrotizing 
enterocolitis was diagnosed in 9% (3/32) of the neonates. None of the 
neonates had retinopathy of prematurity or congenital malformations. We 
found no significant differences in neonatal morbidity between donors and 
recipients. Abnormal cranial ultrasonographic findings were found in 12 of 
the 29 neonates (41%) in whom a scan was performed (IVH grade I-II: n = 
4, unilateral IVH grade III with intraparenchymal echodensity: n = 2,
bilateral IVH grade III with intraparenchymal echodensity: n = 1, PVL 
grade I: n = 3, ventriculomegaly: n = 3, lenticulostriate vasculopathy: n = 
1). In 3 neonates no cranial ultrasound scan was performed. We found 
no significant differences in abnormal ultrasonographic findings between 
donors and recipients.
Long-term outcome
We were able to follow-up all 29 surviving twins during a home visit. 
The derivation of the surviving population is shown in a flow diagram 
in Figure 1. The mean gestational age at birth of the surviving twins was 
31.6 (range: 25-37) weeks and the mean age at follow-up was 6.2  (range: 
4-11) years. The incidence of cerebral palsy was 21% (6/29) (spastic 
quadriplegia: n = 2, spastic diplegia: n = 3, spastic hemiplegia: n = 1). The 
incidence of cerebral palsy in the group treated with serial amnioreduction 
was 26% (5/19). Five children with cerebral palsy had an abnormal mental 
development, and one child with left spastic hemiplegia had a normal 
FiGURE 1 Outcome of 58 fetuses in 29 pregnancies with TTS.
Cases in which parents opted for termination of pregnancy (n = 4) were not included in this analysis.
iUFD, intrauterine fetal demise; NND, neonatal death; CP, cerebral palsy
58 fetuses with TTS
28 (48.3%) double survivors26 (44.8%) IUFD 4 (6.9%) single survivors
4 (14.3%) CP 22 (78.6%) no CP2 (50%) CP 1 (25%) no CP1 (25%) NND 2 (7.1%) NND
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mental development. All children with abnormal mental development 
needed special education. Both infants with quadriplegia were severe 
mentally retarded. Data regarding the 6 surviving twins with abnormal 
neurodevelopmental outcome are listed in Table 3. In the group of children 
without cerebral palsy or abnormal mental development, 22% (5/23) of 
the children had a mild speech delay and required speech therapy. All of 
these children were kept in mainstream education with special assistance 
from a teacher or remedial teaching. 
Four survivors were born after intrauterine fetal demise of their co-twin: 
one of them died in the neonatal period due to sepsis caused by Escherichia 
coli, two survivors have cerebral palsy and only one survivor has a normal 
outcome. The incidence of adverse long-term neurodevelopmental outcome 
in twins whose co-twin died in utero was 67% (2/3). The incidence of 
adverse long-term neurodevelopmental outcome in twins who were both 
born alive was 15% (4/26). The difference in neurodevelopmental outcome 
between survivors whose co-twin died in utero compared to twins who 
were both alive at birth was not significant, probably because study 
numbers were too small.
Gestational age at birth as well as birth weight was not associated with 
a significantly higher incidence of adverse neurodevelopmental outcome. 
We found no significant difference in long-term neurodevelopmental 
outcome between donors and recipients. In the neonatal period, IVH 
grade I-II was diagnosed in 4 neonates. All of them have a normal long-
term psychomotor outcome. One neonate had a bilateral IVH grade III 
with intraparenchymal echodensity and died in the neonatal period due 
to terminal renal failure. Two neonates from the same pregnancy had a 
unilateral IVH grade III with intraparenchymal echodensity. One of them 
died two days after birth due to multi-organ failure. Its co-twin had a right-
sided IVH grade III with intraparenchymal echodensity and has now spastic 
hemiplegia on the left side. PVL grade I was diagnosed in 3 neonates. 
Two of them have an abnormal long-term neurodevelopmental outcome. 
One of them also had ventriculomegaly but has only mild symptoms 
(mild speech and motor delay) without further signs of cerebral palsy or 
abnormal mental development. Another child with ventriculomegaly died 
two days after birth. The neurodevelopmental outcome of the recipient 
twin with lenticulostriate vasculopathy was normal.
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Comment
In this study we analyzed the perinatal mortality and morbidity in TTTS. 
We report a high perinatal mortality rate (50%) in TTTS, emphasizing 
the critical nature of this disease. The perinatal mortality rate in the 
group treated with serial amnioreduction was slightly lower (47%), 
and comparable to previously published mortality rates in pregnancies 
managed similarly123;124;129. We also found a direct relationship between 
stage of TTTS and mortality rate as well as between stage of TTTS and 
adverse outcome (cerebral palsy or death), confirming the prognostic 
significance of the Quintero staging classification. Regarding the neonatal 
morbidity, this study shows a significant difference in systolic blood 
pressure at birth between donors and recipients. Hypertension in recipients 
has previously been reported, and is theoretically more consistent with 
increased afterload rather than increased preload following volume 
overload83. Increased afterload may result from a higher endothelin-1 
level in recipients84. Abnormal cranial ultrasonographic findings were 
found in 41% of the neonates who underwent cranial ultrasonography. 
Denbow et al reported an even higher incidence, 58%146, whereas Hecher 
et al reported a lower incidence (range: 6% to 18%, depending on the type 
of antenatal therapy) of abnormal cranial ultrasound findings123. However, 
the definition of abnormal ultrasound findings in the study of Hecher et al 
did not include IVH grades I and II. 
The main objective of our study was to evaluate the long-term 
neurodevelopmental outcome in TTTS. We report a high incidence 
(21%) of cerebral palsy and abnormal mental development in surviving 
twins with TTTS. This is the first study in which all TTTS survivors 
were at least 4 years of age at follow-up. Since the incidence of adverse 
neurodevelopmental outcome is positively correlated to the duration of 
follow-up, it is important to continue follow-up until school age252;253. 
The incidence of cerebral palsy and abnormal mental development is 
similar to most previous publications on long-term neurodevelopmental 
follow-up. Haverkamp et al found a 23% incidence of severe psychomotor 
retardation in combination with cerebral palsy in a cohort of 40 TTTS 
survivors who were followed until a mean age of 24 months147. Cincotta 
et al found a 22% incidence of cerebral palsy and global developmental 
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delay in 23 surviving twins who were followed to at least 2 years of age 
corrected for prematurity148. In a smaller study of 14 TTTS survivors who 
were followed until 2 years of age, Seng et al report a lower incidence 
(14%) of cerebral palsy with mental retardation39. However, the inclusion 
criteria for TTTS of Seng et al were not based on prenatal ultrasound 
findings, but rather on postnatal inter-twin hemoglobin and birth weight 
differences. Other studies, including our study, have shown that the 
recipient does not necessarily have a higher hemoglobin or a higher 
hematocrit than the donor. Reaching the correct diagnosis of TTTS is 
no longer guaranteed by these postnatal criteria. Therefore, some of 
their patients may not have been affected by TTTS, which would also 
explain the exceptionally high survival rate (88%) in their study. Mari et 
al also report a much lower incidence (5%) of cerebral palsy in a cohort 
of 42 surviving twins who were at least 2 years of age at last follow-up150. 
However, one infant in their cohort had multilocular encephalopathy 
but was lost to follow-up. Another infant died at 6 months of age of 
respiratory as well as neurological complications. Whether this child also 
had cerebral palsy is not clearly mentioned. Most importantly, the rate of 
neonatal deaths in their study was high, 16% (8/51). Half of these neonatal 
deaths occurred in children born at 24 and 25 weeks of gestation. The 
incidence of neurodevelopmental disability in children born at 24 and 
25 weeks’ gestation is reported to range from 12% to 45%239. Two other 
neonates who died in their study were reported to have abnormal cranial 
ultrasound findings (respectively brain infarction and IVH). Therefore 
the suspected incidence of cerebral palsy in the study of Mari et al could 
be higher. In all three neonatal deaths reported in our study, major 
abnormal cranial ultrasound findings were found (bilateral IVH grade III 
with intraparenchymal echodensity, n = 1; unilateral IVH grade III with 
intraparenchymal echodensity, n = 1; ventriculomegaly, n = 1). Therefore, 
the incidence of cerebral palsy in our study would most certainly have 
been higher had these three neonatal deaths not occurred. Mari et al also 
found that survivors born after 27 weeks of gestation had an excellent 
long-term outcome. In our study, 5 of the 6 survivors with adverse 
neurodevelopmental outcome were born after 27 weeks of gestation. We 
found that adverse neurodevelopmental outcome was associated with 
IUFD of a co-twin. This result supports previously published findings in 
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which a high incidence (27%) of serious neurological morbidity was found 
in survivors after death of a co-twin11. The major cause of cerebral white-
matter damage in surviving twins whose co-twin died in utero is acute 
cerebral ischemia due to acute exsanguination of the surviving twin into the 
low-resistance vascular system of the moribund or dead twin through the 
vascular anastomoses11.  
In all previously reported long-term follow-up studies, TTTS pregnancies 
were treated with serial amnioreduction. In our study, the incidence of 
adverse neurodevelopmental outcome in twins with TTTS treated with 
serial amnioreduction was also high (26%). Recent reports suggest 
that laser ablation therapy of placental vascular anastomoses may be 
associated with a lower incidence (4-9%) of cerebral palsy in surviving 
twins compared to serial amnioreduction133;152. To assess the difference 
in mortality and morbidity between laser ablation therapy and serial 
amnioreduction, results of the first randomized control trial (www.
eurofoetus.org) comparing both treatments must be awaited. Considering 
the high incidence of adverse neurodevelopmental outcome in TTTS, we 
recommend that all surviving twins be thoroughly followed up. 
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Abstract
Objective: To determine the long-term neurodevelopmental outcome in 
twin-to-twin transfusion syndrome (TTTS) treated with fetoscopic laser 
surgery. 
Methods: All TTTS-cases treated at our center with laser between August 
2000 and December 2003 were included in the study. Neurological, mental 
and psychomotor development at 2 years of age corrected for prematurity 
was assessed in all TTTS survivors. Neurodevelopmental impairment 
was defined as any of the following: cerebral palsy, deafness, blindness, 
mental or psychomotor development index of the Bayley Scales of Infant 
Development II < 2 SD.   
Results: A total of 82 TTTS pregnancies were treated with fetoscopic laser 
surgery during the study period. Perinatal survival was 70% (115/164). 
The incidence of neurodevelopmental impairment was 17% (19/115) and 
was due to cerebral palsy (n = 8), mental developmental delay (n = 9), 
psychomotor developmental delay (n = 12) and deafness (n = 1). 
Conclusions: The incidence of neurodevelopmental impairment in TTTS 
survivors treated with laser is high and warrants long-term follow-up. 
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Introduction
Monochorionic twinning predisposes to cerebral damage due to 
complications caused by twin-to-twin transfusion (TTTS). TTTS occurs 
in approximately 15% of monochorionic pregnancies and results from 
shunting of blood from one twin, the donor, to the other twin, the 
recipient, through placental vascular anastomoses. Untreated, TTTS is 
associated with high perinatal mortality and morbidity130. The two current 
treatment options in TTTS are serial amnioreduction and fetoscopic laser 
occlusion of vascular anastomoses27;93;129;130. In a recent randomized trial 
comparing serial amnioreduction and laser treatment, perinatal survival 
and neurological outcome at six months of age was significantly better 
in the group treated with laser10. Although fetoscopic laser occlusion of 
vascular anastomoses is increasingly being advocated as the preferred 
treatment for TTTS, only a few studies have been published on the 
long-term neurodevelopmental outcome following such treatment. The 
incidence of major neurological abnormalities in these reports varied from 
6% to 11%151;152;254. 
The main objective of our study was to evaluate long-term 
neurodevelopmental outcome in a large group of TTTS survivors after 
treatment with fetoscopic laser surgery.  
Patients and methods
All survivors of consecutive TTTS-cases treated with fetoscopic laser 
surgery between August 1, 2000 and December 31, 2003 at the Leiden 
University Medical Center were included in the study. The Leiden University 
Medical Center serves as the national referral center for intrauterine laser 
treatment in TTTS pregnancies in the Netherlands. TTTS was diagnosed 
using standard prenatal ultrasound criteria105, and staged according to 
the criteria of Quintero9. The following perinatal data were recorded: 
gestational age at the time of laser treatment, stage of TTTS, gestational 
age at delivery, mode of delivery and birth weight. Inter-twin birth weight 
discordance was assessed and calculated as follows: ((birth weight larger 
twin – birth weight smaller twin)/ birth weight larger twin) x 100%. Birth 
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weight discordance was defined as more than 20% difference in birth 
weight.
The follow-up visit was assessed at 2 years of age (corrected for 
prematurity) and included a physical and neurological examination and 
an assessment of cognitive and neuromotor development using the Dutch 
version of the Bayley Scales of Infant Development, 2nd edition (BSID-
II) (both by certified examiners). Bayley scale scores provide mental 
development indexes (MDI) and psychomotor development indexes (PDI). 
The mean score for both MDI and PDI is 100. A score below 70 is more 
than 2 SD below the mean score and indicates a severe delay. Infants 
with very low MDI or PDI scores (< 50) were assigned a score of 49 in the 
database. Cerebral palsy (CP) was defined according to the European CP 
Network and classified as diplegia, hemiplegia, quadriplegia, dyskinetic or 
mixed255. 
A composite outcome, termed neurodevelopmental impairment (NDI), 
was defined as any of the following: CP, MDI score of less than 70, PDI 
score of less than 70, bilateral blindness, or bilateral deafness requiring 
amplification. Overall adverse outcome was defined as intrauterine fetal 
death, neonatal death, infant death or NDI. Outcome was compared 
between donor and recipient twins. 
The institutional review board of the Leiden University Medical Center 
approved the study and all parents gave written informed consent for their 
children.
Statistics
Results of categorical variables were compared using Fisher’s exact test 
or Chi-square test, as appropriate. Unpaired Student’s t test was used to 
compare normally distributed values between two groups. For comparisons 
between donors and recipients, the paired Student t test was used for 
normally distributed continuous variables and the Mc Nemar test for 
analysis of paired nominal variables. Multiple logistic regression analysis 
with “random twin effect” was used to measure the independent effects 
of potential prognostic factors on outcome. A model with “random twin 
effect” was applied to adjust for possible correlated effects within twins. 
The results of the logistic models were expressed as an odds ratio (OR) and 
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95% confidence intervals (CI). Chi-square test for trend was used in order 
to evaluate the relationship between stage of TTTS and outcome. A p-value 
< 0.05 was considered to indicate statistical significance. Analysis was 
performed using SPSS version 11 (SPSS Inc., Chicago, IL, USA). Multiple 
logistic regression analysis was performed with EGRET version 2.0.1 for 
Windows (Cytel Software Corporation, Cambridge, Massachusetts, USA).
Results 
During the study period, 82 TTTS pregnancies were treated with fetoscopic 
laser surgery at our center. Quintero stage was I in 9 cases, II in 35 cases, 
III in 32 cases and IV in 6 cases. Laser surgery treatment for Quintero 
stage I was only performed when symptomatic polyhydramnios warranted 
intervention. Mean gestational age at laser surgery was 20.0 weeks. 
Intrauterine fetal demise occurred in 41 fetuses (single intrauterine fetal 
demise, n = 15; double intrauterine fetal demise, n = 26). Mean gestational 
age at birth of the surviving infants was 33.9 ± 3.1 weeks (range: 27 to 40 
weeks). Neonatal death occurred in 8 neonates. Overall perinatal survival 
was 70% (115/164). We were able to follow-up all 115 surviving twins. Four 
families refused to travel to our center for follow-up visit due to the long 
travel distance, but agreed to allow the complete follow-up examination 
(including BSID-II test) at their own home. Baseline characteristics of the 
TTTS survivors are presented in Table 1. 
TABLE 1 Baseline characteristics in the 115 TTTS long-term survivors.
 Long-term survivors 
  (n = 115 infants)
Gestational age at laser surgery - wka 20.2 ± 3.0  
Median Quintero stage (range)  2 (1-4)
Gestational age at birth - wka 33.9 ± 3.1  
Female - no. (%) 55 (48%)
Vaginal delivery - no. (%) 80 (70%)
Birth weight - ga 2015 ± 678  
aValue given as mean ± SD
Twin-to-twin transfusion syndrome: from placental anastomoses to long-term outcome
154
The incidence of NDI was 17% (19/115) and was due to cerebral palsy 
(n = 8), severe mental developmental delay (n = 9), severe psychomotor 
developmental delay (n = 12) and deafness (n = 1). Cerebral palsy was 
classified as quadriplegia (n=4), diplegia (n= 2) and hemiplegia (n= 2). 
The incidence of adverse outcome (death or NDI) was 41% (68/164). 
Details on long-term outcome are presented in Table 2.  
TABLE 2 Long-term outcome in 115 TTTS survivors after fetoscopic laser surgery.
 Long-term survivors 
  (n = 115 infants)
Cerebral palsya - no. (%) 8 (7%)
Mental development index < 2 SD - no. (%) 9 (8%)
Psychomotor development index < 2 SD - no. (%) 12 (10%)
Bilateral deafness - no. (%) 1 (1%)
Bilateral blindness - no. (%) 0 (0%)
Neurodevelopmental impairmentb - no. (%) 19 (17%)
aCerebral palsy included spastic quadriplegia (n = 4), spastic diplegia (n = 2) and spastic hemiplegia (n = 2)
bNeurodevelopmental impairment is defined as any of the following: cerebral palsy, mental development index < 2 SD, 
psychomotor development index < 2 SD, bilateral deafness or blindness. 
Intrauterine fetal demise in donors and recipients occurred in 21% (17/82) 
and 29% (24/82), respectively (p = 0.12). Neonatal death occurred in 5% 
(4/82) of donors and 5% (4/82) of recipients (p = 1.0). Characteristics 
and outcome in surviving donor and recipient twins at 2 years of age are 
presented in Table 3. 
We found a direct relationship between stage of TTTS and death (Chi-
square test for trend = 5.8, df = 1, p = 0.016) as well as stage of TTTS and 
adverse outcome (Chi-square test for trend = 9.2, df = 1, p = 0.002) 
(Table 4).
Multiple logistic regression was carried out to measure the independent 
associations between NDI and various clinical parameters (gestational 
age at laser, gestational age at birth, birth weight, Quintero stage and 
donor versus recipient status).  We found a trend towards an independent 
association between higher Quintero stages and NDI (OR 6.6 for each 
stage, 95% CI 0.7 – 66.0, p = 0.079) and lower gestational age at birth and 
NDI (OR 1.6 for each week, 95% CI 0.8 – 3.0, p = 0.080).
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Comment
The main objective of our study was to evaluate the long-term 
neurodevelopmental outcome in TTTS survivors treated with fetoscopic 
laser surgery. We were able to follow-up all (100%) TTTS survivors and 
report a high incidence (17%) of NDI. The long-term neurolodevelopmental 
outcome found in this study is in agreement with the short-term 
neurological outcome reported previously by our research group, in which 
we found a similar incidence (14%) of severe cerebral lesions in TTTS 
survivors after laser treatment206. 
TABLE 3 Characteristics and outcome in donor and recipient twins.
 Donor Recipients p-value
 (n = 61) (n = 54)
Birth weight - ga 1773 ± 608  2076 ± 567  < 0.001
Weight at 2 years of age - kga 11.7 ± 1.3  12.3 ± 1.3  < 0.001
Length at 2 years of age - cma 86.8 ± 4.1  87.6 ± 3.8   0.005 
Head circumference at 2 years of age - cma 48.5 ± 1.4  48.9 ± 1.4  0.006
Cerebral palsy - no. (%) 3 (5%) 5 (9%) 0.25
Mental development indexa 96 ± 16 96 ± 18 0.90
Psychomotor development indexa 91 ± 13 89 ± 18 0.52
Neurodevelopmental impairmentb - no. (%) 10 (16%) 9 (17%) 1.0
aValue given as mean ± SD
bNeurodevelopmental impairment is defined as any of the following: cerebral palsy, mental development index < 2 SD, 
psychomotor development index < 2 SD, bilateral deafness or blindness.
TABLE 4 Mortality rate and adverse outcome (neurodevelopmental impairment or death) by stage of TTTS. 
TTTS stage Deatha Adverse outcomeb,c
 I 6% (1/18) 6% (1/18)
 II 29% (20/70) 40% (28/70)
 III 36% (23/64) 52% (33/64)
 IV 42% (5/12) 50% (6/12)
aChi-square test for trend = 5.8, df = 1, p = 0.016 
bChi-square test for trend = 9.2, df = 1, p = 0.002 
cAdverse outcome = intrauterine fetal demise, neonatal death or neurodevelopmental impairment. 
Twin-to-twin transfusion syndrome: from placental anastomoses to long-term outcome
156
Four studies from three different research groups have reported on long-
term outcome in TTTS after laser surgery. The incidence of NDI found 
in this study is somewhat higher than in these other reports. However, 
special care must be taken when comparing results from various studies, 
as discrepant results may partly be due to different methodology, selection 
criteria and definitions of NDI. De Lia et al report a 6% (6/93) incidence 
of severe handicaps in TTTS survivors after laser surgery131. Mean age 
at follow-up was 14 months (range 1 to 34 months), which may be too 
soon for accurate assessment of CP or major developmental delay. Most 
importantly, the methods used to determine neurodevelopmental outcome 
were not specified, suggesting that accurate assessment of mental and 
psychomotor development was not performed. Sutcliffe et al found a 9% 
(6/66) incidence of CP in a cohort of TTTS survivors treated with laser152. 
Follow-up was however incomplete (81%) and in 47% (31/66) of patients 
neurological outcome was assessed using information from the general 
practitioner. In the group assessed by a pediatrician, 14% (5/36) had CP. 
Children assessed by pediatricians were also tested with a standardized 
developmental test (Griffiths’ Developmental Test Scales). However, 
details on the number of infants with severe developmental delay (defined 
as a score < 2 SD) were not reported or scored as primary outcome, as 
opposed to the definition used in this study. The two largest follow-up 
cohorts have been reported by a research group from Germany. Using 
standardized developmental test and neurological examination, Banek et 
al and Graef et al report an incidence of major neurological deficiencies 
of 11% (10/89) and 6% (10/167), respectively151;254. In both studies, 
the definition of major neurological deficiencies did not include severe 
developmental delay. Therefore, as opposed to this study, infants with 
severe developmental delay but without CP were not included in the group 
with major abnormalities. Also, developmental outcome in the majority of 
children (112/167) in the study from Graef et al was only assessed by the 
Snijders-Oomen Non-Verbal-Intelligence Test and therefore motor abilities 
were not tested254. The incidence of CP in the studies from Banek et al and 
Graef et al, respectively 11% and 6%, was nevertheless similar to the 7% 
incidence of CP found in this study151;254.
After treatment of TTTS with amniodrainage, most studies on long-term 
outcome report a high incidence of NDI, ranging from 22 to 26%12;147;148;226. 
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Only one study in TTTS treated with amniodrainage reported a lower 
incidence of CP or multicystic encephalomalacia of 7% (3/42)150, without 
assessment of neurodevelopmental delay. Overall, the reported incidence 
of NDI appears to be higher in TTTS survivors treated with serial 
amniodrainage than with laser surgery. However, different methodology 
may also explain the discrepancy in results between various follow-up 
studies. To assess the true difference in NDI in TTTS survivors treated 
with either laser surgery or serial amnioreduction, results of the long-term 
follow-up in the first randomized control trial comparing both treatments 
must be awaited10.
Absence of a control group is an important limitation of this study. A case-
control study comparing the long-term outcome in monochorionic twins 
with TTTS treated with laser and monochorionic twins without TTTS is 
currently being performed at our institution153. 
We found no difference in NDI between donor and recipient twins, 
suggesting that both are equally at risk for adverse neurodevelopmental 
outcome. These results are in agreement with previous studies12;151;254. 
Donor twins are significantly smaller at birth than recipient twins, and 
remain smaller and shorter at 2 years of age. These findings are in 
agreement with previous reports12. According to the ‘fetal origins of adult 
disease’ or ‘Barker hypothesis’, lower birth weight  is associated with an 
increased risk for coronary heart disease, diabetes, hypertension and stroke 
in adulthood256. Whether reduced birth weight in donor twins in TTTS may 
also lead to increased incidence of adult diseases is not known yet. 
We also found increasing Quintero stage to be associated with combined 
adverse outcome (death or NDI). Our results confirm previous 
findings9;12;126;257. Although the prognostic value of Quintero stages is 
subject of debate93;258, our results suggest an important prognostic value of 
Quintero staging. Multivariate analysis also showed that higher Quintero 
stages are almost independently associated with NDI. Similarly, we found 
a trend towards an independent association between lower gestational age 
at birth and NDI. Prematurity is a well recognized risk factor for adverse 
neurodevelopmental outcome in twins as well as in singletons239;258.
The objective of fetal therapy should be to reach a high percentage of 
intact-survival. Even though fetoscopic laser surgery appears to be the 
best available treatment option for TTTS, the idealistic goal of high intact-
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survival rate has not yet been reached. Timing of cerebral injury leading 
to NDI in TTTS treated with fetoscopic laser surgery is not clear. Cerebral 
injury may occur before, during or after laser surgery. Therefore, whether 
cerebral injury and subsequent NDI could be prevented by advances in laser 
surgery techniques such as more selective or more complete coagulation 
of anastomoses, or by adaptation of inclusion criteria for laser surgery is 
not known. Considering the high incidence of adverse neurodevelopmental 
outcome in TTTS, we recommend that all surviving twins be thoroughly 
followed up.
C h a p t e r  13
General discussion

Twin-to-twin transfusion syndrome (TTTS) is a severe complication 
of monochorionic twin pregnancies resulting from unbalanced inter-
twin blood flow between the donor twin and the recipient twin through 
placental vascular anastomoses. TTTS leads to hypovolemia and 
oligohydramnios in the donor and hypervolemia and polyhydramnios in 
the recipient. During the last decades, new insights have been gained in the 
pathogenesis, diagnosis and management of TTTS. An important milestone 
in the history of TTTS was the definition of clear and uniform diagnostic 
criteria105 and a staging system9. Most importantly, new therapeutic 
modalities have led to improved outcome10. Finally, increased attention on 
TTTS from (medical) journals has resulted in improved “TTTS-awareness” 
in perinatologists, mid-wives and parents. A PubMed search with the term 
“twin-twin transfusion syndrome” between 1965 and 2005 yielded a total 
of 952 hits. The vast majority of these studies are of recent date. As shown 
in figure 1, the number of publications on TTTS is increasing every year 
with a current average of 3 new publications per week.
However, despite the multitude of data currently available, various aspects 
of TTTS are still enigmatic and remain to be elucidated.














FiGURE 1 Number of TTTS publications per year.
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The pathogenesis of TTTS is nowadays regarded as a multifactorial 
process. Various studies have shown that unbalanced inter-twin blood 
flow occurs principally in the absence of equilibrating superficial arterio-
arterial anastomoses194. However, the view that TTTS may develop only 
from simple blood transfer from donor to recipient has been discarded. 
Inter-twin transplacental transfer of various hormones, in particular 
hormones related to the renin angiotensin system, play an important role 
in the development of TTTS259. Understanding of the pathophysiology of 
TTTS is hampered by the absence of a suitable animal model. Computer 
models for TTTS have proved to be a valid alternative for animal models. 
However, computer models require input from clinical data. Determination 
of anastomotic blood flow is an example of the type of data which can 
be used to validate these computer models. In the TTTS case presented 
in Chapter 3, we calculated that the blood flow across the anastomoses 
was approximately 28 ml/24h at 29 weeks’ gestation. Meanwhile, an 
almost identical TTTS case was treated at our institution, in which we 
also measured the percentage of transfused adult red blood cells (or 
adult hemoglobin) in the “new” recipient after birth. Blood flow through 
the only patent residual arterio-venous anastomosis in this second TTTS 
case was determined to be 18ml/24h at 29 weeks’ gestation, which is in 
excellent agreement with the arterio-venous flow measured in the previous 
case. These results confirm the accuracy of the two different calculation 
methods. These mathematical experiments which enabled us to calculate 
arterio-venous anastomotic flow, can also be repeated in similar TTTS 
cases found by other research groups. The main pre-requisites required 
for these tests are: (1) hemoglobin levels (fetal and adult hemoglobin 
values) measured before and after the various intrauterine transfusions 
and at birth and (2) a placental injection study showing patent arterio-
venous anastomoses in only one direction. These measurements and their 
correlations with different anastomotic patterns may further enhance 
computer modeling for TTTS and improve our understanding of the 
pathogenesis of TTTS.
It is now generally accepted that TTTS is not a homogeneous disease, and 
should be subdivided into two major forms: chronic TTTS and acute TTTS. 
Diagnosis of chronic TTTS is based on strict antenatal ultrasound criteria. 
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The main criterium required to reach the diagnosis of chronic TTTS is 
the twin oligo-polyhydramnios sequence (TOPS). However, as shown in 
the two reported cases in Chapter 6, significant chronic inter-twin blood 
transfusion can also occur in the absence of TOPS. We named this atypical 
form of chronic TTTS, twin anemia-polycythemia sequence (TAPS) and 
established new diagnostic criteria required to reach the diagnosis of TAPS. 
We have recently detected another case of TAPS at our center with similar 
hematological and placental findings as in the two previously reported 
cases. In a consecutive series of 81 monochorionic twins/triplets without 
chronic TTTS delivered at our center since 2002, TAPS was found in only 3 
cases, which yields an incidence of TAPS of 4% (3/81).  This would suggest 
that TAPS is not a very frequent phenomenon in monochorionic twinning. 
However, recent studies report an unexpected and unexplained high risk 
(5%) of late fetal death in monochorionic twins without TTTS260, which 
may, hypothetically, be caused by TAPS. In addition to the “natural” form 
of TAPS, recent studies also report the existence of an iatrogenic form of 
TAPS214.  In a large study of 151 TTTS cases treated with laser, Robyr et 
al found that 13% of the cases developed isolated anemia-polycythemia 
sequence without oligo-polyhydramnios sequence214, so-called iatrogenic 
TAPS. Interestingly, it was usually the former recipient who became anemic, 
whereas the former donor became polycythemic213;214. In a recent study with 
mathematical modeling, we were able to explain this clinical presentation 
of feto-fetal transfusion reversal after incomplete laser therapy and predict 
significant discordant hematocrit values in both twins in the absence 
of amniotic fluid abnormalities due to residual anastomoses261. This 
phenomenon results from, first, the increased colloid oncotic pressure 
present in the former recipient prior to and shortly after laser, and second, 
continued feto-fetal transfusion261.
The acute form of TTTS can be divided in acute perimortem TTTS and 
acute perinatal TTTS. The occurrence of acute perimortem TTTS has been 
undoubtedly proven and is known to be associated with a high risk of 
perinatal mortality and morbidity in the surviving twin13-16;30-33. In contrast, 
acute perinatal TTTS is only based on a few, often incomplete case 
reports34-39. Most case reports of acute perinatal TTTS failed to determine 
the inter-twin difference in reticulocyte count (or erythropoietin levels) 
and lacked accurate placental injection study. Therefore some of the cases 
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may well have been TAPS cases instead of acute perinatal TTTS. In our 
series of 81 consecutive uncomplicated monochorionic twins, no cases of 
acute perinatal TTTS have been observed. However, we noticed another 
important perinatal hematological phenomenon which may often occur 
in monochorionic twinning and is related to birth order and placento-
fetal transfusion. As shown in Chapter 7, second-born twins have higher 
hemoglobin levels than first-born twins. Hypothetically, after clamping of 
the first-born’s umbilical cord, uterine contractions may allow placental 
blood from the first twin’s low-pressure placental bed to be transfused 
through the low-resistance superficial vascular anastomoses into the 
higher pressure circulation of the second twin. Large inter-twin hemoglobin 
differences in monochorionic twins without chronic TTTS may thus be due 
to acute placento-fetal transfusion rather than feto-fetal transfusion.
The optimal management of TTTS is limited by a paucity of well-designed 
studies. Most studies are observational and few studies have focused on 
the long-term outcome. Only two randomized controlled trials on the 
management of TTTS have been published. Moise et al compared serial 
amnioreduction and septostomy and reported similar short-term outcomes 
between both treatments140. Senat et al compared serial amnioreduction 
and fetoscopic laser surgery and found that perinatal mortality and short-
term neurologic morbidity were significantly lower in the group treated 
with laser surgery10. Despite the significant improvement due to treatment 
with fetoscopic laser surgery, perinatal mortality and morbidity in TTTS 
remain strikingly high, especially when considering that both fetuses 
were probably initially structurally normal. Several studies presented in 
this thesis, report in detail the significant short and long-term perinatal 
morbidity in TTTS survivors treated with laser. The most deleterious type 
of morbidity encountered in TTTS survivors is severe cerebral injury. We 
found that 14% of TTTS survivors after laser surgery have severe cerebral 
injury on cranial ultrasound. Nevertheless, the incidence of severe cerebral 
injury in TTTS treated with laser is still significantly lower than in TTTS 
treated with amnioreduction. In the randomized trial from Senat et al, 
extensive cystic periventricular leucomalacia grade III or IV occurred less 
often in the laser group than in the amnioreduction group, 6% versus 
14%, respectively (RR 0.39, 95% CI 0.18 - 0.86, p = 0.02)10. The timing of 
General discussion |   Chapter 13
165
cerebral injury in TTTS treated with laser is not known, and could occur 
before, during or after laser surgery. To answer this question, a sequential 
fetal MRI study performed before and after laser surgery is required. 
The origin of cerebral damage in TTTS is not clear and may be related 
to hemodynamic imbalance in cerebral flow causing hypoxic-ischemic or 
hemorrhagic injury. Recently, Rodeck et al presented a new hypothesis (the 
placental ‘steal’ phenomenon) which can explain the severe neurological 
outcome seen in TTTS cases treated with amnioreduction262. They suggest 
that amnioreduction may lead to a radical shift of blood from the fetus 
into the placenta causing hypoxic-ischemic brain damage. Since single 
amnioreduction is also performed routinely in patients during fetoscopic 
laser surgery procedures, the placental ‘steal’ phenomenon may also occur 
in TTTS treated with laser.
The 14% incidence of severe cerebral injury in TTTS survivors after laser 
treatment found in our study is in accordance with the 17% incidence of 
neurodevelopmental impairment detected in long-term survivors (see 
Chapter 12). Nevertheless, the reported incidence of neurodevelopmental 
impairment in TTTS treated with laser appears to be lower than in TTTS 
treated with serial amniodrainage (see also Chapter 11)12;147;148;151;152;226;254.  
Obviously, caution is advised when comparing the various results in view of 
the observational nature of these follow-up studies and the methodological 
differences between the studies. To assess the true difference in 
neurodevelopmental impairment in TTTS survivors treated with either laser 
surgery or serial amnioreduction, results of the long-term follow-up in the 
ongoing randomized trial must be awaited10.
In conclusion, despite significant progression during the last decades, 
the management of TTTS remains one of the most challenging medical 
problems in fetal medicine. More research is necessary to further improve 
the prognosis of TTTS.

C h a p t e r  14
Future perspectives
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Fetal medicine is a new discipline, gradually evolving from a field with 
mainly diagnostic function to a broader field with also life-saving 
therapeutic possibilities. However, few interventions in fetal medicine 
are evidence-based. Most fetal medicine studies are observational and 
often limited by small numbers of included patients. To date, only few 
randomized controlled trials in fetal medicine have been performed. 
Interestingly, two of these trials involved the treatment of TTTS10;140. 
Hopefully, TTTS can pave the way for more randomized controlled studies 
in fetal medicine. 
There are still several aspects in TTTS requiring further investigation:
1. The exact pathogenesis of TTTS needs to be further unraveled. Due to the 
absence of animal models, computer modeling of TTTS may prove to 
be a valuable alternative. However, for computer models to be reliable, 
they require realistic input from in vivo cases. Intensive collaboration 
between perinatologists and computer modeling scientists may lead to 
new important discoveries. New research should also keep focusing on 
the role of various hormonal factors. These data may then in return be 
used to improve computer modeling of TTTS. 
 Routine placental injection study of all monochorionic placentas, with 
and without TTTS, has already yielded interesting discoveries (e.g. 
in our studies) and can still lead to new insights. Injection studies of 
TTTS placentas treated with laser may also help in understanding the 
underlying cause of the high incidence of residual anastomoses. This 
information may be crucial for the individual fetal surgeon to reduce 
the frequency of residual anastomoses. Furthermore, determination of 
the type and number of placental vascular anastomoses can be used 
to study the possible relation between angioarchitecture and timing 
of onset of TTTS. As suggested at the last Eurofoetus meeting (Paris, 
May 2006) late onset TTTS (i.e. after 26 weeks) may occur when a 
large amount of anastomoses is present. Finally, more placental casting 
studies are needed to determine the incidence and clinical implications 
of the recently reported deep anastomoses which are not visible on 
the placental surface263;263;264. We recently finished a casting study of 
monochorionic placentas with TTTS (after laser treatment) and without 
TTTS and are currently in the process of analyzing the data.
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2. The diagnosis of TTTS and its related complications may, in the 
near future, gain more accuracy with the use of improved imaging 
techniques. Several studies have investigated the value of (Doppler) 
ultrasound examination in predicting the development of TTTS or 
the outcome in TTTS, including a study performed at our institution 
by Sueters et al (TULIPS study)68;109. Other studies have reported that 
detection of an arterio-arterial anastomosis decreases the risk of 
developing TTTS by 9-fold66;68. Fetal magnetic resonance imaging (MRI) 
is a new promising technique which is nowadays increasingly being 
used17;265-267. Fetal brain MRI is particularly useful in TTTS as it appears 
to detect brain lesions earlier and with better definition than prenatal 
ultrasound177. However, more research is required to evaluate the 
optimal timing of fetal MRI in TTTS and determine the exact prognosis 
of each type of detected lesion. A study entitled “Cerebral Imaging 
in Monochorionic Twins: CIMT study” will soon start at the Leiden 
University Medical Center. The objective of this study is to evaluate the 
incidence, character and origin of cerebral lesions in monochorionic twins 
with TTTS treated with laser using sequential fetal and neonatal MRI 
and 4D ultrasound. A group of monochorionic twins without TTTS will 
serve as control group. The most important research question is whether 
cerebral injury occurs before or after laser surgery. If severe cerebral 
lesions occur before laser and can be detected accurately, then this could 
have major implications for future management strategies in TTTS. 
3. The optimal management of TTTS, and especially the occurrence of early 
and late complications in TTTS treated with laser, requires further 
investigation. Future studies should focus on the optimization of various 
treatments to improve the outcome in TTTS. New techniques, such as 
combined laparoscopy and fetoscopy in complete anterior placenta 
developed at our center, may further improve outcome (Eurofoetus 
meeting, Paris 2006). Recently, we also proposed the use of laser 
surgery in TTTS up to 28 weeks of gestation, as neonatal morbidity 
was lower compared to TTTS cases treated with amnioreduction 
(Eurofoetus meeting, Paris 2006). Other major issues, such as reduction 
of preterm delivery and rupture of membranes after fetoscopy, may 
further increase survival rates in TTTS.
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4. There is paucity of long-term follow-up studies in monochorionic 
twins. More data on long-term studies in monochorionic twinning 
are strongly required. We are currently investigating the long-term 
neurodevelopmental outcome at 2 years of age in all monochorionic 
twins with and without TTTS delivered at our center between June 
2002 and September 2005. We also intend to examine this cohort of 
monochorionic twins at 5 years of age to assess the neurodevelopmental 
outcome at school age. Well documented cohorts of monozygotic twins 
with single intrauterine growth restriction form also an ideal group to 
test the ‘Barker hypothesis’256. According to this hypothesis, the risk of 
adult diseases such as coronary heart disease, diabetes, hypertension 
and stroke is increased in adults who were growth restricted during 
fetal life256. Monozygotic twins are genetically identical but may be 
subjected to a different intrauterine environment. Whether monozygotic 
twins with discordant fetal growth also have a discordant risk of adult 
diseases requires further investigation. 
5. in general, there are several important aspects to be taken into 
consideration for future research in TTTS. One of the main limitations 
of most TTTS studies is the small size of included patients, which is 
inherent to the rarity of the disorder itself. To overcome this major 
problem, future study designs should preferentially be multicentered. 
A second general problem concerns the definition of adverse outcome. 
To date, most TTTS studies focus on “survival” instead of “disease-
free survival”. Given the high percentage of cerebral injury in TTTS, 
future studies should aim at evaluating long-term neurodevelopmental 
outcome, or at least short-term neurological outcome.   
 To reach a consensus on the optimal treatment in monochorionic 
twin pregnancies and TTTS in particular, more randomized trials 
are required. Various trials have already been proposed. Moise et al 
suggested that a randomized trial of combination amnioreduction/
septostomy versus laser surgery in early stage TTTS should be 
performed140. Quintero et al suggested that a trial of laser surgery versus 
expectant management is indicated in monochorionic twins with highly 
discordant intrauterine growth restriction135. Lastly, given the high 
rate of unexpected late fetal deaths in uncomplicated monochorionic 
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twins, Barigye et al suggested that a trial should be designed to test the 
potentially beneficial role of early delivery in monochorionic twins260. 
 
 Although these trials may certainly be indicated, studies in TTTS should 
not only focus on perinatal “survival” but especially on “intact-survival”. 
If the fetus is truly to become a unique patient268, then primary outcome 
measures in fetal medicine, and TTTS in particular, should be “survival 
without severe morbidity”.
C h a p t e r  15
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Twin-to-twin transfusion syndrome (TTTS) is a severe complication of 
monochorionic twin pregnancies associated with high perinatal mortality 
and morbidity rates. Placental vascular anastomoses, almost invariably 
present in monochorionic placentas, are the essential anatomical 
substrate for the development of TTTS. TTTS is thought to result from 
unbalanced inter-twin blood flow between the donor twin and the recipient 
twin through the vascular anastomoses, leading to hypovolemia and 
oligohydramnios in the donor and hypervolemia and polyhydramnios in the 
recipient. Despite significant developments in the diagnosis, staging and 
management of TTTS, the pathogenesis of TTTS is still poorly understood 
and, most importantly, perinatal mortality and morbidity in TTTS remain 
strikingly high.
In this thesis, several studies on TTTS are presented regarding various 
aspects of this disease, including studies on monochorionic placentas 
to investigate the pathogenesis of TTTS, description of a new form of 
chronic TTTS and the short and long-term outcome in TTTS treated with 
fetoscopic laser surgery. 
In Chapter 2, an overview of the literature is presented. This review analyzes 
the possible pathophysiologic mechanisms involved, discusses the latest 
findings in diagnosis, therapy and prognosis, and focuses on neonatal and 
pediatric morbidity associated with TTTS. 
In Chapter 3 we describe a novel technique to calculate the net feto-fetal 
blood flow through placental arterio-venous anastomoses in a case of 
TTTS treated with laser surgery and subsequent intrauterine transfusion. In 
this study we determined that the net blood flow through the five residual 
unidirectional arterio-venous anastomoses was approximately 28 ml/24h, 
much lower than previously measured with Doppler ultrasound. This 
finding may also explain the inaccuracy of Doppler flow measurements, as 
such low flow velocities cannot possibly be detected with current Doppler 
techniques. Measurements of anastomotic blood flow are of major 
importance for the validation and development of accurate computer 
modeling in TTTS.
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In Chapter 4 we studied the role of velamentous cord insertion and 
discordant placental territories in the pathogenesis of TTTS by comparing 
monochorionic placentas with and without TTTS. Previously, several 
studies reported an increased incidence of velamentous cord insertions in 
TTTS placentas and suggested a direct relation between velamentous cord 
insertion, unequal placental territories and the development of TTTS. In 
this study we examined 76 monochorionic placentas with TTTS and 63 
monochorionic placentas without TTTS. The incidence of velamentous cord 
insertion (per fetus) in the TTTS group and the no-TTTS group was 13% 
and 14% (p = 0.79), respectively. Placental territory discordancy in the TTTS 
group and the no-TTTS group was 20% in both groups (p = 0.83). In the 
TTTS group, donor twins had more often a velamentous cord insertion than 
recipient twins (24% and 3%, respectively, P < 0.001) and smaller placental 
territories (44% and 56% respectively, p < 0.001). Our findings suggest that 
velamentous cord insertion and placental territory discordancy are not 
critical factors for the development of TTTS.
In Chapter 5 the frequency of residual placental vascular anastomoses 
after fetoscopic laser surgery for TTTS was studied. Presence of residual 
anastomoses was investigated in relation to adverse outcome and to inter-
twin hemoglobin difference at birth. Residual anastomoses were detected 
in 33% (17/52) of placentas. Adverse outcome (fetal demise, neonatal 
death or severe cerebral injury) was similar in the groups with and without 
residual anastomoses, 18% (6/34) and 29% (20/70), respectively (p = 
0.23). Large inter-twin hemoglobin differences (> 5 g/dL) were found in 
65% (11/17) of cases with residual anastomoses and 20% (7/35) of cases 
without residual anastomoses (p < 0.01). The first conclusion of this study 
is that laser treatment needs to be improved as only 2/3 of monochorionic 
placentas are functionally “dichorionized”. The second conclusion is 
that residual anastomoses in this study are not associated with adverse 
outcome. Lack of association between residual anastomoses and adverse 
outcome may partly be due to the small size of most residual anastomoses 
(< 1mm diameter in 64% of the cases) and the presence of “protective” 
residual superficial anastomoses in 35% of the cases. Finally, we 
concluded that residual anastomoses are often associated with neonatal 
hematological complications. 
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In Chapter 6 we describe two pairs of monochorionic twins without TTTS 
but with marked discordant hemoglobin levels. We named this new form 
of TTTS, the twin anemia-polycythemia sequence (TAPS). In the two 
reported TAPS cases, both donor twins were severely anemic requiring 
blood transfusion and both recipients were polycythemic, one requiring 
partial volume exchange transfusions. Inter-twin difference in reticulocyte 
counts was extremely high, suggesting a chronic form of inter-twin blood 
transfusion. Placental injection studies revealed a preponderance of very 
small (< 1 mm) arterio-venous anastomoses in one direction. Nowadays, 
routine prenatal measurements of middle cerebral artery peak systolic 
velocity using Doppler ultrasound are recommended after laser surgery 
to rule out fetal anemia or (iatrogenic) TAPS. We suggest that routine 
Doppler studies also be performed in uncomplicated monochorionic twin 
pregnancies without TOPS. Signs of fetal anemia in a monochorionic twin 
should then alert the perinatologist of the possibility of TAPS. TAPS should 
be diagnosed when a large inter-twin discordance in fetal or neonatal 
hemoglobin levels and reticulocyte counts is found, in the absence of 
TOPS. Placental injection studies may then reveal a preponderance of very 
small arterio-venous anastomoses.
Discordant hemoglobin levels occur not only in chronic TTTS and in 
TAPS, but are also reported to occur in uncomplicated monochorionic 
pregnancies due to acute peripartum TTTS. In Chapter 7 we studied the 
inter-twin difference in hemoglobin levels at birth in monochorionic twins 
without TTTS compared to a control group of dichorionic twins, in relation 
to birth order and placental vascular anatomy. We found that hemoglobin 
differences occur more frequently in monochorionic twins without chronic 
TTTS than in dichorionic twins, but only when measured on the second 
day of life. Furthermore, hemoglobin differences in monochorionic 
twins are associated with birth order and with the presence of superficial 
vascular anastomoses. We found that second-born monochorionic twins 
have significantly higher hemoglobin values than first-born twins. Our 
findings support the hypothesis that second-born monochorionic twins 
are more likely to receive a large placental blood transfusion rather than 
lose blood into the placenta. We also report that hemoglobin differences 
in monochorionic twins are greater in the presence of superficial vascular 
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anastomoses. In analogy to acute perimortem TTTS, it is conceivable 
that superficial vascular anastomoses may also be responsible for rapid 
placento-fetal blood transfusion during delivery. 
Chapter 8, 9 and 10 focus on the short-term outcome in TTTS treated 
with fetoscopic laser surgery. The neonatal outcome in TTTS survivors 
treated with laser at our center is presented in Chapter 8. We compared 
the outcome in a TTTS group after laser treament with a control group of 
monochorionic twins without TTTS delivered at our center. We found that 
neonatal mortality in the TTTS and no-TTTS group was 8% (6/76) and 3% 
(3/90), respectively (p = 0.03). Overall, the incidence of adverse neonatal 
outcome (neonatal mortality, major neonatal morbidity or severe cerebral 
lesions) in the TTTS and no-TTTS group was 26% (20/76) and 13% 
(12/90), respectively (RR = 1.97, 95% CI = 1.03 to 3.77). We concluded 
that the risk for adverse neonatal outcome is two-fold increased in TTTS 
treated with laser than in monochorionic twins without TTTS. 
Details on the short-term neurological outcome in TTTS survivors 
treated with fetoscopic laser surgery are presented in Chapter 9. Again we 
compared the results with a control group of monochorionic twins without 
TTTS. Incidence of antenatally acquired severe cerebral lesions in the TTTS 
group was 10% (8/84) and 2% (2/108) in the no-TTTS group (p = 0.02). 
Incidence of severe cerebral lesions at discharge was 14% (12/84) in the 
TTTS group and 6% (6/108) in the no-TTTS group (p = 0.04). Antenatal 
injury was responsible for severe cerebral lesions in 67% (8/12) of the 
TTTS group. We conclude that the incidence of severe cerebral lesions in 
TTTS treated with fetoscopic laser surgery is high and results mainly from 
antenatal injury. 
Details on the short-term cardiac outcome in TTTS survivors treated with 
fetoscopic laser surgery are presented in Chapter 10 and compared to a 
control group of monochorionic twins without TTTS.  Echocardiography 
was performed within one week after delivery. At birth, blood pressure 
was measured in all survivors and endothelin-1 was determined in 
umbilical cord blood. Data on right ventricular outflow tract obstruction 
in TTTS treated with laser surgery at our center but delivered elsewhere 
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were reviewed retrospectively from medical records. We found that the 
incidence of right ventricular outflow tract obstruction in recipients was 4% 
(3/75). We found no difference in afterload parameters between donors 
and recipients after laser treatment. We concluded that the incidence of 
congenital heart disease in TTTS survivors treated with fetoscopic laser 
occlusion of vascular anastomoses is around 5%, which is higher than in 
the general population (0.5%). In particular, the increased risk of right 
ventricular outflow tract obstruction in recipient twins warrants close 
cardiac monitoring during fetal and neonatal life.
The long-term neurodevelopmental outcome in TTTS is presented in 
Chapter 11 and 12. Chapter 11 describes the long-term neurodevelopmental 
outcome in TTTS treated conservatively. All TTTS-cases admitted at 
our center between January 1990 and December 1998 were included 
in the study. Perinatal mortality was 50% (29/58). Neurological and 
mental development at school age was assessed during a home visit in all 
TTTS survivors (n = 29). The incidence of adverse neurodevelopmental 
outcome in TTTS survivors was 21% (6/29) and was due to cerebral 
palsy (n = 6) and developmental delay (n = 5). The incidence of adverse 
neurodevelopmental outcome in the group of survivors who were treated 
with amnioreduction was 26% (5/19). Two of the four children born after 
intrauterine fetal demise of their co-twin had cerebral palsy.
Chapter 12 describes the long-term neurodevelopmental outcome in TTTS 
treated with fetoscopic laser surgery. All TTTS-cases treated consecutively 
at our center between August 2000 and December 2003 were included in 
the study. Perinatal mortality was 30% (49/164). Neurological, mental 
and psychomotor development at 2 years of age was assessed in all 
TTTS survivors (n = 115). Overall, the incidence of neurodevelopmental 
impairment was 17% (19/115) and was due to cerebral palsy (n = 8), 
mental developmental delay (n = 9), psychomotor developmental delay 
(n = 12) and deafness (n = 1). In both long-term follow-up studies, we 
concluded that neurodevelopmental delay in TTTS, regardless of type of 
antenatal treatment, is high and warrants long-term follow-up. 
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In conclusion, although laser surgery appears to be the best available 
treatment option for TTTS, perinatal mortality and morbidity rates in TTTS 
treated with laser are still significant. More research and new developments 




Er zijn 2 soorten tweelingen: een-eiig en twee-eiig. Twee-eiige tweelingen 
komen vaker voor dan een-eiige tweelingen (65% versus 35%). Alle twee-
eiige tweelingen hebben ieder een eigen gescheiden placenta (dichoriaal). 
Dichoriale placenta’s bevatten vrijwel nooit vaatverbindingen, ook wel 
vaatanastomoses genoemd, die de bloedcirculatie van beide foetussen 
met elkaar verbindt. De meeste een-eiige tweelingen hebben daarentegen 
een zogenaamde gezamenlijke placenta (monochoriaal). Monochoriale 
placenta’s bevatten juist wel vrijwel altijd vaatanastomoses, waardoor 
de circulatie van beide foetussen met elkaar verbonden is. Ten gevolge 
van deze vaatanastomoses, kan in 15% van de monochoriale een-eiige 
tweelingen het tweeling-transfusie syndroom (TTS) ontstaan. Voor de 
Nederlandse situatie betekent dit dat er naar schatting jaarlijks ongeveer 
60 à 90 TTS zwangerschappen voorkomen. TTS ontstaat doorgaans in 
het 2e trimester van de zwangerschap. Het eerste symptoom is meestal 
het plotseling ontstaan van te veel vruchtwater (polyhydramnion) bij één 
van de foetussen. Het polyhydramnion ontstaat doordat de ene foetus 
(de recipiënt) via de vaatanastomoses teveel bloed ontvangt  van de 
andere foetus (de donor). De donor is dientengevolge ondervuld en heeft 
zeer weinig vruchtwater (oligohydramnion). Het polyhydramnion bij de 
recipiënt kan leiden tot een acute toename van de buikomvang van de 
zwangere en vervolgens tot vroegtijdige weeën en vroeggeboorte. Indien er 
dan geen actie ondernomen wordt, kan TTS leiden tot een schrikbarend 
hoge mortaliteit en morbiditeit (> 80%). 
Tot enkele jaren geleden was er in Nederland maar één behandeling 
mogelijk voor TTS, namelijk het herhaaldelijk aftappen van overtollig 
vruchtwater (amniondrainage), hetgeen primair bedoeld was om de 
klachten van de zwangere te reduceren en tegelijktertijd de kans op 
vroeggeboorte te verminderen. Deze behandeling heeft echter geen direct 
effect op TTS zelf, waardoor het ziekteproces onverminderd door kan gaan. 
Sinds Augustus 2000 wordt in het Leids Universitair Medisch Centrum een 
nieuwe therapie, foetoscopische laser coagulatie van de vaatanastomoses, 
toegepast. Deze techniek werd in de jaren ’90 in de Verenigde Staten 
uitgevonden. Hierbij worden door middel van een foetoscoop en laserlicht 
de vaatverbindingen op de placenta dicht gecoaguleerd. (De foetoscoop 
is een soort “kijkbuis” die via een kleine incisie in de buikwand in de 
baarmoeder wordt ingebracht.) Het effect van deze laser behandeling bij 
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kinderen met TTS was nog niet goed onderzocht.
Het primaire doel van dit proefschrift was het beschrijven van de korte en 
lange termijn gevolgen van deze laser behandeling voor de kinderen met 
TTS. Dit onderzoek , genaamd Leidse TTS study (LETTS’ study), ging in 
juni 2002 van start. Tijdens de loop van deze studie, werden ook andere 
studies naar TTS opgestart. Onder ander werd er een aantal studies 
verricht naar de oorzaak van TTS. Hiervoor werden de monochoriale 
placenta’s uitvoerig bestudeerd, hetgeen o.a. leidde tot de identificatie van 
een nieuwe, atypische vorm van TTS. 
Hoofdstuk 2 bevat een samenvatting van de literatuur en een opsomming 
van de vele nieuwe inzichten ten aanzien van de pathogenese, diagnostiek 
en behandeling van TTS. 
In Hoofdstuk 3 beschrijven wij een nieuwe techniek om de netto 
bloedstroom (flow) door placentaire vaatanastomoses te berekenen. 
Deze berekening is uitgevoerd aan de hand van een bijzondere met 
laser behandelde TTS casus. De ex-recipiënt in deze casus vertoonde 
na de laserbehandeling tekenen van bloedarmoede (anaemie), hetgeen 
een éénmalige intra-uteriene bloedtransfusie noodzakelijk maakte. Het 
placenta onderzoek na de geboorte liet zien dat er nog 5 arterio-veneuze 
rest-anastomoses aanwezig waren die van de ex-recipiënt naar de ex-
donor liepen. Gebruikmakend van de daling van het hemoglobine bij 
de ex-donor tussen het moment van de intrauteriene transfusie en het 
moment van geboorte, hebben we kunnen uitrekenen dat de flow door de 
rest-anastomoses ongeveer 28 ml/dag was. Deze berekeningen kunnen 
gebruikt worden om computer modellen te maken om TTS te simuleren 
en zodoende het inzicht te vergroten. Door de afwezigheid van adequate 
diermodellen, zijn deze computer modellen van groot belang voor verder 
onderzoek naar TTS.
In Hoofdstuk 4 hebben wij het verband onderzocht tussen de aanwezigheid 
van velamenteuze navelstreng inserties, een onevenredige (discordante) 
placenta verdeling en het ontstaan van TTS beschreven. Voorheen werd 
gesuggereerd dat er een directe relatie zou zijn tussen velamenteuze 
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navelstreng inserties, discordante placenta verdeling en TTS. In ons 
onderzoek hebben we een grote serie monochoriale placenta’s met en 
zonder TTS vergeleken. De incidentie van velamenteuze navelstreng 
inserties in de groep met en zonder TTS was respectievelijk 13% (20/152) 
en 14% (18/126) (p = 0.79). Het gemiddelde verschil in placenta oppervlak 
in de groep met en zonder TTS was identiek (20%). In de TTS groep hadden 
donor tweelingen vaker een velamenteuze navelstreng insertie dan de 
recipiënten (respectievelijk 24% en 3%, p < 0.001) en een kleiner placenta 
deel (respectievelijk 44% en 56%, p < 0.001). Onze bevindingen suggereren 
dat velamenteuze navelstreng inserties en discordante placenta verdeling 
geen directe oorzaak van TTS zijn.
In Hoofdstuk 5 hebben wij onderzocht hoe vaak er in TTS placenta’s die 
met laser behandeld waren, nog sprake was van rest-anastomoses. Tevens 
bekeken wij de klinische gevolgen van deze rest-anastomoses. Wij vonden 
in 33% (17/52) van de met laser behandelde placenta’s rest-anastomoses. 
De meeste rest-anastomoses (64%) waren extreem klein (diameter < 1 
mm). De aanwezigheid van rest-anastomoses was echter niet geassociëerd 
met een slechtere uitkomst (gedefiniëerd als intrauteriene of neonatale 
sterfte, of ernstige hersen (cerebrale) schade). Rest-anastomoses waren 
daarentegen wel duidelijk geassociëerd met grotere hemoglobine-
verschillen (> 5 g/dL) tussen de beide kinderen. Grote hemoglobine-
verschillen werden gedetecteerd in 65% (11/17) van de gevallen met 
rest-anastomoses vergeleken met 20% (7/35) van de gevallen zonder rest-
anastomoses (p < 0.01). Aldus hebben wij aangetoond dat 1/3 van de door 
ons met laser behandelde TTS placenta’s nog rest-anastomoses bevatten 
en dat deze rest-anastomoses vooral kunnen leiden tot hematologische 
complicaties. 
In Hoofdstuk 6 beschreven wij twee monochoriale tweeling-paren met een 
nieuwe, atypische vorm van chronische TTS, die wij tweeling anaemie-
polycythemie sequentie (TAPS) hebben genoemd. TAPS onderscheidt zich 
van de klassieke chronische TTS doordat er bij antenataal echografisch 
onderzoek geen typische tweeling oligo-polyhydramnion sequentie 
(TOPS) aanwezig is. Beide donoren waren bij de geboorte anaemisch 
en werden behandeld met een bloedtransfusie. De beide recipiënten 
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daarentegen waren polycythemisch, waarbij een van de recipiënten partiële 
wisseltransfusies nodig had. Het reticulocyten aantal bij de donoren 
was extreem hoog, hetgeen wees op een chronische vorm van TTS. 
Onderzoek van de placenta liet slechts enkele minuscule arterioveneuze 
vaatanastomoses zien. Recentelijk zijn er meer gevallen van TAPS (zonder 
TOPS) na laserbehandeling beschreven. Er wordt derhalve geadviseerd 
om na laserbehandeling vanwege TTS routinematig door middel van echo 
Doppler naar de aanwezigheid van foetale anaemie te kijken. Wij adviseren 
ook om Doppler onderzoek routinematig te gebruiken om TAPS uit te 
sluiten in ongecompliceerde monochoriale tweelingzwangerschappen. 
Daarnaast lijkt het raadzaam dat perinatologen in geval van onverwacht 
grote hemoglobine-verschillen post partum bij monochoriale tweelingen 
zonder TTS, ook het aantal reticulocyten bepalen en de placenta laten 
onderzoeken.
Hemoglobine-verschillen bij monochoriale tweelingen hoeven niet alleen 
door chronische TTS of TAPS veroorzaakt te worden, maar zouden ook 
kunnen ontstaan door een acute vorm van TTS die optreedt rondom de 
geboorte (peri-partum TTS). In Hoofdstuk 7 hebben wij de hemoglobine 
verschillen bij monochoriale tweelingen zonder TTS vergeleken met die 
van dichoriale tweelingen. Wij vonden vaak grote hemoglobine verschillen 
bij monochochoriale tweeling-paren, met name wanneer de bepaling op 
de 2e dag na de geboorte werd herhaald. Hemoglobine-verschillen waren 
vooral geassociëerd met de volgorde van geboorte en de aanwezigheid van 
oppervlakkige vaatanastomoses. Het kind dat als tweede was geboren, 
had vaker hogere hemoglobine waardes. Onze bevindingen passen bij de 
hypothese dat, na de geboorte van het eerste kind, er bij het tweede kind, 
via de oppervlakkige vaatanastomoses, een grotere placento-foetale bloed 
transfusie zou kunnen optreden.
Hoofdstuk 8, 9 en 10 bevatten studies naar de korte termijn uitkomsten na 
laser behandeling vanwege TTS.
In Hoofdstuk 8 hebben we gekeken naar de neonatale uitkomsten bij TTS 
tweelingen behandeld met laser, vergeleken met monochoriale tweelingen 
zonder TTS. Neonatale mortaliteit in de groep met TTS en zonder TTS 
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was 8% (6/76) en 3% (3/90). De incidentie van een slechte uitkomst 
(gedefiniëerd als neonatale sterfte of ernstige neonatale morbiditeit) was 
2 keer hoger in de groep met TTS vergeleken met de groep zonder TTS, 
namelijk respectievelijk 26% (20/76) en 13% (12/90) (p = 0.03). In het licht 
van deze bevindingen adviseren wij om TTS tweelingen na laser behandeling 
te beschouwen als een hoog-risico groep met een verhoogde kans op 
neonatale complicaties.  
In Hoofdstuk 9 wordt de incidentie, het karakter en de origine van cerebrale 
schade in TTS tweelingen na laser behandeling beschreven. Het in dit 
hoofdstuk beschreven onderzoek, werd verricht door middel van cerebrale 
echografie, waarbij het eerste echografische onderzoek binnen 24 uur 
na de geboorte plaats vond. Hierbij betrof de controle groep wederom 
monochoriale tweelingen zonder TTS. De incidentie van antenataal 
opgelopen ernstige cerebrale schade in de groep met en zonder TTS was 
respectievelijk 10% (8/84) en 2% (2/108) (p = 0.02). De incidentie van 
ernstige cerebrale schade bij ontslag in de groep met en zonder TTS was 
respectievelijk 14% (12/84) en 6% (6/108) (p = 0.04). Antenatale schade 
was derhalve verantwoordelijk voor 67% (8/12) van de ernstige cerebrale 
schade bij TTS tweelingen. Gezien de hoge incidentie van cerebrale schade 
adviseren wij om bij alle TTS tweelingen (zowel na laser behandeling, als 
zonder laser behandeling) post-partum echografisch onderzoek van de 
hersenen te laten verrichten.
In Hoofdstuk 10 zochten wij naar hart (cardiale) afwijkingen bij TTS 
tweelingen die behandeld waren met laser en vergeleken deze groep met een 
controle groep van monochoriale tweelingen zonder TTS. Dit onderzoek 
vond plaats door middel van cardiale echografie binnen 1 week na de 
geboorte. De incidentie van obstructie van de bloed flow door de rechter 
hartkamer was 4% (3/75). Over het geheel genomen was de incidentie van 
congenitale hart aandoeningen bij TTS tweelingen behandeld met laser 
veel hoger (rond de 5%) dan in de gewone bevolking (0.5%). Derhalve 
is alertheid geboden ten aanzien van de verhoogde kans op foetale en 
neonatale cardiale afwijkingen.
Hoofdstuk 11 en 12 bevatten studies over de lange termijn uitkomst bij TTS. 
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In Hoofdstuk 11 beschrijven wij een studie naar de lange termijn uitkomsten 
bij  TTS tweelingen na conservatieve behandeling. Alle kinderen met TTS 
geboren in het Leids Universitair Medisch Centrum tussen 1990 en 1998 
werden geïncludeerd in deze studie. De perinatale mortaliteit betrof 50% 
(29/58). Alle kinderen hadden inmiddels de school-leeftijd bereikt. De 
primaire uitkomstmaat was een abnormaal neurologisch onderzoek en/of 
achterstand in de geestelijke (mentale) ontwikkeling. De incidentie van een 
abnormale geestelijke en/of lichamelijke (psychomotore) ontwikkeling was 
21% (6/29). De incidentie van abnormale psychomotore ontwikkeling in de 
TTS groep die behandeld was met amniodrainage was 26% (5/19).  
In Hoofdstuk 12 beschrijven wij de lange termijn uitkomst bij TTS na laser 
behandeling. Alle kinderen met TTS die tussen 2000 en 2003 in het 
Leids Universitair Medisch Centrum met laser behandeld zijn, werden 
geïncludeerd in deze studie. De perinatale mortaliteit betrof 70% (49/164). 
De neurologische status en de psychomotorische ontwikkeling werden 
bepaald op de leeftijd van 2 jaar, gecorrigeerd voor de prematuriteit. 
Een abnormale psychomotore ontwikkeling werd gedefiniëerd als één of 
meerdere van de volgende factoren: spasticiteit, doofheid, blindheid of een 
mentale of motorische ontwikkelingsindex van onder de 70 (dat is meer 
dan 2 standdaarddeviaties verlaagd). De incidentie van een abnormale 
psychomotore ontwikkeling was 17% (19/115) en was gebaseerd op 
spasticiteit (n = 8), doofheid (n = 1), achterstand in mentale ontwikkeling 
(n = 9) en achterstand in motorische ontwikkeling (n = 12). In beide 
hoofdstukken concluderen wij dat kinderen met TTS langdurige follow-up 
behoeven, gezien de hoge kans op spasticiteit en ontwikkelingsachterstand. 
Samenvattend kunnen we stellen dat hoewel laser behandeling de beste 
beschikbare therapeutische optie voor TTS is, de perinatale morbiditeit 
en mortaliteit nog steeds aanzienlijk blijft. Om de korte en lange termijn 
prognose voor TTS zwangerschappen verder te verbeteren, is voortgaand 
onderzoek derhalve noodzakelijk. 
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ASD  Atrial septal defect
BSID  Bayley Scales of Infant Development
CHD  Congenital heart disease
CP  Cerebral palsy
DC  Dichorionic
Hb  Hemoglobin
IUFD  Intrauterine fetal demise
IVH  Intraventricular hemorrhage
LUMC  Leiden University Medical Center
MC   Monochorionic
MCA-PSV Middle cerebral artery peak systolic velocity
MDI  Mental development index
NDI  Neurodevelopmental impairment
NND  Neonatal death
PDI  Psychomotor developmental index
PVL  Periventricular leucomalacia
RA  Residual anastomoses
RVOTO Right ventricular outflow tract obstruction
TAPS  Twin anemia-polycythemia sequence
TOPS  Twin oligo-polyhydramnios sequence 
TTTS  Twin-to-twin transfusion syndrome
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